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Introduction 1
1 Introduction
1.1 Wet granulation
Wet granulation is a well-established and widely used technique in industries
processing food, chemicals, detergents, fertilisers and pharmaceuticals. More than
70% of the global industry’s granulations are made using wet granulation (Ennis,
1997). Wet granulation of powders refers to the process whereby aggregates with
sizes ranging from about 0.1 to 2.0 mm are produced and can be defined as a process
whereby particles are agglomerated into larger semi-permanent aggregates, in which
the original particles can still be identified. These granules are formed by spraying a
liquid binder onto the particles while they are agitated in a tumbling drum, fluid bed,
high shear mixer or similar device (Ennis and Litster, 1997; Kristensen and Schaefer,
1987).
Addition of the proper amount of liquid wets the solid surfaces and generates the
necessary binding forces by the formation of liquid bridges or by a combination of
capillary pressure, surface tension and viscous forces, until more permanent bonds are
formed during subsequent drying or sintering.
Granulation has many advantages like the improvement of flow, the reduction of
segregation and dust and the enhancement of compressibility. Besides it ensures the
production of products with a consistent quality.
On the other hand improper granulation causes problems such as caking, segregation
and poor tableting properties in the down-stream processes. Therefore, wet
granulation is considered to be one of the most critical unit operations in the
manufacturing of solid dosage forms such as granules, pellets and tablets.
Granulation is a very complicated process and difficult to master due to the numerous
and sometimes unknown factors that can affect the process and hence the product
properties. Therefore, almost everything associated with the wet granulation process
such as material properties, equipment, batch size, amount of binder solution and
processing time must be controlled if one is to have a reproducible product and to
ensure the production of granules with desired properties. However, in order to
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elucidate the importance of these parameters granulation growth, liquid saturation,
binder addition and wet granulation equipment will be discussed.
1.2 Granule growth
The growth process begins as soon as liquid is added to the agitated powder mass and
may continue after the liquid addition step has been completed. The growth of
granules, which occurs during liquid addition and kneading, has been divided into
three stages, as shown in figure 1:
a Nucleation of particles.
b Coalescence between colliding agglomerates.
c Layering of smaller particles onto established agglomerates.
         a.
                  Liquid       Solid
        b.
                                   +
        c.
                        +
Figure 1: Mechanism of wet granulation: a. nucleation, b. coalescence, c. layering.
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Whenever a powder is mixed with a liquid, the liquid wets the particle surface and the
system tends to reduce its surface free energy by forming liquid bridges between the
particles. If the strength of the liquid bridges is sufficient to withstand the separating
forces caused by agitation, the particles stick together in the form of a loose
agglomerate called nucleus.
Agglomeration of the powder may proceed by further nucleation and by coalescence
or layering depending on the particle size and size distribution of the material.
The sticking of two large granules is referred to as coalescence, whereas the sticking
of the fine materials onto the surface of large pre-existing granules is often termed
layering. Coalescence will be the dominant growth mechanism if the agglomerates
possess a high agglomerate strength (Tardos et al., 1997).
Growth by coalescence continues until a critical agglomerate size has been reached
(Ennis et al., 1991). This critical size is higher when the viscosity of the binder is high
and for powders with a smaller particle size. Agitation gradually consolidates the
formed agglomerates by increasing their liquid pore consolidation as they collide with
each other and with the surface of the granulator.
Agglomeration can only resist deformation and breakage below the critical
agglomerate size, which depends on the external applied energy and the agglomerate
strength (Tardos et al., 1997). If the agglomerates are too weak to resist the impact
and shear forces in the mixer, agglomerate breakage will occur simultaneously with
growth by coalescence (Knight et al., 1998; Eliason et al., 1998, 1999). As a result,
particles and small fragments formed by breakage might participate in growth by
layering as the smaller fragments are layered on the surface of surviving agglomerates
(Linkson et al., 1973). At this stage the granulation process will operate in a balance
between agglomerate growth and degradation.
Although a qualitative understanding of the mechanisms of granule growth and the
effect of different variables on granule growth behaviour are available, it is still
difficult to predict the granulation behaviour of a new formulation from only its
fundamental properties. This necessitates extensive experimental studies for new
materials and formulations.
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1.2.1 Liquid saturation
Liquid saturation of the agglomerates during wet granulation is an essential parameter
controlling granule growth. Liquid saturation (S) is the degree of intergranular voids
filled with liquid phase and is controlled by the liquid content and intergranular
porosity. It is determined from the intergranular porosity ∈, particle density ρ and the
moisture content H of the granules on dry basis.
                                    S = {H (1 - ∈)/∈}*ρ                                    (equation 1)
It is well known that amount of the liquid required for the production of satisfactory
granules depends on a large number of factors, which include powder properties,
liquid characteristics and the granulation technique used. Powder properties such as
particle size distribution, particle shape, solubility and ability to absorb liquid play a
significant role in respect to the amount of liquid required and agglomerate growth.
Particles having a mean particle size below 10 µm are usually difficult to
agglomerate, because their cohesiveness yields agglomerates of high strength
(Kristensen et al., 1985a; Schaefer, 1996b) having a reduced deformability. Therefore
more binder liquid is required in order to render the agglomerates sufficiently
deformable for agglomerate growth by coalescence. This increases the risk of
overwetting and uncontrollable agglomerate growth. On the other hand, the
agglomeration of large powder particles is also difficult. Breakage will often dominate
and no agglomeration occurs because of low agglomerate strength (Newitt and
Conway-Jones, 1958). However, a comprehensive knowledge of the properties of the
materials to be granulated can help in predicting the amount of the granulation liquid
required and the process conditions in order to conduct a successful wet granulation.
An increase in the solubility of the solids corresponds to a decrease in the amount of
liquid required (Lustig-Gustafsson et al., 1999).
Liquid characteristics include viscosity, surface tension and its ability to fill the void
spaces of the powder (Hancock et al., 1994). However, if the amount of water could
be predicted before granulation trials this would offer many advantages during
development and scaling-up of the granulation process. In this context, Schaefer and
Worts (1978) and Watano et al. (1991) reported that at steady state moisture content a
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correlation exist between the particle size and the moisture content, hence a suitable
moisture content for formulations could be determined.
Newitt and Conway-Jones (1958) described the different states of liquid saturation
representing the stages of liquid distribution in a bed of solid particles (Fig. 2).
        a.                                                                         b.
        c.                                                                         d
Figure 2: Different stages of liquid saturation during granulation: (a) pendular state,
                (b) funicular state, (c) capillary state and (d) droplet state.
In the pendular state (where the relative amount of the liquid phase in the wet
agglomerates is about 25%) the individual particles create liquid bridges between
them by holding the liquid at the points of contact, the contributing forces are surface
tension and negative suction pressure due to the curvature of the liquid. As soon as the
liquid bridges that can be created are formed, the agglomerates reach an average
critical size.
By continuous addition of the granulation liquid the interparticle pore volume is filled
and the wet particles reach the funicular state (the relative amount of liquid phase in
wet agglomerates is 25 to 80%). When the interparticle pores are entirely filled by the
liquid, the agglomerates are saturated and the mixture reaches the capillary state (the
relative amount of liquid phase in the wet agglomerate is > 80%). Then the liquid will
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be used to create liquid bridges between agglomerates, filling the new spaces created
between agglomerates. Once these new pores are completely filled the state of liquid
dispersion is reached. In this stage the liquid surrounds the solid particles.
1.2.2 Incorporation of binders
In wet granulation the role of binders is to promote size enlargement. The presence of
a binder will determine the physical properties of granules as well as their
consolidation and compaction behaviour. Consolidation of moist agglomerates is a
basic mechanism involved in granule growth. This effect is largely determined by the
type of binder (Krycer et al., 1983), the binder concentration and the method of
incorporation (Rue et al., 1980; Reading and Spring, 1984). The growth of
agglomerates is affected by binder viscosity as the agglomerate formation and growth
depend on the distribution of the liquid binder, which is facilitated by a low binder
viscosity. The subsequent growth by coalescence is promoted by a high binder
viscosity (Ennis et al., 1991; Schaefer and Mathiesen, 1996 b), but it could result in
uncontrolled agglomerate growth. A high viscosity could also result in an
inhomogeneous binder distribution and hence in weak granules due to insufficient
bonding. On the other hand a high binder viscosity can act as a lubricant, reducing the
power consumption during granulation. Therefore, the selection of a suitable binder
and the optimisation of its concentration are important in order to achieve a successful
granulation.
The minimum binder viscosity required to form granules increases with the particle
size of the solid material (Keningley et al., 1997), as a lower binder viscosity and a
large particle size will decrease the agglomerate strength (Keningley et al., 1997) and
produce more fines (Ormos et al., 1973; Ragnarson and Sjoren, 1982).
1.3 Effect of granule quality on the tablet properties
As granulation is mostly intended for the preparation of tablets the compaction
process as well as the properties of tablets depend on granule characteristics such as
porosity, friability, pore size distribution, size distribution and density.
Porosity controls the strength of the granules. Highly porous granules are weak and
friable and could break during handling generating dust, which is undesirable in most
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cases. On the other hand it is desirable to produce porous granules, since it will
facilitate compaction as the fragmentation of granules during compression is related to
granule porosity before compression (Wikberg and Alderborn, 1991). Granules with
higher porosity have a higher fragmentation propensity and result in stronger tablets.
Relatively dense and compact granules require a lot of mechanical force in order to be
compressed into tablets. A low bulk density of the granules resulted in an increase in
the compactability of the granule bed during compression (Zuurman et al., 1994).
Strong granules (i.e. low friability) are advantageous for subsequent steps in the
production process (such as final mixing and transport) because friable granules have
a detrimental effect on flow and can cause demixing. Therefore, a granule friability
below 50% (Inghelbrecht and Remon, 1998) is important for handling and subsequent
processing (mixing and feeding into the hopper) during tablet production.
Granule size can also affect the compaction properties of the granules. Stronger
tablets were obtained with a decreasing size of the granules (Wells and Walker, 1983;
Wikberg and Alderborn, 1990). Because coarse granules possess a smaller surface
area less lubricant will be required to obtain smooth compaction. On the contrary
smaller granules could result in sticking problems during compression due to
insufficient lubrication. In addition, too many fines in the granules can result in tablet
capping.
The granule properties not only affect tablet strength, but also the disintegration and
dissolution, an increase of granule size and granule density could result in a slower
tablet dissolution.
1.4 Common types of wet granulation techniques
It is known that granule properties are not only determined by the formulation
variables (amount of granulation liquid, type and concentration of the binder), but also
by the process parameters during granulation and the granulation technique.
Wet granulation offers a wide range of techniques for granule formation, from the
production of porous granules to the production of dense agglomerates depending on
the type of granulator used. Several types of wet granulators are available, each
granulation process resulting in different granule characteristics. The wet granulators
can be classified as following:
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• Low shear granulators (planetary mixer granulators, cone mixer
granulators and Z- blade mixer granulators).
• High shear granulators (horizontal mixer/granulator, vertical
mixer/granulator).
• Fluid bed granulators (top spray fluid bed, rotor fluid bed).
In the pharmaceutical industry the two most frequently used wet granulation
techniques are high shear granulation and fluid bed granulation.
1.4.1 High shear granulation
High shear granulation is characterised by the fact that mixing of the powder and
granulation takes place in the same apparatus. This type of granulator is equipped
with an impeller rotating at a moderately high speed (100 to 500 rpm) and a chopper
rotating at higher speed. Mixing, agglomeration and densification of wetted materials
are achieved through shearing and compaction forces exerted by the main impeller.
The binding liquid can be poured, pumped or spray atomised onto the powder. High
shear granulation has some major advantages such as the fact that a broad range of
powders (in both particle size and bulk density) can be processed, a significant
increase in the bulk density of granules over that of the starting materials and a short
process time for both mixing and granulation. The main disadvantages of high shear
granulation are: the significant increase in the bulk density of the granules, an
uncontrolled growth of the granules and the different handling steps between the unit
operations. However, in recent years, high shear granulators have been introduced that
allow wet granules to be dried inside the granulation bowl by either gas stripping or
microwave drying.
1.4.2 Fluid bed granulation
Fluid beds are commonly used granulators in pharmaceutical industry, which produce
porous granules. It was first described by Wurster in 1959. The major advantages of
fluid bed granulation are that granule growth can be controlled, a low batch-to-batch
variation and no product handling is required since mixing, granulation and drying
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can take place in the same machine. In addition it is also used for coating and
pelletisation.
The principle of fluid bed granulation is drawing air through a conical shaped
container by a ventilator, which is set to move the particles up in the central part of
the expansion chamber and down again at the walls. The fluidising air is heated to a
temperature typically ranging from 40 to 80°C. The binding solution is added by
spraying.
Due to the lack of shear forces in the fluid bed, many powders have to be delumped
by sieving before loading into the machine.
Granulation in fluid bed takes place in a well controlled manner and results in
granules with a moderate bulk density, which are suitable for compression into
tablets. However, the process is not suitable for granulation of coarse materials,
cohesive materials and voluminous powders.
Fluid bed granulation is described as a complex process which is influenced by
several process parameters (Rambali et al., 2003). Acceptable results are not always
obtained (Rambali et al., 2001) because the granule size depends on fundamental
properties such as droplet size of the binder solution sprayed onto the powder and
powder bed moisture content (Rambali et al., 2001; Schaefer and Worts, 1978;
Watano et al., 1996 a, b, c), but it remains a suitable process to prepare granules for
tabletting, because the lack of any shear forces during granulation results in low
strength, porous granules (Sunada et al., 1998).
1.5 Extrusion
1.5.1 Introduction
Extrusion is another possible way of producing granules. It involves a process of
forcing a material through an orifice by means of pressure. Materials can be extruded
in the solid state using a liquid which acts as a plasticiser or in the molten state using a
heated extrusion barrel (melt extrusion). The extruded product is referred to as
extrudate (Morton-Jones, 1989; Rauwendal, 1994).
Rauwendal (1994) classified extruders, depending on their mode of operation, into
two main groups: continuous and discontinuous (batch type) extruders as shown in
figure 3. Discontinuous extruders operate in a cyclic way and have a reciprocating
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member to transport the material, whereas continuous extruders are capable of
developing a steady continuous flow of materials utilising a rotating member to
transport the materials. The continuous extruders can further be subdivided into disk
extruders, drum extruders and screw extruders. The screw extruders are also
classified, based on the number of screws incorporated, into single, twin and multi-
screw extruders. Twin screw extruders are further classified into co-rotating and
counter-rotating types.
       Discontinuous                                                             Continuous
  Ram                     Reciprocating                                                                 Drum
                                    Screw                                                 Disk
                                                                 Screw
 Single screw                                                                                        Multi screw
                                                              Twin screw
                Co-rotating                                                                       Counter rotating
        Intermeshing              Non-                                Intermeshing                 Non-
                                         intermeshing                                                       intermeshing
Figure 3: Classification of the extruders
Although the extrusion technique is widely used in the pharmaceutical industry for the
production of pellets, few research work has been done in order to use extrusion for
the production of granules (extrusion/granulation) (Gamlen and Eardley, 1986;
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Lindberg et al., 1987; Lindberg, 1988a, b). Although granulation using single screw
extruders has been reported (Goodheart et al., 1973), the majority of extrusion
granulation studies were carried out using twin screw extruders. Gamlen and Eardley
(1986) reported on the production of paracetamol extrudates using twin screw
extrusion and stated that the short time from wetting to extrusion was the most
significant advantage of this process. Lindberg et al. (1988a) found that screw speed
and powder feed rate were the significant factors influencing the mean residence time.
Kleinebudde and Lindner (1993) stated that the water content of extrudate has an
important influence on the extrusion parameters. As a co-rotating twin screw extruder
is used in this research project it will be further described.
1.5.2 Twin screw extruder
The extruder used during this study is an intermeshing co-rotating twin screw extruder
type MP19 TC-25 (APV Baker, Newcastle-under-Lyme, UK) with a length to
diameter ratio of 25/1. As illustrated in figure 4 the extruder is composed of a barrel, a
control panel and a driving unit. It is also equipped with a Brabender twin screw
powder feeder, a Technodrives DC motor, a Tricool cooling system and a peristaltic
pump (for introducing the granulation liquid).
Figure 4: Schematic diagram of a twin screw extruder with a) feeding hopper, b)
barrel, c) die block, d) die, e) control panel, f) driving unit, g) screws.
The control panel is used for setting the screw speed, the barrel temperature and the
powder feed rate. Processing parameters such as die pressure, actual barrel
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temperature and power consumption are recorded during the process and shown on
the control panel. The extruder barrel is divided into five zones of which the
temperature can be set individually.
The screws used in this study had a standard design composed of seven zones as
shown in figure 5. These zones are: a conveying zone, a transition zone, a first mixing
zone, a second conveying zone, a second mixing zone, a third conveying zone, a feed
zone towards the die. The function of these zones is described below:
Zone 1: conveying zone
This zone is composed of conveying elements and functions to receive the powder
and transport it forward. It also mixes and smoothens out any instability in the powder
feed rate.
Figure 5: The design of the co-rotating twin screw (MP 19 TC-25).
Zone 2: transition zone
This zone is composed of conveying elements. The granulation liquid is added at this
zone. It also mixes the powder with the granulation liquid and conveys the wet mass
to the next zone.
Zone 3: first mixing zone or agglomeration zone
This zone is composed of 10 mixing paddles (3 mm thick) fixed perpendicularly to
the screw axis. These paddles compress the wet mass and enhance mixing,
agglomeration and densification. Another function of this zone is the homogenisation
of powder and binding liquid.
zone 1 zone 2 zone 3 zone 4 zone 5 zone 6 zone 7
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Zone 4: second conveying zone
This zone is composed of conveying elements. It mixes and breaks down the
agglomerates formed in the first agglomeration zone and conveys the agglomerated
material to the next zone.
Zone 5: second mixing zone or agglomeration zone
This zone is composed of 6 mixing paddles. At this zone further agglomeration and
densification of the material takes place.
Zone 6: third conveying zone
This zone is composed of conveying elements. It breaks down the agglomerates
formed in the second agglomeration zone and conveys the agglomerated material to
the next zone.
Zone 7: feed zone towards the die
This zone is composed of densification element. Because of the structure of this zone
accumulation of agglomerates occurs, resulting in an increased pressure.
1.5.3 Extrusion/granulation parameters
It is known that agglomeration is caused by the complex interaction of several
processing and formulation variables. The knowledge of the influence of each
variable is essential for controlling the process as well as for obtaining the desired
granule properties. During continuous granulation controlling those parameters is
even more critical since the granulation process is run over a long period and a
constant granule quality is required at all times.
During extrusion/granulation using a twin screw extruder, the following process
parameters and formulation variables influence the granulation process and the
resulting granules:
• Screw speed
• Total feed rate (powder and liquid feed rate)
• Screw design
• Barrel temperature
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• Water concentration
• Binder type, concentration and way of addition
1.6 Continuous wet granulation
Although in pharmaceutical manufacturing several individual operations are carried
out in a continuous way (e. g. milling, tabletting and packaging) the production of
granules is still, to a large extent, a batch-wise process. This production method
provides an advantage towards quality assurance as the batch can be accepted or
rejected. However, the increasing demand of pharmaceutical solid dosage forms
necessitates the production of larger volumes of granules, requiring larger equipment.
Hence it demands more capital investment, companies have to dedicate more
resources to it (personnel and space) and it complicates the scale-up process
(Leuenberger, 2001). Therefore, continuous granulation becomes an interesting
process to the pharmaceutical industry because the same equipment can process
smaller as well as large quantities by just extending the process time, thus eliminating
any scale-up issues.
Continuous granulation involves the use of a suitable device to continuously mix, wet
mass and discharge the ingredients of a pharmaceutical formulation to produce
granules suitable for drying and subsequent handling (Lindberg, 1988b). In the recent
years there is a growing interest in the pharmaceutical industry for continuous wet
granulation as an alternative approach for batch-wise processing. The rationale behind
this interest are the advantages offered by continuous granulation (Lindberg, 1988b;
Leuenberger, 2001):
1 High production capacity
2 Reduction of cost and labour
3 Saving on space and time
4 Ease of automation
5 Avoiding scale up problems
6 Flexibility of batch size
7 Minimal wastage and less product at risk
However, some disadvantages of continuous granulation were also reported
(Lindberg, 1988b; Leuenberger, 2001):
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1 Limited applicability of continuous granulation within the
pharmaceutical industry as the pharmaceutical plant typically
manufactures numerous products at a small volume, whereas
continuous production is best suited for production of a single high-
volume product
2 The process is not suitable to process substances sensitive to heat or
moisture
3 Moisture content (hence quality) of the granules depends on the
accuracy of the powder and liquid dosing system
4 The absence of a batch size, even though batches during continuous
processing have been defined by the amount of material produced
within a working shift or within a period of 24 hours
5 Formulations containing several low-dosed components require a pre-
blending stage
6 Viscous granulation solutions are difficult to pump
7 Powders with poor flow properties can not be dispensed accurately by
the feeder
8 After starting the process it takes some time to achieve equilibration
conditions
As all conventional machines for wet granulation (high shear and fluidised bed
granulation) can only be operated in a batch-wise manner, several attempts have been
made to develop continuous wet granulation techniques.
Bonde (1998) classified the existing continuous granulators into two groups:
continuous fluid bed granulators and continuous mechanical granulators. Although
roller compaction can be considered as a continuous mechanical dry granulation
process this technique will not be discussed as the topic of this project is wet
granulation.
Research was conducted on the fluid bed granulator in order to run it in a continuous
manner. A continuously operating single cell fluid bed granulator was described by
Hajdu et al. (1984), which simultaneously mixed, agglomerated and dried. However,
the differences in process conditions required for each granulation experiment make it
complicated and difficult to achieve. A multi-cell fluid bed granulator was developed
to overcome the problems associated with the single cell fluid bed granulator. It
comprises of a horizontal processing chamber divided into a number of segments by
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means of doors which can be opened or closed according to the current stage of the
granulation process. Unfortunately, these machines were not accepted in the
pharmaceutical industry due to their complexity and the poor co-ordination between
mixing, agglomeration and drying. In the past years some, more acceptable,
continuous fluid bed techniques (Contipharm from Niro/Aeromatic-fielder and
Continuous Fluid Bed Granulator from Glatt) were developed to avoid the problems
associated with the above mentioned multi-cell fluid bed granulator. Research work
conducted on these machines showed a random mixing and transport of materials
within the product chamber (Gotthardt et al., 1999).
The quasi-continuous production which combines a high shear granulator and the
multicell fluid bed dryer is another attempt to achieve a continuous wet granulation
(Leuenberger, 2001). This technique is based on semi-continuous production of small
batches (mini-batches) per unit time, as a consequence the amount of material
processed could be varied. This technique has the advantage of avoiding scale-up,
which can be conducted by extending the production time. The batch size is no longer
determined by the machine size, but by the working time or the number of mini-
batches produced. Granulation carried out using this technique showed a good
reproducibility between the mini-batches produced in terms of granule and tablet
properties, however the process appeared slightly complicated as an exact co-
ordination between the granulator and drying units is required. Nevertheless, this
machine found some acceptance in the pharmaceutical industry (Leuenberger, 2001).
Within the continuous mechanical granulators two techniques are discussed: turbine
mixer granulation and extrusion/granulation. The turbine mixer granulator was
described by Bonde (1998) and Lindberg (1988a). It contains a high-speed turbine
used to disperse the powder and break up the granulation liquid into small droplets,
forming agglomerates during the very short residence time in the granulation
chamber. This granulator is characterised by a very high production capacity.
Research work on the use of extrusion for continuous wet granulation of
pharmaceuticals is very sparse. Gamlen and Eardley (1986) used a Baker-Perkins MP
50 twin screw extruder for the extrusion of a paracetamol formulation at a high drug
load. Although these formulations were satisfactorily granulated during the short
residence time in the extrusion barrel, this process revealed serious problems like die
blocking and material sticking. Lindberg et al. (1987) and Lindberg (1988b) evaluated
continuous wet granulation of an effervescent mixture using the Baker-Perkins MPF
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50D twin screw extruder and reported similar problems as Gamlen and Eardley
(1986). However, no data describing the properties of the granules produced by
extrusion/granulation have been reported.
Schroeder and Steffens (2002) described a continuous wet granulation system using a
modified planetary roller extruder in combination with gas injection to adjust the
porosity and to improve the tabletting properties.
Recently Ghebre-Sellassie et al. (2002) presented a twin screw granulator/chopper as
a continuous wet granulator/dryer system. This system is composed of a twin screw
granulator/chopper to agglomerate the powder, at the outlet of the extruder a belt
conveyer continuously transports the wet granules to a microwave dryer and finally
the granules to a size reduction mill.
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2 Objectives
In recent years there is a clear trend within the pharmaceutical industry towards
increasing the production scale, fast running processes and increasing GMP and
validation requirements. As granulation is an essential unit-operation during the
manufacturing of pharmaceuticals, these factors have stressed the need to develop a
granulation process which has as few steps as possible and is able to work
continuously without the need for expensive and time consuming scale-up trials. As
granulation using an extruder offers these possibilities, the overall aim was to develop
a wet granulation process using extrusion that complies with the needs of the
pharmaceutical industry to reduce development time and costs as well as to minimize
the scaling-up efforts.
The first part evaluates an extrusion/granulation process using twin screw extrusion in
combination with a wet sizing step. It includes the evaluation and optimisation of
process parameters and formulation variables (placebo formulations containing
lactose as well as formulations containing high drug dose) by assessing the process
efficacy based on the granule and tablet properties obtained.
The second part of the study deals with the development of a fully continuous
granulation technique using a modified twin screw extruder and also evaluates the
influence of processing and formulation variables on granule and tablet quality (for
placebo and drug formulations). An essential step is also to determine if the process
can be run continuously and to quantify the capacity of this technique.
The third part of the study assesses the feasibility of performing a continuous single
step granulation/tabletting process using cold extrusion and evaluates the parameters
influencing tablet quality. This part also describes the bonding mechanism between
particles in tablets prepared by this technique.
The final part describes the influence of storage conditions (relative humidity and
temperature) on the stability of tablets produced by the different techniques developed
in the previous chapters.
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3 Continuous twin screw extrusion for the wet granulation of
lactose
Published in Int. J. Pharm., 239 (2002), 69-80.
3.1 Introduction
In the field of solid dosage forms wet granulation is still frequently used during tablet
production. Over the past decades, several batch-wise wet granulation techniques,
such as high shear and fluid bed granulation, have been developed and extensively
studied. As continuous processing offers significant advantages over batch production
(automation and a reduction of batch-to-batch variation, labor cost and processing
time), several types of equipment allowing continuous wet granulation have been
developed, the main types being continuously operating mixer granulators and fluid
bed granulators (Bonde, 1998). In addition some reports indicated the potential of
twin screw extrusion as a continuous wet granulation technique. Gamlen and Eardley
(1986) studied the influence of formulation parameters on the quality of paracetamol
extrudates. These authors stated that, despite the high incidence of extrudate surface
defects, the extrusion technique was suitable for the granulation of paracetamol. Other
researchers (Lindberg et al., 1987, 1988; Lindberg, 1988) showed that wet granulation
via extrusion yielded granules with desired properties and that those properties were
influenced by formulation and process variables. Kleinebudde and Lindner (1993)
studied the twin-screw extrusion/granulation process using lactose/microcrystalline
cellulose, but did not evaluate granule characteristics. The purpose of the present
work was to study the influence of the formulation variables and process parameters
on the production of α-lactose monohydrate granules using continuous twin screw
extrusion and to compare this technique with high shear granulation, a well
established wet granulation technique in the pharmaceutical industry.
3.2 Materials
α-Lactose monohydrate 200M was obtained from DMV (Veghel, The Netherlands)
and polyvinylpyrrolidone (PVP, Kollidon K30) was received from BASF
(Ludwigshafen, Germany).
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3.3 Preparation of extrudates and granules
The extrusion was performed on a MP 19 TC 25 laboratory scale co-rotating twin
screw extruder (APV Baker, Newcastle-under-Lyme, UK) having a length-to-
diameter ratio of 25/1 and equipped with a standard screw profile with two mixing
sections (Fig. 1). The die block (2.6 cm thick) was directly mounted at the outlet of
the extruder barrel. It is designed to fit the screw ends and then the aperture gradually
changes into an oval shape of 2.2 by 1.0 cm (Fig. 2). No additional screen was
attached to the die block because this screen would block since low water
concentrations were used during granulation.
Figure 1: Co-rotating standard screw profile: feeding zone (1), transition zone (2),
mixing zone (3), transport zone (4), mixing zone (5), transport zone (6)
and feed zone towards the die (7).
            a                                                      b
Figure 2a: Inside of the die block mounted to the extruder barrel with aperture shape
to fit the screws ends.
b: Outside of the die block with oval die.
zone 1 zone 2 zone 3 zone 4 zone 5 zone 6 zone 7
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During extrusion the powder volume in the feed hopper was maintained at a constant
level (85 – 100% of the total feeder capacity). Extrudates were prepared via wet and
dry binder addition. The granulation liquid (pure water or an aqueous PVP solution)
was pumped into the first zone of the extruder barrel by means of a peristaltic pump
(Watson Marlow, Cornwall, UK). Powder and granulation liquid feed rates were
determined prior to each experiment by repeatedly weighing the powder and the
liquid amount delivered over a period of 5 min. In case of dry binder addition, PVP
and α-lactose monohydrate were previously blended for 15 min at 60 rpm in a
planetary mixer (Kenwood Major, Hampshire, UK).
The barrel temperature of the extruder was set at 25°C. Extrudates were collected 10
min after the process was started in order to allow the system to equilibrate.
Immediately after extrusion the extrudates (400 g) were wet sized using a 1 mm
oscillating sieve (Frewitt, Fribourg, Switzerland), operated at a minimal distance
between rotor and sieve. The granules were oven-dried at 25°C for 20 h, sieved
through a 1400 µm sieve and evaluated for yield, granule friability, compressibility
and porosity.
Based on preliminary experiments using pure α-lactose monohydrate and water (as a
granulation liquid) a set of reference conditions for the extrusion process was
selected: a screw speed of 250 rpm, a total input rate of 5.6 kg.h-1 and a water
concentration during extrusion of 7.5% (w/w).
These settings were used to evaluate the between day reproducibility (n=6) of the
extrusion process of a formulation without PVP as well as of a mixture formulated
with 2.5% PVP (wet addition). To evaluate the dissolution properties,
hydrochlorothiazide (10%) (Ludeco, Brussels, Belgium) was added as a model drug to
the formulation with and without 2.5% PVP (wet addition) and prepared at reference
conditions. All water concentrations were based on the wet extruded mass, while PVP
and hydrochlorothiazide concentrations were based on dry weight.
Fig. 3 shows an overview of the experiments performed to examine the influence of
water concentration, PVP concentration and method of PVP addition (Fig. 3a) and to
evaluate the influence of screw speed and total input rate (the total amount of powder
and the granulation liquid fed during one hour) (Fig. 3b).
During high shear granulation, α-lactose monohydrate at a load of 0.16 kg.l-1 was
granulated without and with 2.5% PVP (wet addition) in a Gral 10 (Machines
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Collette, Wommelgem, Belgium). Granulation was performed at different water
concentrations (7.5, 10.0 and 12.5%) and impeller speeds (400, 500 and 600 rpm),
while the chopper speed was kept constant at 3000 rpm. After a 2 min mixing period
of the powder, the required amount of granulation liquid (water or an aqueous PVP
solution) was continuously added over a period of 10 min using a peristaltic pump
(Watson Marlow, Cornwall, UK). Wet massing was continued for 2 min following
complete liquid addition. Preliminary studies on the high shear granulation showed no
differences in the granule properties between granules wet sieved using an oscillating
sieve and those sieved after drying. The granules prepared by high shear granulation
were dried, sieved through 1400 µm sieve to remove any lumps and evaluated as
described for those prepared using extrusion.
3.3.1 Compression of tablets
The granules (250-710 µm) were blended with 0.5% (w/w) magnesium stearate (<90
µm) (BUFA, Brussels, Belgium) in a Turbula mixer (W.A. Bachofen, Basel,
Switzerland) for 1 min. Tablets (250 mg) were prepared using an eccentric
compression machine (Korsch EKO, Berlin, Germany) equipped with a flat faced
double punch of 9 mm at a compression force of 10 kN per tablet.
3.3.2 Granule evaluation
3.3.2.1 Particle size analysis
The particle size distribution of the granules (F < 1400µm) was determined using laser
diffraction (Master Sizer, Malvern, UK) after suspending the particles in air. The
volume diameter (dv) was used to calculate the following fractions F < 250 µm, F 250 - 1000
µm and F >1000 µm. The analysis was performed at minimal air pressure (0.4 bar) to
avoid disagglomeration and/or disintegration of the granules during the test.
The surface of the granules was evaluated by scanning electron microscopy (SEM)
(JSM 5600 LV scanning electron microscope, JEOL Europe, Zaventem, Belgium).
3.3.2.2 Granule porosity
The granule porosity was determined by the Autopore III mercury porosimeter
(Micromeritics, Norcross, GA, USA).
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3.3.2.3 Yield
The yield of the granulation process was calculated as F<1400µm(%)*F250-1000µm(%)/ 100
where F<1400µm is the fraction of dried granules smaller than 1400 µm and F250-1000µm  is
the granule fraction between 250 –1000 µm as determined during particle size
analysis.
3.3.2.4 Friability
The granule friability was determined in a friabilator (PTF E Pharma Test, Hainburg,
Germany), at a speed of 25 rpm for 10 min, by subjecting 10 g (Iwt) of granules (F 250-
1000 µm) together with 200 glass beads (mean diameter 4 mm) to falling shocks.
Afterwards the glass beads were removed and the weight of the granules retained on a
250 µm sieve (Fwt) was determined after vibrating for 5 min (Retsch VE 1000,
Germany) at an amplitude of 2 mm. The friability was calculated as ((Iwt - Fwt)/Iwt)
*100.
3.3.2.5 Bulk and tapped density
The bulk volume (V0) of 50 g granules (F 250-1000 µm) was recorded in a 100 ml
measuring cylinder as well as the volume after 1500 taps (V1500) in a tapping machine
(J. Englesman, Ludwigshafen, Germany). Bulk and tapped densities were calculated
as 50 g / Vo and 50 g / V1500, respectively. The compressibility index (C%) was
calculated from the bulk and tapped density using the following equation
                           C% = {(ρf - ρi) / ρf } *100
where ρi is the bulk density and ρf  is the tapped density
3.3.3 Tablet evaluation
Immediately after production tablets were stored at 25°C and 60% RH for 24 h prior
to evaluation.
3.3.3.1  Tablet friability
The tablet friability was determined using a friabilator (PTF E Pharma Test,
Hainburg, Germany) at a speed of 25 rpm for 4 min. The percentage weight loss was
expressed as the tablet friability.
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3.3.3.2 Tablet tensile strength
The hardness, thickness and diameter of the tablets (n=6) was determined (PTB 311
Pharma Test, Hainburg, Germany) after a 24 h storage period at 25°C and 60% RH.
The tablet tensile strength T was calculated using the equation described by Fell and
Newton (1968)
                            T = 2F/π.d.t
where F, d and t denote the the diametral crushing force, the tablet diameter and the
tablet thickness, respectively.
3.3.3.3 Disintegration time
The disintegration time was determined (n=6) using the apparatus described in Eur.
Ph. III (PTZ-E Pharma-Test, Hainburg, Germany). Tests were performed in distilled
water at 37°C using disks.
3.3.3.4 Dissolution test
Dissolution tests were performed on hydrochlorothiazide tablets in 900 ml HCl (0.1N)
using the paddle method. The dissolution medium was maintained at 37 ± 0.5°C,
while the rotation speed was set at 100 rpm (USP XXIII). Samples (5 ml) were
withdrawn after 5, 10, 15, 20, 25, 30, 45 and 60 min and concentrations were
spectrophotometrically determined at 272 nm (Beckman DU – 65, Fullerton, CA,
USA).
3.4 Statistical analysis
Statistical analysis was carried out using the software package SPSS version 10.0.
First the data were tested for normal distribution with a Kolmogorov-Smirnov test and
the homogeneity of the variances with a Levene’s test.
The influence of a studied parameter on the granule and tablet properties was
determined using one-way ANOVA (p<0.05). To further compare the effects of
different parameters a multiple comparison among pairs of means was performed
using a Scheffe test with p<0.05 as a significance level. The influence of PVP
concentration and addition method was evaluated only within the optimal range of
water concentration. Properties of granules and tablets prepared by continuous twin
screw extrusion were compared with those obtained by high shear at the respective
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optimal water concentrations. Tablet friability and granule yield results could not be
analyzed as only one measurement was performed per factor level.
3.5 Results and discussion
Table 1 reviews the data on the between day reproducibility of twin screw extrusion
for the granulation of α-lactose monohydrate. The data indicated that the extrusion
process can be considered reproducible in relation to all granule and tablet properties.
The performance of the twin screw extrusion as a granulation process at the different
formulation and process parameters is visualized in Fig. 3 a and b, respectively, and
shows that the extrusion/granulation process was only possible within a specific range
of these parameters. The formulation parameters clearly influenced the yield (Fig. 4),
whereas varying the process parameters did not (data not shown). A minimum water
concentration of 6% was required for the extrusion of formulations without PVP, as
the frictional forces during extrusion were too high below this water concentration.
The extrudates produced without PVP at a water concentration between 6 and 7.5%
could be smoothly wet sieved and resulted in a yield of ± 60%. However, a further
increase of the water concentration during extrusion to 8.5% dramatically decreased
the yield to 39%. This low yield is due to sticking of the material to the sieve during
wet sieving as the fraction above 1400 µm was always zero and the fraction below
250 µm remained nearly constant and varied between 16 and 25%.
With respect to the yield the optimal water concentration during extrusion of pure α-
lactose monohydrate ranges between 6 and 7.5%. On the other hand, the yield
obtained from high shear granulation of α-lactose monohydrate without PVP never
exceeded 20%, even at water concentrations above those used during extrusion (Fig.
5) (only the data obtained at 500 rpm are shown, since at this impeller speed the best
results were obtained). This low yield obtained for high shear granulation is due to the
improper agglomeration (F < 250 µm 31%) (Fig. 5) combined with the high amount of
lumps (F > 1400 µm 48%) at low water concentration (7.5%) and to the high amount of
lumps (F > 1000 µm 56%) at high water concentration (12.5%). When comparing both
techniques for the granulation of α-lactose monohydrate it is clear that twin screw
extrusion provides an interesting alternative for conventional high shear granulation,
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       a
          b
Figure 3: Overview of the experiments performed to evaluate (a) the influence of
water concentration during extrusion and PVP-concentration (screw speed:
250 rpm; total input rate 5.6 kg.h-1) and (b) the influence of screw speed
and total input rate (water concentration during extrusion: 7.5%, w/w) on
the properties of α-lactose monohydrate granules. Method of binder
addition: ({) without PVP; () wet addition of PVP; (+) dry addition of
PVP.
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Table 1: Between day reproducibility of the wet granulation process of α-lactose monohydrate via extrusion. Granules were produced (n=6) at
reference conditions without and with 2.5% PVP (wet addition) (water concentration during extrusion: 7.5% (w/w); screw speed: 250
rpm; total input rate: 5.6 kg.h-1). Tablets were compressed at 10 kN using the 250 – 710 µm granule fraction.
Friability Yield Compressibility Tensile strength Friability Disintegration
(%) (%) < 250 µm 250-1000 µm > 1000 µm (%) (Mpa) (%) (s)
16 66 18 69 13 12.8 0.53 2.11 129
12 63 20 67 13  9.0 0.55 1.82 149
8 62 20 65 15  13.0 0.54 1.82 148
24 51 38 54 9 13.5 0.48 2.12 106
20 57 32 59 9 9.1 0.44 1.76 88
24 58 30 64 6 8.9  0.50 2.02 120
Avg. 17 60 26 63 11 11.1 0.50  1.94 123
St. Dev.  6  5  8  5  3  2.2  0.04 0.16 24
14 41 12 74 13 12.4 0.82 0.51 603
20 40 19 72 9 14.2 0.82 0.72 571
15 47 11 79 10 12.4 0.73 0.63 609
22 41 18 69 14 12.4 0.85 0.71 563
21 42 17 72 11 13.4 0.72 0.71 647
25 37 13 73 14 12.6 0.79 0.79 694
Avg. 20 41 15 73 12 12.7 0.79 0.67 615
St. Dev.  4  3  3  3  2  0.7 0.05 0.07 49
With PVP
Tablet properties
Particle size distribution (%)
Granule properties
Without PVP
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Figure 4: Influence of water concentration during extrusion on the yield of α-lactose
monohydrate granules formulated without PVP (O) and with 1.25% PVP wet (V),
2.5% PVP wet (X), 2.5% PVP dry (◊ ) and 5% PVP dry ( ) extruded at a screw
speed of 250 rpm and a total input rate of 5.6 kg.h-1.
not only because of the higher process efficiency, but also because it requires a considerably
lower amount of liquid for the granulation process.
PVP addition had an important effect on the performance of both techniques. When, at a
water concentration during extrusion of 7.5% increasing concentrations of PVP were added
to the α-lactose monohydrate, the yield gradually decreased to less than 15% at 5% PVP (Fig.
4). Varying the water concentration at the different PVP concentration revealed that the
optimal water concentration during extrusion decreased with increasing PVP concentration:
5.5 to 6.5%, 5.5 to 6.5% and 4 to 5% for 1.25, 2.5 and 5% PVP, respectively (Fig. 4). The
possibility of wet granulation using extrusion at a considerable lower water concentration
when PVP is added can be explained by the lubricating activity of PVP, resulting in a
reduction of frictional forces and heat generated during granulation, as well as the binding
capacities of PVP.
For high shear granulation, different PVP concentrations were not tested, but the addition of
2.5% PVP dramatically increased the yield at all water concentrations tested. However, only
at 10% water a yield of ± 50% was obtained (Fig. 5). When comparing the granulation
efficiency it can be concluded that for high shear granulation of α-lactose monohydrate the
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Figure 5: Influence of water concentration during high shear granulation on the granule
properties of α-lactose monohydrate granules formulated without PVP and with
2.5% PVP wet at 500 rpm impeller speed and 3000 rpm chopper speed. Granule
friability (o) without PVP and (O) with PVP, yield (∆) without PVP and (V) with
PVP and fines ( ) without PVP and (Q) with PVP.
addition of PVP and a higher water concentration was required compared to extrusion. This
difference can be attributed to the different way the binding liquid was added and to the
higher densification during twin screw extrusion (Kristensen et al., 1985). These data
indicated that twin screw extrusion is more efficient as a wet granulation technique for α-
lactose monohydrate than high shear granulation.
Fig. 6 shows SEM pictures taken from dried granules (F 250-1000 µm) produced by extrusion at
reference conditions. The surface of the granules produced without PVP was rather smooth
and the individual particles could not be clearly identified (Fig. 6a), possibly due to the
partial dissolution of α-lactose monohydrate particles as a result of the high shearing forces
during extrusion. When examining the granules with 2.5% PVP the original particles were
still discernible (Fig. 6b). Similar observations were made for granules prepared using high
shear granulation (Fig. 7) with the exception that these granules appeared more porous.
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a
b
Figure 6: Scanning electron micrographs of α-lactose monohydrate granules produced by
extrusion at reference conditions (7.5% water concentration, 250 rpm screw speed
and 5.6 kg.h-1  total input rate).
a. Without PVP b. With PVP (2.5% w/w, wet)
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a
b
Figure 7: Scanning electron micrographs of α-lactose monohydrate granules produced by
high shear granulation at 10% water, 500 rpm impeller speed and 3000 rpm
chopper speed.
a. Without PVP b. With PVP (2.5% w/w, wet)
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The porosity was measured for the granules produced by extrusion at reference conditions
and ranged between 5.8 and 7.5%, independent of the PVP concentration. The porosity of
granules produced using high shear granulation at 7.5% water and 500 rpm impeller speed
ranged between 49.7 and 40.4% for formulations with and without PVP, respectively, which
confirms the SEM observations. The difference in porosity can be explained by the different
degree of densification of both techniques.
The influence of water and PVP concentration on the properties of granules prepared using
twin screw extrusion was investigated. Although optimizing the water concentration during
extrusion is important for the performance of the process and to ensure an acceptable yield, it
did not have an important influence on the other granule properties. The compressibility
never exceeded 15%, indicating the good flowability of the granules (Railker et al., 2000).
The friability of the granules increased with increasing water concentration, but remained
below 30%. The high yield and the low granule friability are probably due to the higher
densification of the wet mass during extrusion, thereby ensuring a good distribution of
granulation liquid and increasing the contact area between the individual particles which
allows more bonds to be formed. PVP addition did not significantly affect the granule
properties prepared by extrusion at all concentrations tested. α-Lactose monohydrate granules
produced without PVP by high shear showed a higher granule friability (> 60%), a lower
yield (< 20%), a higher fraction of fines (F < 250 µm) (> 35%) and a higher compressibility (<
20%) than those prepared by extrusion (Fig. 5). The granules containing 2.5% PVP produced
by high shear granulation at a water concentration of 10% showed similar properties (Fig. 5)
as those prepared by extrusion at the respective optimum water concentration (5.5 to 6.5%).
The influence of the water concentration during extrusion and of PVP concentration on the
tablet properties is shown in Fig. 8 a, b and c. Increasing the water concentration during
extrusion tended to decrease the friability of tablets formulated without PVP and resulted in a
significant, though not important, increase in tablet tensile strength. The addition of PVP
(1.25%) decreased the tablet friability to less than 1%, while the tablet tensile strength
significantly increased to about ± 0.7 MPa and the disintegration time to more than 6 min.
Increasing the PVP concentration to 5% resulted in a significant increase of tablet tensile
strength and disintegration time. In view of the tablet tensile strength and friability, at least
1.25% PVP was required during granulation of α-lactose monohydrate using extrusion.
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            c
Figure 8: Influence of water concentration during extrusion on the properties of α-lactose
monohydrate tablets formulated without PVP (O) and with 1.25% PVP wet (V),
2.5% PVP wet (X), 2.5% PVP dry (◊) and 5% PVP dry ( ) extruded at 250 rpm
screw speed and 5.6 kg.h-1 kg/h total input rate. (a) Tablet tensile strength (b)
Tablet friability and (c) Disintegration time.
However, it should be stressed that PVP addition was not required to achieve a high yield,
whereas, at least 2.5% PVP was required for the high shear granulation of α-lactose
monohydrate. Although without PVP good tablet properties were obtained from granules
prepared by high shear, the yield of this granulation technique for pure α-lactose
monohydrate was too low.
Comparison of the properties of the tablets prepared from granules produced by high shear
granulation (Fig. 9) with those obtained by extrusion revealed that tablets from granules
prepared by high shear showed a significant higher tensile strength and faster disintegration
time for the formulations without as well as with PVP.
When comparing the granule and tablet properties obtained for both methods of PVP addition
no significant differences were observed, except for the tablet disintegration time at a water
concentration of 5% during extrusion.
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Figure 9: Influence of water concentration during high shear granulation on the properties of
tablets prepared from α-lactose monohydrate granules formulated without PVP and
with 2.5% PVP wet at 500 rpm impeller speed and 3000 rpm chopper speed. Tablet
tensile strength (o) without PVP and (O) with PVP, friability (∆) without PVP and
(V) with PVP and disintegration time ( ) without PVP and (Q ) with PVP.
The average t90% dissolution time of the tablets (with 2.5% PVP) containing
hydrochlorothiazide was 25 ± 1 min and complied with the USP XXIII monograph requiring
that not less than 60% of the drug is dissolved within 60 min.
Variation of the screw speed and the total input rate clearly affected the process feasibility.
Combining a low screw speed with a high total input rate led to increased friction, whereas a
too low total input rate resulted in insufficient filling of the extruder barrel (Fig. 3b).
Changing the screw speed from 200 to 450 rpm did not influence the granule nor the tablet
properties, with the exception of the granule friability which significantly increased (but
remained below 30%) with increasing screw speed. The total input rate did not significantly
influence the granule and tablet properties. Thus optimizing the screw speed and the total
input rate is required for the feasibility of the process, however, these parameters have a
limited impact on the granule and tablet properties.
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3.6 Conclusion
It can be concluded that twin screw extrusion is a suitable alternative for the wet granulation
of α-lactose monohydrate. Optimizing the process parameters and the water concentration are
required to obtain an acceptable yield, but they had no important effect on the granule or
tablet properties. Although good granule properties were obtained without PVP, the addition
of PVP was required to improve tablet properties. In contrast to extrusion, high shear
granulation did not allow granulation without PVP and required a higher water concentration
for the granulation of formulations containing PVP. It can be concluded that the technique of
extrusion granulation is more efficient as granulation technique than high shear granulation.
Besides it has the advantage of allowing semi-continuous granulation. Further experiments
will be performed in order to adapt the process so that the wet sieving step is not required,
thus obtaining a fully continuous process.
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4 Extrusion/granulation and high shear granulation of different grades of
lactose and highly dosed drugs: a comparative study
Accepted for publication in Drug Dev. Ind. Pharm.
4.1 Introduction
In the pharmaceutical industry the choice of a suitable granulation process depends, to some
extent, on the physical properties of the powders to be granulated and on the requirements of
the final granules. The physical characteristics of granules, such as particle size distribution,
friability and porosity, are of interest as they will affect the down stream processes. The
granulation technique as well as the processing parameters employed during granulation have
a significant effect on the granule characteristics, hence the properties of the tablets prepared
from the granules. In addition the physical properties of the raw materials will also affect the
granulation process as well as the granule properties. A granulation technique that allows to
level out any differences that might exist between the starting materials would therefore be of
interest.
Extrusion/granulation is a semi-continuous wet granulation technique, which was shown to
be more efficient for the granulation of α-lactose monohydrate 200M than conventional high
shear granulation (Keleb et al., 2002). The aim of this study was to evaluate the robustness of
the extrusion/granulation process using different lactose grades to examine the influence of
lactose particle size and morphology on the granulation process and on the granule and tablet
properties in comparison with high shear granulation. In addition the feasibility of processing
formulations containing a high concentration of a drug having poor compaction properties
(paracetamol) or having poor flow and disintegration properties (cimetidine) was evaluated.
4.2 Materials
The different grades of lactose used were: crystalline α-lactose monohydrate (Pharmatose
450M, 200M, 100M, 90M) and anhydrous β-lactose (Pharmatose DCL 21) (DMV, Veghel,
The Netherlands). The physical properties of the lactose grades are listed in Table 1.
Paracetamol was received from Mallinckrodt (Capitol Boulevard, NC, USA) and cimetidine
was purchased from Roig Farma (Barcelona, Spain). Polyvinylpyrrolidone (PVP, Kollidon
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K30) and crospovidone (Kollidon CL) were received from BASF (Ludwigshafen,
Germany).
Table 1: The physical properties of different grades of lactose.
4.3 Methods
4.3.1 Extrusion/granulation
Granulation was performed on a MP 19 TC 25 laboratory scale co-rotating twin screw
extruder (APV Baker, Newcastle-under-Lyme, UK) having a length - to - diameter ratio of
25/1 and equipped with a standard screw profile with two mixing sections and a die block.
The granulation liquid (pure water or an aqueous PVP solution) was pumped into the first
zone of the extruder barrel using a peristaltic pump (Watson Marlow, Cornwall, UK).
Granulation was carried out at 25°C barrel temperature, 250 rpm screw speed, 5.6 kg.h-1 total
input rate and 7.5% (w/w) water content during extrusion. If required, crospovidone,
paracetamol or cimetidine were blended before granulation with α-lactose monohydrate for
15 min at 60 rpm in a planetary mixer (Kenwood Major, Hampshire, UK). Extrudates were
collected 10 min after the granulation was started in order to allow the system to equilibrate,
then the extrudates (400 g) were immediately wet sized using a 1 mm oscillating sieve
(Frewitt, Fribourg, Switzerland), operated at a minimal distance between rotor and sieve
(Keleb et al., 2002). The wet granules were oven-dried at 25°C for 20 h. All water
concentrations were based on the wet mass, whereas PVP, crospovidone, cimetidine and
paracetamol concentrations were based on dry weight.
The extrusion granulation process was evaluated by monitoring power consumption and
barrel temperature. If the power consumption exceeded 80% of the maximum capacity the
process was stopped in order to avoid machine damage.
Grade Particle size* Morphology Bulk density Solubility
(µm) (g/cm 3 )
α-Lactose monohydrate  90M 135 non-granular 0.76 1 in 5
α-Lactose monohydrate  100M 130 non-granular 0.75 1 in 5
α-Lactose monohydrate  200M 40 non-granular 0.55 1 in 5
α-Lactose monohydrate  450M 20 non-granular 0.47 1 in 5
Anhydrous β-lactose 150 granular 0.67 1 in 2.2
*Average particle size by sieving (certificate of analysis, DMV)
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4.3.2  High shear granulation
The granulation was performed in a high shear granulator (Gral 10, Machines Collette,
Wommelgem, Belgium) at 500 rpm impeller speed, 3000 rpm chopper speed and 10% (w/w)
water concentration. If required, crospovidone, paracetamol or cimetidine were blended
before granulation with α-lactose monohydrate for 15 min at 60 rpm in a planetary mixer
(Kenwood Major, Hampshire, UK). The granulation liquid (pure water or an aqueous PVP
solution) was added using a peristaltic pump (Watson Marlow, Cornwall, UK). After a 2 min
mixing period of the powder, the required amount of granulation liquid was continuously added
over a period of 10 min. Wet massing was continued for 2 min following complete liquid
addition. The wet granules were oven-dried at 25°C for 20 h.
4.3.3 Compression of tablets
The same method as described in Chapter 3 was used to manufacture the tablets.
4.3.4 Granule evaluation
The same methods as described in Chapter 3 were used to determine the yield of the process
and the particle size, friability and density (bulk and tapped) of the granules.
4.3.5 Tablet evaluation
The same methods as described in Chapter 3 were used to determine the friability, tensile
strength and disintegration time of the tablets.
4.3.5.1 Tablet porosity
The tablet skeletal volume was determined (n=10) using He-pycnometry (Micromeritics,
Norcross, GA, US) and the dimensions of the tablet were measured using a micrometer from
which the bulk volume was calculated. The tablet porosity ε was determined (n=3) by the
following equation ε = ((bulk volume – skeletal volume)/ bulk volume) * 100.
4.3.5.2 Dissolution test
Dissolution tests on paracetamol tablets were performed in 900 ml phosphate buffer (pH 5.8)
using the paddle method (Vankel, Cary, NC, US). The dissolution medium was maintained at
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37 ± 0.5°C, while the rotation speed was set at 50 rpm (USP XXIV). Samples (5 ml) were
withdrawn after 5, 10, 15, 20, 25 and 30 min and concentrations were spectrophotometrically
determined at 243 nm (Lambda 12 Perkin Elmer, Norwalk, US). Similarly dissolution tests
were performed on cimetidine tablets in 900 ml water using the basket method (Vankel, Cary,
NC, US). The dissolution medium was maintained at 37 ± 0.5°C, while the rotation speed
was set at 100 rpm (USP XXIV). Samples (5 ml) were withdrawn after 3, 6, 9, 12 and 15 min
and concentrations were spectrophotometrically determined at 218 nm (Lambda 12 Perkin
Elmer, Norwalk, US).
4.4 Statistical analysis
Statistical analysis was performed using the computer program SPSS version 11.0.
The influence of lactose particle size, particle morphology, composition, storage conditions
and granulation technique on granule friability, tablet tensile strength and disintegration time
was analysed using one-way ANOVA. For further comparison a multiple comparison among
pairs of means was performed using the Scheffé test with P < 0.05 as a significance level.
The data were tested for normal distribution with a Kolmogorov-Smirnov test and the
homogeneity of variances was tested with the Levene’s test.
4.5 Results and discussion
4.5.1 Granulation of different lactose grades
Extrusion/granulation of the different grades of α-lactose monohydrate (without PVP)
resulted in a similar barrel temperature and power consumption as shown in Table 2. For
formulations with PVP the barrel temperature and power consumption decreased as lactose
particle size increased due to the decrease in particle surface area which resulted in improved
particle lubrication. All particle sizes were processed smoothly, except for α-lactose
monohydrate 90M as its larger particle size resulted in high frictional forces.
Extrusion/granulation of anhydrous β-lactose was associated with a remarkable increase in
barrel temperature and in power consumption mainly because its granular particles have a
hard and irregular structure.
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Besides it should be reported that although α-lactose monohydrate 200M was fed smoothly
using a double screw feeder to transport the powder into the extruder barrel (Keleb et al.,
2002), other lactose grades having a larger or smaller particle size exhibited some problems
during feeding. A gradual decrease in feed rate and difficulties with the screw rotation of the
feeder (or even blocking of the screw movement) were observed for α-lactose monohydrate
100M, 90M and anhydrous β-lactose. α-Lactose monohydrate 450M tended to adhere to the
hopper surface, mainly due to the cohesiveness of its particles. These feeding problems did
not hamper obtaining accurate feeding rates during short term experiments, but could cause
inaccurate feeding rates during longer processing times. There is a need for the selection of
adequate feeding systems in order to allow a broad range of materials with different flow
properties to be easily processed.
Table 2: Process parameters during extrusion/granulation of different lactose grades.
During extrusion/granulation optimisation of the water concentration was essential for
processing as well as for obtaining good granule properties. The water concentration was
optimised in a previous study for α-lactose monohydrate 200M (Keleb et al., 2002) and this
PVP Temperature Power consumption
(%) (°C) (%)
0 44 27
2.5 40 29
0 42 26
2.5 35 24
0 36 28
2.5 29 21
0 39 20
2.5 29 17
0 58 72
2.5 50 65
α-Lactose monohydrate 450M
α-Lactose monohydrate 200M
α-Lactose monohydrate 100M
α-Lactose monohydrate 90M
Anhydrous β-lactose
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water concentration was used for the granulation of all grades of lactose. The particle size of
lactose did have an influence on the optimal water concentration, which can be explained by
the different viscoelastic properties of the wet mass, affecting extrudability, agglomeration as
well as wet sieving (Kleinebudde and Lindner, 1993; Keleb et al., 2002).
During extrusion/granulation of anhydrous β-lactose and α-lactose monohydrate 90M at
reference water concentration a lower yield was obtained for the latter and a further reduction
of the water concentration was required. Anhydrous β-lactose has a higher solubility and
according to Lustig-Gustafsson (1999) a lower water concentration will be required for
successful granulation. However, α-lactose monohydrate 90M required less water than
anhydrous β-lactose. This difference is probably due to the differences in surface area and
powder bed porosity.
Table 3: The granule properties of the different lactose grades processed by
extrusion/granulation and high shear granulation
Lactose PVP Water Friability Yield Compressibility
type (%) (%) (%) (%) <250 µm 250-1000 µm >1000 µm (%)
α-lactose monohydrate 90M 0 7.5 32 34 46 49 5 9
α-lactose monohydrate 100M 0 7.5 22 54 24 65 11 12
α-lactose monohydrate 200M 0 7.5 17 60 26 63 11 11
α-lactose monohydrate 450M 0 7.5 20 58 17 61 22 14
Anhydrousβ-lactose 0 7.5 23 59 26 61 14 13
α-lactose monohydrate 90M 2.5 7.5 15 17 13 75 12 15
α-lactose monohydrate 90M 2.5 6.5 23 33 14 76 10 15
α-lactose monohydrate 100M 2.5 7.5 13 41 19 78 2 13
α-lactose monohydrate 100M 2.5 6.5 16 51 29 65 5 15
α-lactose monohydrate 200M 2.5 7.5 20 41 15 73 12 14
α-lactose monohydrate 200M 2.5 6.5 16 52 29 65 5 15
α-lactose monohydrate 450M 2.5 7.5 19 33 22 59 19 14
Anhydrousβ-lactose 2.5 7.5 8 61 23 63 14 13
α-lactose monohydrate 90M 0 10 84 32 34 52 14 16
α-lactose monohydrate 100M 0 10 91 33 33 56 10 16
α-lactose monohydrate 200M 0 10 72 17 56 32 12 10
α-lactose monohydrate 450M 0 10 52 24 44 47 12 15
Anhydrousβ-lactose 0 10 81 38 55 42 4 15
α-lactose monohydrate 90M 2.5 10 15 20 10 64 27 14
α-lactose monohydrate 100M 2.5 10 17 25 7 72 20 14
α-lactose monohydrate 200M 2.5 10 22 48 19 69 12 14
α-lactose monohydrate 450M 2.5 10 28 30 38 53 9 15
Anhydrous β-lactose 2.5 10 27 51 37 58 5 13
Extrusion/granulation
High shear granulation
PARAMETERS GRANULE PROPERTIES
Particle size distribution
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Comparison of the optimal water concentration for the two different granulation techniques
showed that extrusion/granulation required a lower water concentration than high shear
granulation. The properties of granules produced by extrusion/granulation and high shear
granulation are shown in Table 3. For extrusion/granulation and high shear granulation the
particle size affected the granule properties. For formulations without PVP a significantly
higher friability was obtained for α-lactose monohydrate grades having a larger particle size.
Table 4: The properties of tablets prepared by compression of different lactose grades
processed by extrusion/granulation and high shear granulation.
Lactose PVP Water Tensile strength Friability Disintegration
grade (%) (%) (MPa) (%) (s)
α-lactose monohydrate 90M 0 7.5 0.75 1.7 164
α-lactose monohydrate 100M 0 7.5  0.47 1.9 192
α-lactose monohydrate 200M 0 7.5 0.50 1.9 123
α-lactose monohydrate 450M 0 7.5 0.32 2.2 189
Anhydrousβ-lactose 0 7.5 0.88 1.1 348
α-lactose monohydrate 90M 2.5 7.5 1.11 0.7 648
α-lactose monohydrate 90M 2.5 6.5 0.99 0.8 589
α-lactose monohydrate 100M 2.5 7.5 0.75 0.9 697
α-lactose monohydrate 100M 2.5 6.5 1.00 0.7 577
α-lactose monohydrate 200M 2.5 7.5 0.97 0.7 615
α-lactose monohydrate 200M 2.5 6.5 1.04 0.7 577
α-lactose monohydrate 450M 2.5 7.5 1.12 0.6 594
Anhydrousβ-lactose 2.5 7.5 1.26 0.7 299
α-lactose monohydrate 90M 0 10 0.13 2.9 66
α-lactose monohydrate 100M 0 10 0.15 2.7 116
α-lactose monohydrate 200M 0 10 0.67 1.7 83
α-lactose monohydrate 450M 0 10 0.28 1.7 112
Anhydrousβ-lactose 0 10 0.59 1.2 163
α-lactose monohydrate 90M 2.5 10 0.32 0.9 417
α-lactose monohydrate 100M 2.5 10 0.31 1.2 360
α-lactose monohydrate 200M 2.5 10 0.91 0.8 266
α-lactose monohydrate 450M 2.5 10 0.51 0.6 373
Anhydrousβ-lactose 2.5 10 0.73 0.7 286
PARAMETERS TABLET PROPERTIES
Extrusion/granulation
High shear granulation
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The lower yield for α-lactose monohydrate grades with a larger particle size is in agreement
with the data of Mackaplow et al. (2000) who found that granulation of α-lactose
monohydrate with a large particle size yielded weak granules. This was explained by the fact
that water did not provide the necessary strength to the agglomerates and breakage would
often dominate due to the low agglomerate strength.
Comparison of extrusion/granulation with high shear granulation showed that the former
resulted in a significantly lower granule friability and a higher yield.
Table 4 shows the properties of tablets produced from granules prepared by extrusion
granulation and high shear granulation.
The particle size of α-lactose monohydrate did affect tablet tensile strength after
extrusion/granulation. The properties of tablets obtained after high shear granulation were
more affected by particle size as an effect on both tensile strength and disintegration time was
observed.
In contrast to the lactose particle size, the lactose grade has a similar effect on the tablet
properties obtained by both techniques. Tablets prepared from anhydrous β-lactose exhibited
a significantly higher tensile strength and a lower friability than those prepared from α-
lactose monohydrate 90M, irrespective of the granulation technique used. This is probably
due to the higher compactability of anhydrous β-lactose.
The tablet properties obtained from granules compressed after extrusion/granulation showed
a significantly higher tensile strength compared to the high shear prepared granules,
indicating that extrusion/granulation resulted in improved tablet properties.
4.5.2  Granulation of paracetamol
During extrusion/granulation of all formulations containing paracetamol a similar barrel
temperature and power consumption was recorded. The barrel temperature and the power
consumption varied between 31 and 39°C and between 21 and 29%, respectively. All
paracetamol formulations without PVP showed no problems during wet sieving, while at a
7.5% water concentration the extrudates (containing 2.5% PVP) stuck to the sieve during wet
sizing and the water concentration had to be lowered in order to solve the problem (Keleb et
al., 2002). High shear granulation of pure paracetamol without PVP was not possible, even at
higher water concentrations.
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Table 5: Influence of granulation technique on the granule and tablet properties of paracetamol formulations.
Paracetamol Water PVP Friability (%) Yield (%) Compressiblilty Tensile strength Friability Disintegration
(%) (%) (%) 250-1000 µm (%) <250µm 250-1000µm >1000µm (%) MPa (%) (s)
20 7.5 0 27 34 27 37 36 13 0.53 2.5 115
40 34 42 38 47 15 12 0.56 3.0 422
60 39 40 38 43 19 12 0.60 3.3 1157
80 50 39 41 41 18 13
100 76 36 41 39 20 11
20 7.5 2.5 30 19 26 69 5 14 1.06 1.2 636
40 32 20 11 66 26 14 0.96 1.4 906
60 33 20 21 58 21 14 0.96 1.7 1023
80 30 20 31 48 21 10 0.95 1.9 1712
97.5 42 20 28 40 32 11 1.12 1.9 3299
92.5*
20 10 0 66 30 27 52 21 14 0.38 2.8 93
40 61 34 20 65 15 12 0.36 15.0 476
60 61 30 16 67 17 13
80 61 32 18 66 16 12
100
20 10 2.5 21 42 7 70 25 13 0.95 1.1 359
40 18 24 5 66 29 8 0.82 1.6 1071
60 32 18 3 63 34 10 0.71 2 1489
80 22 16 8 65 27 14 0.75 2.2 2799
97.5 33 16 6 65 29 11
Particle size analysis
Processing variables
*Formulation containing 5% crospovidone
Extrusion/granulation
High shear granulation
poor compatibility
poor compatibility
poor compatibility
Tablet properties
Granulation not possible
Granule properties
poor compatibility
poor compatibility
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Table 5 shows the properties of paracetamol granules prepared by extrusion/granulation and
high shear granulation. Extrusion/granulation without PVP resulted at all paracetamol
concentrations in a yield of about 40%. At 20% paracetamol a granule friability of 27% was
obtained. However, the friability significantly increased as the paracetamol concentration
increased, reaching 76% for pure paracetamol granules. This trend in the friability data was
directly correlated with the gradual decrease of α-lactose monohydrate present in the
granules. All granules without PVP obtained by high shear granulation showed a significantly
higher granule friability and a lower yield than those prepared by extrusion/granulation.
Although extrusion/granulation showed a higher efficiency than high shear granulation, it
failed to produce good quality paracetamol granules without PVP.
Addition of 2.5% PVP at reference water concentration only significantly improved the
friability at a paracetamol concentration above 80%, but resulted in a markedly lower yield.
For high shear granulation, addition of PVP always resulted in a significant decrease of the
friability, while the effect on the yield depended on the drug concentration. The yield
gradually decreased as the paracetamol concentration increased due to an increasing amount
of lumps formed at higher paracetamol concentration.
The compressibility of all formulations ranged between 8 and 14%, indicating the good flow
properties of the granules, irrespective of the granulation technique.
From these results it is obvious that extrusion/granulation is more efficient than high shear
granulation for the granulation of paracetamol.
Table 5 also shows the properties of tablets containing different concentrations of
paracetamol prepared by extrusion granulation and high shear granulation. For tablets
compressed from granules prepared by extrusion/granulation a tendency for capping and
lamination was observed at paracetamol concentration above 80%. Tablets without PVP
containing up to 60% paracetamol had a tensile strength below 0.59 MPa.
For tablets prepared from granules without PVP produced by high shear granulation the
tendency for capping and lamination was already observed at 60% paracetamol, while tablets
containing up to 40% paracetamol had a tensile strength below 0.38 MPa. Those results are in
agreement with Becker et al. (1997) who reported that paracetamol tablets produced without
binder have a low strength.
Addition of PVP allowed to prepare tablets containing a higher paracetamol concentration
and yielded stronger tablets.
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It is obvious that it was possible to prepare tablets from paracetamol granules containing only
drug and 2.5% PVP (and no lactose) when extrusion/granulation was used, whereas no tablets
were obtained from this formulation using high shear granulation. Although addition of PVP
resulted in a considerable reduction of the tablet friability it remained above 1%.
Similar disintegration times for tablets prepared by extrusion/granulation and high shear
granulation were obtained. Increasing the paracetamol concentration resulted in a significant
increase in the disintegration time. For paracetamol tablets (without PVP) prepared by both
techniques, only those containing 20% paracetamol, complied with the requirements of the
US pharmacopoeia (80% paracetamol released within 30 min). The results of the dissolution
experiments on paracetamol tablets with PVP are shown in Fig. 1. Addition of PVP
dramatically enhanced the dissolution rate of paracetamol tablets. This effect can be
attributed to the interaction of PVP with paracetamol due to the formation of hydrogen bonds
(Garekani, 1996).
Comparison of the dissolution of paracetamol tablets obtained by both processes clearly
showed that tablets prepared from granules obtained by extrusion/granulation showed a faster
dissolution than those obtained by high shear granulation. For tablets containing 97.5%
paracetamol produced via extrusion/granulation the dissolution profiles did not comply with
the pharmacopoeial requirements. However, after the addition of 5% crospovidone a fast
dissolution rate was obtained.
These results indicated that extrusion/granulation allowed to obtain tablets with a higher
paracetamol concentration and resulted in improved tablet properties in comparison with high
shear granulation.
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Figure1a: Dissolution profiles of tablets (with 2.5% PVP) containing 20% (O), 40% (Q),
60% (♦), 80% (  ) and 97.5% (V) paracetamol and containing 92.5% paracetamol
and 5% crospovidone (  ). The tablets were prepared from granules produced by
extrusion/granulation.
Figure 1b: Dissolution profiles of tablets (with 2.5% PVP) containing 20% (O), 40% (Q),
60% (♦) and 80% (  ) paracetamol. Tablets were prepared from granules
produced by high shear granulation.
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4.5.3  Granulation of cimetidine
Granulation of cimetidine by extrusion/granulation at reference conditions was associated
with a high barrel temperature (52-54°C) and a high power consumption (54-58%). The
extrudates obtained had a rough surface and were difficult to wet size due to the hardness of
the extrudates. The low water concentration in combination with the pressure exerted on the
extrudates at the die block as well as the elevated barrel temperature could be responsible for
the extrudate hardness. Increasing the water concentration to 17.5 and 14.5% for the
formulation without and with PVP, respectively, reduced the barrel temperature to below
39°C and the power consumption to below 23%. Moreover, cimetidine extrudates produced
at those water concentrations were easily wet sized.
High shear granulation of cimetidine without PVP was not feasible even at a water
concentration up to 17.5%, whereas the addition of PVP allowed to process cimetidine.
Table 6 compares the properties of cimetidine granules prepared by extrusion/granulation and
high shear granulation. For extrusion/granulation of cimetidine (without PVP) at reference
conditions a friability of 11% and a yield of 32% were obtained. This low yield was mainly
due to the hardness of the extrudates, which made it difficult to break them down into
granules during wet sizing. Increasing the water concentration to 17.5% made the extrudates
suitable for wet sizing and increased the yield to 62%. Addition of 2.5% PVP to cimetidine
resulted in a yield of 46 and 22% and a friability of 12 and 64% for extrusion granulation and
high shear granulation, respectively. The compressibility ranged between 13 and 18% for all
granules produced by both techniques, indicating their good flow properties.
These results show that extrusion/granulation is far more efficient for the wet granulation of
cimetidine compared to high shear granulation.
Table 6 also shows the properties of cimetidine tablets produced by extrusion/granulation and
by high shear granulation. Similar tablet properties were obtained for both granulation
techniques. For all tablets a friability below 1% and a tensile strength above 0.79 MPa was
obtained. However, the disintegration time was above 60 min (formulations without
disintegrant) and the dissolution failed to meet the US pharmacopoeia requirements. The
addition of 5% crospovidone significantly reduced the disintegration time and ensured that
these cimetidine formulations complied with the US pharmacopoeia dissolution requirements
(60% cimetidine released within 15 min) as shown in Fig. 2.
The fact that cimetidine tablet properties are not affected by the granulation method is in
contrast to paracetamol tablets where the granulation method showed to be the predominant
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factor for the tablet production. This different behaviour of both drugs can be explained by
their differences in compactability. Paracetamol has poor compactability properties, and
therefore the tablet properties are highly dependent on the granule properties, which mainly
depend on the granulation method. On the contrary, cimetidine has good compaction
properties, and thus granulation had a less predominant role.
Figure 2: Dissolution profiles of tablets containing 92.5% cimetidine, 2.5% PVP and 5%
crospovidone prepared by compression after extrusion/granulation (O) and after
high shear granulation (   ).
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Table 6: Influence of granulation technique on the granule and tablet properties of cimetidine formulations.
PVP PVP-CL Water Friability Yield Compressibility Tensile strength Friability Disintegration
(%) (%) (%) (%) (%) <250µm 250-1000µm >1000µm (%) (MPa) (%) (s)
Extrusion/granulation
0 0 7.5 11 32 30 64 7 13 1.76 0.8 > 3600
2.5 0 7.5 12 46 27 67 6 14 1.86 0.7 > 3600
0 5 17.5 43 54 40 57 3 14 1.23 0.7 52
2.5 5 14.5 30 40 48 50 2 18  1.70 0.7 154
High shear granulation
0 0 10.0
0 0 17.5
2.5 0 10.0 64 22 58 40 2 16 1.83 0.5 > 3600
2.5 5 14.5 89 9 87 13 0 18 0.93 1.3 124
Tablet properties
Particle size distribution
No granules obtained
No granules obtained
Parameters Granule properties
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4.6 Conclusion
This study showed that during granulation of different lactose grades, particle size and
morphology had only a minor influence on the extrusion/granulation process, whereas
significant differences were observed after high shear granulation.
On comparing granules and tablets produced by both granulation processes, materials
processed by extrusion granulation showed superior properties than those granulated by high
shear.
Granulation of highly dosed drugs (paracetamol or cimetidine) using extrusion/granulation
was more efficient than high shear granulation, resulting in a higher yield and lower friability
for a lower water concentration.
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5 Twin screw granulation as a simple and efficient tool for
continuous wet granulation
Published in Int. J. Pharm., 273 (2004), 183-194
5.1 Introduction
Wet granulation is considered one of the most important processes in the manufacturing of
solid dosage forms. Production of solid dosage forms using granules has several advantages
such as enhanced flowability, improved compactability, reduced segregation and less dust.
The most commonly used wet granulation techniques are high shear and fluid bed
granulation.
There is an increasing need for alternative processes that are more economic, reliable and
reproducible, taking into consideration the possibility of automation and process continuity.
Continuous processes offer two advantages: there is no scale-up study necessary resulting in
a shorter development time and a 24 h automatic production line (lights-out operation) would
be possible. Recently, this subject is gaining more interest and several techniques have been
reported for continuous granulation.
Leuenberger (2001) reported a quasi-continuous granulation technique using a specially
designed high shear mixer/granulator, which is connected to a multicell fluid bed dryer. This
technique resulted in granules of a similar or even better quality compared to those produced
by conventional granulation equipment. Schroeder and Steffens (2002) used a modified
planetary roller extruder for continuous wet granulation. Lindberg et al. (1987 and 1988)
were the first to report on the possibility of using a twin screw extruder for the continuous
granulation of an effervescent paracetamol preparation. However, no data were presented on
the suitability of these granules for compaction. In 1993, Kleinebudde and Lindner studied
the twin screw extrusion process as a granulation tool. The influence of processing
parameters and formulation variables on the extrudates was evaluated, but the quality of
granules was not reported.
In previous chapters (see also Keleb et al., 1999, 2002) we studied twin screw extrusion in
combination with an oscillating granulator for the wet granulation of α-lactose monohydrate.
This technique was more efficient than high shear granulation and the granules produced had
improved properties. However, wet sieving of the material discharged from the twin screw
extruder was still required to obtain granules. The aim of this study was to eliminate this wet
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sizing step by changing the screw configuration. Some reports indicated that granule quality
is influenced by this parameter: Lindberg et al. (1987 and 1988) reported that a low agitation
screw profile resulted in a higher yield on granulation and a lower granule porosity than a
medium agitation screw profile. Similarly, Lindberg (1988) stated that screw configuration
significantly influenced the granule porosity. In addition the process continuity, the maximal
capacity and the influence of processing parameters and formulation variables on the granule
and tablet properties were evaluated during this research work.
5.2 Materials
α-Lactose monohydrate 200M was used as excipient (DMV, Veghel, The Netherlands) with
a particle size distribution of: 60% < 45 µm, 83% < 75 µm, 92% < 100 µm, 98% < 150 µm,
100% < 250 µm (DMV International, 1998). Polyvinylpyrrolidone (PVP, Kollidon K30)
was selected as a binder (BASF, Ludwigshafen, Germany) and hydrochlorothiazide (Ludeco,
Brussels, Belgium) as a model drug for poorly water soluble drugs.
5.3 Methods
5.3.1 Preparation of granules
The extrusion was performed on a MP 19 TC 25 laboratory scale co-rotating twin screw
extruder (APV Baker, Newcastle-under-Lyme, UK) having a length - to - diameter ratio of
25/1. During granulation the powder volume in the feed hopper was maintained between 85
and 100% of the feeder capacity. Powder and granulation liquid feed rates were determined
prior to each experiment by repeatedly weighing the powder and the liquid amount delivered
over a period of 5 min. The granulation liquid (pure water or an aqueous PVP solution) was
pumped into the first zone of the extruder barrel by means of a peristaltic pump (Watson
Marlow, Cornwall, UK). To evaluate the dissolution properties, hydrochlorothiazide (10%)
(Ludeco, Brussels, Belgium) was added as a model drug to a formulation without and with
2.5% PVP. Prior to granulation, hydrochlorothiazide was blended with α-lactose
monohydrate in a planetary mixer (Kenwood Major, Hampshire, UK) for 15 min at 60 rpm.
The extruder was set at a constant temperature of 25°C. Granules were collected 10 min after
the process was started in order to allow the system to equilibrate. The granules were oven-
dried at 25°C for 20 h, sieved through a 1400 µm sieve and evaluated for yield, granule
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friability and compressibility. Based on preliminary experiments using α-lactose
monohydrate and water (as a granulation liquid) a set of reference conditions for the
extrusion process was selected: a screw speed of 250 rpm, a total input rate of 5.6 kg/h and a
water concentration during granulation of 8.5 and 7.5% (w/w) for formulations without and
with 2.5% (w/w) PVP, respectively. All water concentrations were based on the wet granule
mass, while PVP and hydrochlorothiazide concentrations were based on dry weight.
The reference conditions were used to optimize the extruder configuration for continuous
granulation. In a first approach the die was modified. For these experiments the extruder was
equipped with a standard screw profile (Fig. 1a). The initial die configuration studied was a
screen (∅1 mm) fixed to the outside of the die block, next the screen was replaced with a 1
mm perforated die plate (2 mm thick) and finally the process was run without the die block.
          a.
          b.
Figure 1: Configuration of the co-rotating screw: feeding zone (1), transition zone (2),
mixing zone (3), transport zone (4), mixing zone (5), transport zone (6), feed zone
towards the die (7).
(a) Standard screw profile.
(b) Modified screw profile with two mixing zones.
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In a second approach, the screw profile was changed. At the end of the screw (zone 7) the
discharge screw element was replaced by a conveying screw element (Fig. 1b). Using this
modified screw profile, the process was run with and without the die block. The optimal
configuration was determined by analyzing the granule yield. Optimization was continued till
a granule yield similar to the semi-continuous extrusion/granulation process (Keleb et al.,
2002) was achieved. To investigate the efficiency of this continuous granulation process, the
granules were evaluated for friability, yield and compressibility. Tablets were evaluated for
tensile strength, friability and disintegration. In addition, the between-day reproducibility
(n=6) of a formulation without and with PVP and the influence of processing parameters and
formulation variables were evaluated.
The maximal capacity of the equipment at optimal configuration was assessed using the
maximum screw speed (450 rpm) in combination with a water concentration of 7.5%. The
granules obtained at each input rate were evaluated. The continuity of the process for α-
lactose monohydrate containing 2.5% PVP was assessed by running the process at reference
conditions for 8 h and each hour evaluating the granules and tablets properties.
5.3.2 Compression of tablets
The same method as described in Chapter 3 was used to manufacture the tablets.
5.3.3 Granule evaluation
The characteristics of the granules (particle size, yield, friability and density) were
determined using the same methods as described in chapter 3.
5.3.4 Tablet evaluation
The same methods as described in Chapter 3 were used to determine the friability, tensile
strength and disintegration time of the tablets.
Dissolution tests were performed on hydrochlorothiazide tablets in 900 ml 0.1N HCl using
the paddle method (Vankel, Cary, NC, US). The dissolution medium was maintained at 37 ±
0.5°C, while the rotation speed was set at 100 rpm (USP XXIII). Samples (5 ml) were
withdrawn after 5, 10, 15, 20, 25, 30, 45 and 60 min and concentrations were
spectrophotometrically determined at 272 nm (Lambda 12 Perkin Elmer, Norwalk, US).
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5.4 Statistical analysis
The influence of water concentration, screw speed and total input rate on the granule and
tablet properties was determined using one-way ANOVA. Properties of granules and tablets
prepared by continuous twin screw granulation over a period of 8 h were analyzed using one-
way ANOVA. For further comparison a multiple comparison among pairs of means was
performed using a Scheffé test with p < 0.05 as a significance level. The influence of PVP
concentration was evaluated only within the optimal range of water concentration. The data
were tested for normal distribution with a Kolmogorov-Smirnov test and the homogeneity of
the variances was tested with a Levene’s test. Tablet friability and granule yield could not be
statistically analyzed as only one measurement was performed per factor level. Statistical
analysis was carried out using the software package SPSS version 11.0.
5.5 Results and discussion
5.5.1 Influence of extruder set-up
Previously Keleb et al. (2002) (see also chapter 3) described extrusion of α-lactose
monohydrate 200M using a twin screw extruder equipped with screws having a standard
screw profile and with a die block (2.2 by 1.0 cm die aperture), yielding extrudates ranging
from small flakes to large extrudates depending on the water concentration used.
Modification of the process parameters did not allow to obtain granules and an additional wet
sizing step was always required. Although Lindberg et al. (1988 and 1987) and Kleinebudde
and Lindner (1993) reported on wet granulation using a twin screw extruder equipped with a
perforated die, our attempts to granulate α-lactose monohydrate using a twin screw extruder
equipped with a 1-mm screen failed due to the high power consumption, the high barrel
temperature, screen distortion and/or screw blocking. Similar problems were observed when
a perforated die plate was used instead of the screen. This failure could be explained by the
low water concentration used in our study and the different material properties. Increasing the
water concentration during extrusion avoided these problems, but this resulted in overwetted
sticky extrudates and not in granules. As the densification of the material before the die
seemed to be too high the twin screw extruder was used without the die block in combination
with the standard screw profile (Fig. 1a) to avoid extrusion of the material. Using this
configuration processing of α-lactose monohydrate at optimum water concentration resulted
Continuous twin screw granulation 65
in a granulation yield of 16% and 22% for α-lactose monohydrate 200M without and with
2.5% PVP, respectively. Using the equipment without die block reduced the resistance to the
material flow in the barrel and thereby the load on the machine. This configuration also
allowed a higher total input rate, resulting in a higher granulation capacity.
The screw profile was modified as the discharge screw element was replaced by a conveying
screw element (Fig. 1b). The effect of this screw modification was evaluated at reference
conditions using the extruder with die block, and allowed to produce granules, but the yield
was still very low (5.4 and 3% for α-lactose monohydrate formulations without and with
PVP, respectively).
However, removing the die block and using the modified screw profile resulted in a yield of
54 and 43% for α-lactose monohydrate without and with PVP, respectively (Table 1), while
no lumps (> 2 mm) were produced. This unexpected increase of the yield was mainly due to a
decrease in large agglomerates. Removal of the die block and replacement of the discharge
screw element by a conveying screw element dramatically reduced the pressure built up at the
end of the barrel and avoided compression of the granules. This configuration resulted in a
comparable yield with the extrusion/granulation technique combined with wet sieving (60%)
as reported by Keleb et al. (2002). In addition the particle fraction smaller than 125 µm (F<125
µm) was below 3 and 9 for formulations with and without PVP, respectively. As the twin
screw extruder with this optimal configuration yielded granules while no extrusion took place
the process will be further referred to as twin screw granulation. In a second part of the study,
the granulation process using this twin screw granulation technique was further investigated.
Table 1 shows the properties of granules and tablets obtained after twin screw granulation at
reference conditions. α-Lactose monohydrate granules without and with 2.5% PVP had a
granule friability below 21%, a yield above 43% and a compressibility below 13%.
α-Lactose monohydrate tablets without PVP had a tensile strength of 0.80 MPa, a friability of
1.6% and a disintegration time of 159 s. Addition of PVP improved the friability (0.8%) and
the tensile strength (1.21 MPa) and increased the disintegration time to 509 s. The quality of
α-lactose monohydrate granules and tablets produced by twin screw granulation indicated the
efficacy of this process. The between day reproducibility showed that the process is
reproducible with respect to the granule and tablet properties (Table 1).
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Table 1: Between day reproducibility of the twin screw granulation of α-lactose monohydrate. Granules were produced (n=6) at reference
conditions without and with 2.5% PVP.
PVP Friability Yield Compressibility Tensile strength Friability Disintegration
(%) (%) (%) <250µm 250-1000µm >1000µm (%) (MPa) (%) (s)
0 14 55 12 68 20 10 0.64 1.7 173
23 53 25 62 13 10 0.87 1.7 157
24 53 24 65 11 14 0.77 1.7 155
21 58 17 69 14 14 0.81 1.5 169
21 55 10 66 24 13 0.75 1.6 159
22 47 29 54 17 13 0.74 1.4 140
avg 21 54 20 64 17 12 0.80 1.6 159
sd 3.5 3.8 7.7 5.5 4.8 1.8 0.08 0.1 11.6
2.5 12 44 12 62 26 13 1.29 0.7 497
17 47 12 64 24 15 1.23 0.9 494
10 46 10 65 25 13 1.21 0.8 506
12 41 6 62 31 13 1.18 0.8 474
13 42 11 63 27 13 1.23 0.8 520
10 38 4 58 38 13 1.14 0.7 562
avg 12 43 9 62 29 13 1.21 0.8 509
sd 2.6 3.4 3.4 2.4 5.2 0.8 0.05 0.1 30
Granule properties Tablet properties
Particle size distribution
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5.5.2 Influence of formulation
5.5.2.1 Influence of water concentration
The influence of water concentration during granulation on the granule properties is
shown in Fig. 2. The water concentration had a crucial influence on the granulation
process as well as on the granule yield (F250-1000 µm) confirming earlier findings
(Kleinebudde and Lindner, 1993; Keleb et al., 2002). Granulation was only feasible
within a specific water concentration range. The determination of the optimum water
concentration was based on the yield on granulation. The optimum water
concentration is lower when PVP was added and was 8.5 and 7.5% for the granulation
of α-lactose monohydrate without and with PVP, respectively. These water
concentrations are lower than those used for conventional wet granulation techniques,
such as fluid bed or high shear. Moreover, experiments showed that this water
concentration can be further reduced by increasing the PVP concentration to 5%.
Granulation at a low water concentration not only allowed to reduce the drying time,
but could also allow to perform drying in a continuous way.
At optimum water concentration a yield of about 50% was obtained and no lumps (> 2
mm) were formed. Decreasing the water concentration resulted in a higher F<250µm
mainly due to insufficient granulation, while increasing the water concentration above
the optimum level resulted in a gradual increase of the granule fraction F> 1400µm,
probably due to overwetting of the agglomerates. However, the F<125 µm was below 5
and 11% for all formulations with and without PVP, respectively. At considerably
higher water concentrations the granulation process yielded large flakes instead of
granules. This observation stresses the need for an accurate and constant feeding of
the binding liquid as well as of the powder during the granulation process. Variations
in the feeding rate would result in variable water concentrations and hence have an
important impact on the granulation process as well as on the granule yield.
Table 2 shows the properties of tablets obtained from granules produced at different
water concentrations. Analysis of these results revealed that the water concentration
did not have significant influence on the tablet properties. For α-lactose monohydrate
tablets without PVP the tensile strength ranged between 0.49 and 0.75 MPa, the
friability was above 1.41% and the disintegration time ranged between 124 and 200 s.
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a.
b.
Figure 2: Influence of water concentration during granulation on the properties of α-
lactose monohydrate granules granulated at a screw speed of 250 rpm and a
total input rate of 5.6 kg.h-1. (O) granule yield, (V) granule fraction (1000-
1400 µm), ({) granule friability, (Q) granule fraction < 250 µm. (a)
formulated without PVP. (b) formulated with 2.5% PVP.
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Table 2: The influence of process parameters and formulation variables on the
properties of tablets made from granules produced using twin screw
granulation.
Screw speed PVP Total input rate Water Tensile strength Friability Disintegration
(rpm) (%) (kg/h) (%) (MPa) (%) (s)
250 0 5.6 6.5 0.75 2.2 124
7.5 0.74 1.4 140
8.5 0.69 1.5 144
9.5 0.49 1.6 165
10.5 0.71 1.4 200
250 2.5 5.6 5.5 1.02 0.4 459
6.5 1.02 0.6 493
7.5 1.09 0.7 510
8.5 1.27 0.7 523
9.5 1.17 0.7 575
250 0 5.6 7.5 0.76 1.6 159
250 1.25 5.6 7.5 1.22 0.9 352
250 2.5 5.6 7.5 1.21 0.8 509
200 0 5.6 8.5 0.68 1.6 219
250 0.66 1.6 204
300 0.66 1.6 175
350 0.67 1.5 176
400 0.68 1.7 185
450 0.70 1.5 204
200 2.5 5.6 7.5 1.22 0.7 545
250 1.18 0.6 543
300 1.10 0.6 557
350 0.94 0.7 530
400 1.25 0.7 553
450 1.22 0.6 535
250 0 5.6 8.5 0.77 1.9 205
6.5 0.78 1.8 192
7.5 0.75 1.4 179
8.5 0.70 1.4 173
9.5 0.71 1.1 157
250 2.5 5.6 7.5 1.14 0.7 562
6.5 1.04 0.5 523
7.5 1.11 0.5 576
8.5 1.09 0.8 544
9.5 1.02 0.5 525
450 2.5 5.6 7.5 1.22 0.6 535
10.5 1.10 0.9 496
12.5 1.12 0.6 468
16.5 1.15 0.9 502
18.5 1.11 0.5 501
Maximum capacity
Influence of PVP concentration
Influence of water concentration
Tablet propertiesParameters
Influence of screw speed
Influence of total input rate
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For α-lactose monohydrate tablets with 2.5% PVP the tensile strength ranged between
1.02 and 1.17 MPa, the friability between 0.39 and 0.68% and the disintegration time
between 459 and 575 s. At all water concentrations the tablets with PVP had a
significantly higher tensile strength and disintegration time than those without PVP.
5.5.2.2 Influence of PVP concentration
The addition of 2.5% PVP resulted in a lower F<250 µm, a significantly lower granule
friability and a higher F>1400 µm. The shift in granule size distribution towards large
particles is mainly due to good binding properties of PVP (Wikberg and Alderborn,
1992, Wan et al., 1996). Reducing the PVP concentration to 1.25% PVP resulted in a
similar granule friability and F<250 µm as those obtained for 2.5% PVP, but it slightly
increased the yield and decreased F>1400 µm as shown in Fig. 3. The F<125 µm was below
5 and 11% for formulations with and without PVP, respectively.
The addition of PVP (1.25 or 2.5%) significantly increased tablet tensile strength,
decreased tablet friability to below 1% and significantly increased tablet
disintegration time, however it remained below 10 min (Table 2). Similar properties
were obtained for α-lactose monohydrate tablets containing 1.25 and 2.5% PVP.
These results indicated that 1.25% PVP would be sufficient for the granulation of α-
lactose monohydrate using twin screw granulation.
Figure 3: Influence of PVP concentration on the properties of α-lactose monohydrate
granules containing 0 (     ), 1.25 (    ) and 2.5% PVP (     ).
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5.5.3 Influence of processing parameters
5.5.3.1 Influence of the screw speed
Screw speed had a significant effect on some properties of granules containing PVP
(Fig. 4), while it did not affect the properties of pure α-lactose monohydrate 200M
granules. Increasing the screw speed from 200 to 450 rpm at a constant total input rate
had no significant influence on the granule friability, while it resulted in a decrease of
the granulation yield from 48% to 32% and in an increase of the fraction F> 1400µm
from 31 to 50%. This effect was probably due to incomplete filling of the granulator
barrel as the screw speed increased, creating less friction and collisions between
agglomerates thus allowing the granules to grow. The effect was only observed when
PVP was added, indicating the strong adhesion and binding properties of PVP. The
compressibility was always below 15%, indicating the good flow properties of the
granules. Table 2 shows that the screw speed had no significant influence on the tablet
properties.
Figure 4: Influence of screw speed on the granule properties of α-lactose monohydrate
granules with PVP granulated at a water concentration of 7.5% and a total
input rate of 5.6 kg.h-1 (O) granule yield, (V) F1000-1400 µm, ({) granule
friability, (Q) F< 250 µm.
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5.5.3.2 Influence of total input rate
The influence of total input rate (i.e. powder + liquid feed rate) on the granule
properties is shown in Fig. 5. It is clear that increasing the total input rate had no
influence on the granule properties except on the granulation yield, which increased as
the total input rate increased. As for the effect of screw speed, this can be explained
by the different degree of filling of the granulator barrel. At a higher total input rate,
the filling degree of the barrel was higher, causing an increase in friction and
collisions between the agglomerates and resulting in more agglomerate breakdown
and hence increasing the yield. The compressibility was always below 15%,
indicating the good flow properties of the granules.
Table 2 shows that total input rate had no significant influence on the tablet
properties.
5.5.4 Maximum capacity
The capacity of the twin screw granulator was also determined for α-lactose
monohydrate 200M with 2.5% PVP. As shown in Fig. 5b and Table 2, the total input
rate could be increased from 5.5 up to 18.5 kg/h with limited influence on the granule
and tablet properties.
Beyond 18.5 kg/h the powder accumulated at the inlet of the granulator barrel. As the
power consumption measured at this high input rate remained at 30% (a value similar
to that recorded at lower total input rates) this is an indication that the machine is not
fully loaded at 18.5 kg/h and that the capacity of the granulation process can possibly
be increased by modifying the powder inlet system of the granulator barrel.
5.5.5 Process continuity
The continuity of twin screw granulation was evaluated over a period of 8 h. No
problems were noticed during the 8 h of granulation. Moreover, the power
consumption always ranged between 26 and 28%, and the barrel temperature between
56 and 66°C. The granule and tablet properties are shown in Fig. 6a and b,
respectively. Analysis of the results revealed no significant differences in granule and
tablet properties over the entire granulation period.
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a.
b.
Figure 5: Influence of total input rate on the properties of α-lactose monohydrate
granules with PVP granulated at a water concentration of 7.5%. Screw
speed: (a) 250 rpm, (b) 450 rpm. (O) granule yield, (V) F1000-14000µm, ({)
granule friability (Q), F< 250µm
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Figure 6a: Properties of  α-lactose monohydrate granules with PVP, produced by
continuous twin screw granulation over a period of 8 h, granulated at a water
concentration of 5.5%, screw speed of 250 rpm and a total input rate of
5.6 kg.h-1. (O) granule yield, (V) F1000-1400 µm, ({) granule friability, (Q)
F< 250 µm.
Figure 6b: Properties of tablets made from α-lactose monohydrate granules with PVP
produced by continuous twin screw granulation over a period of 8 h. (O)
friability, (V) tensile strength, (Q) disintegration time.
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From this it can be concluded that the twin screw granulator is suitable for continuous
wet granulation of α-lactose monohydrate 200M.
5.6 Conclusion
The twin screw granulation process optimized in this study allowed continuous and
efficient wet granulation of α-lactose monohydrate 200M. Acceptable tablet
properties were obtained only when PVP was added as a binder during granulation.
Optimization of water concentration and controlling the water and powder feeding
rate during granulation were essential for the process performance and continuity.
Increasing the screw loading improved the granulation performance, especially for
formulations containing PVP.
The study showed that twin screw granulation is a promising continuous wet
granulation technology.
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6 Twin screw granulation as a continuous wet granulation technique:
influence of filler properties and application to highly dosed drug
formulations
6.1 Introduction
In the pharmaceutical industry formulations intended for tablet production are often
granulated prior to tabletting. The granule properties depend on the granulation process, and
are determined by the binder distribution as well as by the granulation mechanism.
Additionally the chemical properties of the materials to be granulated and the variability of
their physical properties (particle size and morphology) will affect processing and determine
the granule and tablet properties.
In the pharmaceutical industry granule production is mainly based on a batch type procedure,
but recently a growing interest for continuous production (especially for high volume
products) is seen. Switching towards continuous production requires a robust process that is
able to compensate for raw material variability, has stable steady state conditions and requires
minimal scale-up.
Continuous twin screw granulation is a continuous wet granulation technique derived from
extrusion granulation (Chapter 3) (Keleb et al., 2002), which allows granulation without wet
sieving (Chapter 5) (Keleb et al., 2004). Lactose is a widely used excipient in the production
of granules and tablets and exists in different grades having different physical properties. The
objective of the present study was to examine the influence of lactose with different particle
size and morphology on the properties of granules and tablets obtained by continuous twin
screw granulation. Finally the continuous twin screw granulation process was applied to two
highly dosed drug formulations containing paracetamol and cimetidine.
6.2 Materials
The same materials were used as described in Chapter 4.
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6.3 Methods
6.3.1 Continuous twin screw granulation
Granulation was performed on a twin screw granulator described by Keleb et al. (2004).
Granulation of the lactose grades and of formulations containing paracetamol and cimetidine
was performed at 25°C barrel temperature, 250 rpm screw speed, 5.6 kg.h-1 total input rate
(powder and liquid feed rate) and 8.5 and 7.5% water concentration for formulations without
and with 2.5% (w/w) PVP, respectively. The granulation liquid (pure water or an aqueous
PVP solution) was pumped into the first zone of the granulator barrel using a peristaltic pump
(Watson Marlow, Cornwall, UK). Granules were collected 10 min after the process was
started in order to allow the system to equilibrate and oven-dried at 25°C for 20 h. If required,
paracetamol or cimetidine were blended before granulation with α-lactose monohydrate for
15 min at 60 rpm in a planetary mixer (Kenwood Major, Hampshire, UK). All water
concentrations were based on wet mass, while PVP, cimetidine and paracetamol
concentrations were based on dry weight. The granulation process was evaluated by
monitoring power consumption and barrel temperature. If the power consumption exceeded
80% of the maximum capacity the process was stopped in order to avoid machine damage.
6.3.2 Compression of tablets
The same method as described in Chapter 3 was used to manufacture the tablets.
6.3.3 Granule evaluation
The same methods as described in Chapter 3 were used to determine the yield of the process
and the particle size, friability and density (bulk and tapped) of the granules.
6.3.4 Tablet evaluation
Tablet friability, tensile strength and disintegration time were determined as described in
Chapter 3. To determine tablet porosity and in-vitro dissolution the methods described in
Chapter 4 were used.
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6.4 Statistical analysis
The influence of lactose particle size and morphology on granule friability, tablet tensile
strength and disintegration time was determined using one-way ANOVA. For further
comparison of the influence of these parameters on the granule and tablet properties a
multiple comparison among pairs of means was performed using the Scheffé test with P <
0.05 as a significance level. The data were first tested for normality with a Kolmogorov-
Smirnov test and for the homogeneity of variances with a Levene’s test. Statistical analysis
was performed using the computer software SPSS version 11.0.
6.5 Results and discussion
6.5.1 Granulation of lactose
As a constant powder feed rate is a prerequisite for a reproducible granule quality, a double
screw feed system was used to ensure a constant powder feed rate during continuous
granulation. However, only α-lactose monohydrate 200M was delivered at a constant rate
during granulation. With the other lactose grades several problems were encountered: a
gradual decrease in feed rate and difficulties with the screw rotation (or even blocking of the
screw movement) were observed for α-lactose monohydrate 100M, 90M and anhydrous β-
lactose. α-Lactose monohydrate 450M tended to adhere to the hopper surface, mainly due to
the cohesiveness of its particles. This did not hamper the accuracy of the feed rate during
short time processing. However, these observations emphasized the need to design feeding
systems allowing a constant and reproducible feeding of a broad range of materials during
long term processing.
The water concentration was optimised for α-lactose monohydrate 200M (Chapter 5) and this
water concentration was used for the granulation of all lactose grades. The water
concentration used during continuous twin screw granulation resulted in a yield between 43
and 60% for all grades of lactose, independent of the use of PVP as a binder. Comparison of
these results to those obtained by extrusion/granulation and high shear granulation (Chapter
4) indicate that continuous twin screw granulation possibly requires less optimisation when
applied to materials with different physical characteristics.
During continuous twin screw granulation of different grades of α-lactose monohydrate the
barrel temperature and power consumption were decreased as lactose particle size increased
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mainly due to improved lubrication (Table 1). However, a higher barrel temperature and
power consumption were observed for anhydrous β-lactose than for the α-lactose
monohydrate grades, mainly due to the higher friction during granulation. Anhydrous β-
lactose consists of granular particles with irregular shape and high strength resulting in a
higher friction.
Table 1: Process parameters during continuous twin screw granulation of different lactose
grades.
The properties of the granules manufactured using continuous twin screw granulation are
listed in Table 2. These properties were not affected by particle size and particle shape. The
granule friability remained below 23% and the compressibility below 15%. The addition of
PVP significantly decreased the friability, while no influence on yield was seen. However,
during extrusion/granulation and high shear granulation of the different lactose grades
particle size and shape influenced the granule properties (Chapter 4), which indicated that
continuous twin screw granulation is more robust than extrusion/granulation and high shear
granulation.
PVP Power consumption Barrel temperature
(%) (%) (°C)
0 29 44
2.5 27 43
0 24 42
2.5 25 44
0 17 34
2.5 15 30
0 20 29
2.5 17 28
0 37 60
2.5 38 57
α-Lactose monohydrate 90M
Anhydrous β-lactose
α-Lactose monohydrate 450M
α-Lactose monohydrate 200M
α-Lactose monohydrate 100M
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Table 2: Granule and tablet properties of different lactose grades prepared by continuous twin screw granulation.
Lactose PVP Water Friability Yield Compressibility Tensile strength Friability Disintegration
type (%) (%) (%) (%) <250 µm 250-1000 µm >1000 µm (%) (MPa) (%) (s)
0 8.5 20 48 25 57 19 13 0.75 1.4 159
2.5 7.5 9 49 16 64 20 14 1.03 0.8 566
0 8.5 22 60 4 72 24 13 0.50 2.1 104
2.5 7.5 15 49 3 74 23 13 0.80 0.9 583
0 8.5 21 54 20 64 17 12 0.76 1.6 159
2.5 7.5 12 43 9 62 29 13 1.21 0.8 509
0 8.5 23 55 21 63 16 14 1.00 1.6 120
2.5 7.5 14 49 15 62 23 13 1.44 0.9 490
0 8.5 9 57 5 74 22 12 0.91 1.1 319
2.5 7.5 10 49 6 70 24 14 1.45 0.7 368
TABLET PROPERTIESPARAMETERS GRANULE PROPERTIES
Particle size distribution
Anhydrous β-lactose
α-Lactose monohydrate 90M
α-Lactose monohydrate 100M
α-Lactose monohydrate 200M
α-Lactose monohydrate 450M
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Table 2 also shows the properties of tablets formulated with granules produced using
continuous twin screw granulation. In all cases the addition of PVP was required to decrease
the tablet friability below 1%. However, the addition of PVP increased the disintegration time
of the tablets.
6.5.2 Continuous twin screw granulation of paracetamol
Paracetamol formulations without and with 2.5% PVP were easily processed. The barrel
temperature was 44 - 45°C and the power consumption around 30%. The granules obtained
were free of lumps. Granulation without PVP resulted in an unacceptable granule friability of
91% and a yield of 44%. Increasing the water concentration to 10.5% did not improve the
friability nor the yield. The improvement of friability after PVP addition can be attributed to
the PVP interaction with paracetamol (formation of hydrogen bonds) as reported by Garkani
(1996). The compressibility ranged between 12 and 14%, indicating good flow properties.
Continuous twin screw granulation of paracetamol resulted in a higher granule yield and a
lower friability than extrusion/granulation and high shear granulation (Chapter 4), which
indicated that continuous twin screw granulation is more efficient for the granulation of
paracetamol.
Paracetamol granules without PVP prepared using continuous twin screw granulation yielded
weak tablets without capping or lamination, in contrast to the tablets produced using
paracetamol granules prepared by extrusion/granulation (Chapter 4). For paracetamol
formulations with 2.5% PVP as a binder, continuous twin screw granulation at the optimal
water concentration allowed to obtain tablets with friability below 1%, while
extrusion/granulation and high shear granulation failed in providing granules that allowed to
manufacture tablets of good quality (Keleb et al., 2004). These results again indicated that
continuous twin screw granulation is more efficient than extrusion/granulation and high shear
granulation.
Fig. 1 shows the dissolution profiles of tablets made from paracetamol/PVP granules. In
order to comply with the pharmacopoeial requirements the addition of 5% crospovidone was
required.
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Table 3: Granule and tablet properties of formulations containing paracetamol and cimetidine prepared by continuous twin screw granulation.
Drug Water PVP Friability Yield Compressiblilty Tensile strength Friability Disintegration
(%) (%) (%) (%) (%) < 250µm 250-1000µm >1000µm (%) (MPa) (%) (s)
100 8.5 0 91 44 43 47 11 12
100 10.5 82 50 32 53 16 13
97.5 7.5 2.5 27 50 13 67 20 14 1.98 0.99 3735
 92.5* 10.5 27 72 10 81 9 14 0.77 1.28 30
100 8.5 0 27 51 28 61 11 15 1.41 0.54 > 3600
97.5 7.5 2.5 16 46 17 67 15 14 1.42 0.88 > 3600
95* 17.5  0 80 45 38 51 10 13 1.30 0.81 35
 92.5* 14.5  2.5 27 42 19 57 24 15 1.93 0.72 148
Weak tablets
Weak tablets
Processing variables Granule properties Tablet properties
Particle size analysis
Cimetidine
* Containing 5% crospovidone
Paracetamol
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Figure 1: Dissolution profiles of tablets containing 80% paracetamol/17.5% α-lactose
monohydrate/2.5% PVP (V), 97.5% paracetamol/2.5% PVP (O) and 92.5%
paracetamol/2.5% PVP/5% crospovidone (  ). The tablets were prepared from
granules produced by continuous twin screw granulation.
6.5.3 Continuous twin screw granulation of cimetidine
Cimetidine was easily granulated by continuous twin screw granulation at reference water
concentration without as well as with binder. The granulation process was associated with a
barrel temperature of 54-56°C and a power consumption of 41-44%. However, increasing the
water concentration to 14.5% reduced the barrel temperature below 42°C and the power
consumption below 21%. Continuous twin screw granulation of cimetidine without PVP at
reference conditions resulted in a granule yield of 51% and a granule friability of 27%.
Addition of 2.5% PVP reduced the friability to 16% with a yield of 46%.
Granulation of cimetidine using continuous twin screw granulation was easier and resulted in
improved granule properties compared to extrusion/granulation and high shear granulation
(Keleb et al., 2004). These results indicated that continuous twin screw granulation is more
efficient for granulation of cimetidine.
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Figure 2: Dissolution profiles of cimetidine tablets (containing 2.5% PVP) without (∆) and
with (V) 5% crospovidone. The tablets were prepared from granules produced by
continuous twin screw granulation.
Table 3 shows the properties of cimetidine tablets compressed from granules produced by
continuous twin screw granulation. A friability below 1% and a tensile strength below 1.4
MPa were recorded. However, the disintegration time was over 1h and the dissolution failed
to meet the USP requirements. Again the addition of 5% crospovidone reduced the
disintegration time to below 154 s with a release of 60% within 15 min.
6.6 Conclusion
This study showed that during granulation of different lactose grades, the particle size and
morphology only had a limited influence on the continuous twin screw granulation process.
Continuous twin screw granulation of highly dosed drugs (paracetamol and cimetidine) was
efficient, resulting in a good yield and a low friability. However, optimisation of the water
and PVP concentration was required to allow smooth granulation as well as to obtain
acceptable granule and tablet properties. From these results it was concluded that continuous
twin screw granulation is an efficient and simple tool for continuous wet granulation.
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7 Cold extrusion as a continuous single-step granulation and
tabletting process
Published in Eur. J. Pharm. Biopharm., 52 (2001), 359-368
7.1 Introduction
Tablets can be compacted by direct compression or after a granulation step. Direct
compression is preferred, but is only possible for a limited number of substances due
to problems such as poor powder flow properties, low tablet strength, capping and
segregation. Granulation is designed to overcome these problems and usually results
in better flowability and compactibility of the powder. In some cases however,
problems still exist during the large-scale production of tablets. There is also an
increasing interest for continuous operation in the pharmaceutical industry. It is clear
that a single-step continuous granulation/tableting process could provide advantages
such as reduced investment and labour cost and easier automation of the process.
Several researchers successfully used the hot-melt extrusion technique for the
continuous production of, mainly sustained release, tablets (Prapaitrakul et al., 1991;
Grunhagen, 1994; Sprockel et al., 1997; Zhang and McGinity 1998; 1999a; 1999b;
2000; Anonymous, 2000), while the potential of cold extrusion as a continuous
granulation technique was also reported (Kleinebudde and Lindner, 1993; Gamlen and
Eardly, 1986; Lindberg et al., 1987; 1988; Lindberg, 1988). We recently investigated
the granulation of α-lactose monohydrate using cold extrusion (Keleb et al., 2002).
During these experiments a remarkably high mechanical strength as well as a fast
disintegration of extrudates, dried without wet sizing, was noticed. This indicated that
a twin-screw extruder equipped with a proper die plate (e.g. having an aperture of 9
mm diameter) could be suited for the production of compact extrudates, which are
consequently cut into tablets and dried. Hence, in this study cold extrusion was
examined as a single-step granulation/tableting technique for the continuous
production of tablets containing components with poor flow and compression
properties.
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7.2 Materials
α-Lactose monohydrate 200M (DMV, Veghel, The Netherlands) was used as an
excipient; water and PVP (Kollidon K30, BASF, Ludwigshafen, Germany) were
used as binders.  Hydrochlorothiazide (Ludeco, Brussels, Belgium) was selected as a
model drug for poorly water soluble drugs.
7.3 Methods
7.3.1 Preparation of tablets
Extrusion was performed on a laboratory scale co-rotating twin-screw extruder
(Model MP 19 TC 25, APV Baker, Newcastle-under-Lyme, UK), having a length-to-
diameter ratio of 25/1 and equipped with stainless steel screws with a standard screw
profile with two mixing sections. The axial mounted die plate has a cylindrical hole of
9 mm diameter. The α-lactose monohydrate powder and the binding liquid (pure
water or aqueous PVP solution) were fed into the first zone of the extruder barrel. The
powder was fed on top of the screws using a screw operated feeder, while the liquid
was pumped into the barrel by means of a peristaltic pump (Watson Marlow Type
505L, Cornwall, UK). In case where hydrochlorothiazide was present in the
formulation it was premixed with α-lactose monohydrate for 15 min in a planetary
mixer (Kenwood, Hampshire, UK) at a mixing speed of 60 rpm. All water fractions
were calculated based on the wet extruded mass, whereas all PVP and drug
concentrations were calculated based on dry tablet weight. The extruder was set at a
constant temperature of 25°C. In order to ensure equilibration of the extruder at the
test conditions, evaluation of the process feasibility and sampling were started 10 min
after the process was started.
Tablets (thickness: 4 mm) were manually cut using surgical blades immediately after
extrusion and then oven dried for 20 h at 25°C. After drying, tablets weighing
between 245 to 265 mg were selected and stored in a dessicator at 60% RH for 24 h
prior to evaluation.
The feasibility of continuous tableting using cold extrusion was evaluated by varying
formulation and process parameters. First the optimum water concentration was
determined at a screw speed of 250 rpm and a total input rate (powder feed rate +
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liquid feed rate) of 5.6 kg.h-1 i.e. the standard processing parameters determined
during the continuous granulation of α-lactose monohydrate by means of extrusion
(Keleb et al., 2002). Before assessing the influence of the process parameters the
reproducibility (n=6) of the overall process was determined at the optimum water
concentration, using pure water as a binding liquid as well as an aqueous PVP
solution. Next, the influence of the process parameters (screw speed and total input
rate) on the process and on the tablet quality was determined. Finally, the performance
of this technique for the incorporation of drugs was investigated at optimum water
concentration and process parameters.
α-Lactose monohydrate tablets (250 mg) were also prepared by direct compression
(compression force 10 kN) of the powder on an eccentric compression machine
(Korsch EKO, Berlin, Germany) equipped with a flat faced double punch of 9 mm
diameter. Prior to compression the powder was blended for 1 min with 0.5%
magnesium stearate (< 90µm) (BUFA, Brussels, Belgium) in a Turbula mixer (W.A.
Bachofen, Basel, Switzerland).
7.3.2 Precision of powder and liquid feed rate
Prior to each experiment the powder and liquid feed rates were verified by collecting
and weighing (n=3) the powder and the liquid discharged during 5 min.
7.3.3 Process evaluation
7.3.3.1 Power consumption and die pressure
During each experiment power consumption and die pressure were constantly
monitored. In order to avoid any damage to the extruder the extrusion process was
stopped if the power consumption reached 80% of its maximal value or when a die
pressure of 15 bar was recorded.
7.3.3.2 Evaluation of extrudates
The extrudates were visually inspected for any defects (discontinuous extrudate, shark
skinning or other deficiencies) and evaluated for their suitability to be cut into tablets
(deformation due to cutting, smoothness of the cutting surfaces and the edges).
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7.3.4 Tablet evaluation
The methods as described in chapter 3 were used to determine the friability, tensile
strength and disintegration time of the tablets. The porosity of the tablets was
determined as described in chapter 4.
7.3.4.1 Dissolution test
Dissolution tests of hydrochlorothiazide tablets were performed in 900 ml HCl (0.1N)
(37 ± 0.5°C) using dissolution apparatus II (Vankel, Technology Group, Cary, NC,
US) at a paddle speed of 100 rpm (USP XXIV). Samples (5 ml) were withdrawn after
5, 10, 15, 20, 25, 30, 45 and 60 min and concentrations were spectrophotometrically
determined at 272 nm (Lambda 12 Perkin Elmer, Norwalk, US).
7.4 Statistical analysis
Before any analysis was performed the data were tested for normal distribution with a
Kolmogorov-Smirnov test and the homogeneity of variances was tested with a
Levene’s test. If possible (at least 5 levels of the factor tested and multiple
measurements at each point) significant correlations were determined using the
Pearson’s correlation test (p<0.05). For all significant correlations (p<0.05) linear
regression analysis was performed. In case where the coefficients (slope and
intercept) obtained by linear regression are significant (p<0.05), these were used to
calculate the trend line.
When no correlation test could be performed, the influence of the studied parameter
on the tablet properties was determined using a one-way ANOVA (p<0.05). To
further compare the effects of different parameters a multiple comparison among pairs
of means was performed using a Scheffe test with p<0.05 as a significance level.
Friability results could not be analysed as only one measurement was performed per
factor level. For all the statistical analysis the computer program SPSS version 10.0
was used.
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7.5 Results and discussion
7.5.1 Precision of powder and liquid feed rate
During determination of the precision of the powder feed rate it was noted that at a
constant screw speed, the powder feed rate decreased with decreasing powder level in
the feeder. Therefore, the powder level in the hopper was always maintained between
85 and 100% of the total feeder capacity. Under these circumstances reproducible
(CV < 2%) powder feed rates were obtained at all feed rates used. For water as well as
for the PVP solutions, the variability of the liquid feed rate was below 1% at all pump
speeds used.
7.5.2 Determination of optimum water concentration
Table 1 shows the influence of the water concentration during extrusion on the
process evaluation parameters. The water fraction of the wet mass had a dramatic
influence on the extrusion process and on the cutting of the extrudates.
Table 1: Influence of the water content during extrusion on the process parameters for
extrusion of α-lactose monohydrate formulated without PVP and with 2.5%
(w/w) PVP at a screw speed of 250 rpm and a total input rate of 5.6 kg.h-1.
Formulation Process evaluation
PVP Water Power consumption Die pressure Remarks
(%, w/w1) (%, w/w2) (%) (bar)
0 9.5 - - Extrusion not possible, mass too dry
10.5 29 3
11.5 24* 1*
12.5 27 2
13.5 20 0 Deformation of tablets during cutting
14.5 17 0 Deformation of tablets during cutting
2.5 7.5 44 7 Extrudate very dry, difficult to be
8.5 28 7 Extrudate very dry, difficult to be
9.5 25* 3*
10.5 22 1
11.5 17 0 Deformation of tablets during cutting
12.5 19 0 Deformation of tablets during cutting
1 Based on dry tablet weight ,2 Based on wet extruded mass, * Average of 6 batches
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At standard process parameters, production of α-lactose monohydrate tablets with
acceptable shape was feasible only at a water concentration between 10.5 to 12.5 %
(w/w) and between 9.5 to 10.5 % (w/w) for formulations without and with PVP,
respectively. The lower water concentration required for continuous processing of
formulations with PVP can be attributed to the lubricating effect of PVP. Within the
respective optimum water concentration the extrudates had a smooth surface, could be
cut without causing any deformation and the resulting tablets exhibited smooth
surfaces and edges (Fig. 1). Higher water concentration resulted in poorly shaped
tablets due to extensive deformation during cutting, while at lower water
concentration continuous processing was impossible as within 5 min the power
consumption and the die pressure exceeded their maximum set limit. Within the range
of water concentration which allowed continuous extrusion, the power consumption
varied between 20 and 30% of its maximal value and the die pressure did not exceed
10 bar.
Figure 1: Extrudates and tablets produced by cold extrusion of α-lactose
monohydrate formulated without PVP at a screw speed of 250 rpm, a total
input rate of 5.6 kg.h-1 and a water content during extrusion of 11.5 %
(w/w), respectively.
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The influence of water concentration during extrusion on the properties of α-lactose
monohydrate tablets formulated without and with 2.5% (w/w) PVP is shown in Fig. 2
a and b, respectively. The friability varied from 0.5 to 1.0 % for tablets without PVP
and from 0.6 to 0.8 % for tablets with PVP. To evaluate the influence of water
concentration on tablet properties, tablets produced at a water concentration above the
optimum were also included despite their suboptimal shape. There was a significant
positive correlation between the water concentration during extrusion and the porosity
(without PVP: r=0.792, with PVP r= 0.899) and a significant negative correlation
between the water concentration during extrusion and the tensile strength (without
PVP: r= -0.656, with PVP r= 0.739) and the disintegration time (without PVP: r=-
0.584, with PVP r=-0.851). ANOVA analysis revealed that at the lowest water
concentration tested these tablet properties were significantly different from those of
tablets at the highest water concentration.
Figure 2a: Influence of the water content during extrusion on the tensile strength (V),
the porosity (O) and the disintegration time (Q) of α-lactose monohydrate
tablets formulated without PVP at a screw speed of 250 rpm and a total
input rate of 5.6 kg.h-1.
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Figure 2b: Influence of the water content during extrusion on the tensile strength (V),
the porosity (O) and the disintegration time (Q) of α-lactose monohydrate
tablets formulated with 2.5% (w/w) PVP at a screw speed of 250 rpm and
a total input rate of 5.6 kg.h-1.
At all optimum water levels tablets with acceptable tensile strength (> 0.5 MPa),
friability (< 1%) and disintegration time (< 10 min) were obtained: tablets formulated
without and with PVP have a tensile strength above 0.75 and 1.85 MPa, a friability
below 1.0 and 0.8 % and a disintegration time below 1 and 5 min, respectively.
Comparison of the properties of tablets produced at the same water concentration but
formulated without and with 2.5 % (w/w) PVP revealed that the addition of PVP
significantly increased the tensile strength, the porosity and the disintegration time. It
can be concluded that optimisation of the water concentration during extrusion is
required for each formulation in order to allow continuous extrusion, but that within
the possible working range changes in the water concentration during extrusion had
only a limited influence on the tablet properties.
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7.5.3 Process reproducibility
To evaluate the reproducibility of the extrusion process of α-lactose monohydrate the
water concentration was maintained at 11.5 and 9.5% (w/w) for formulations without
and with PVP, respectively. Table 2 shows the between-day variation (n=6) of the
process evaluation parameters and of the tablet properties. All experiments were
performed at a screw speed of 250 rpm and a total input rate of 5.6 kg.h-1. Variation of
the power consumption measurements was below 28%, whereas die pressure varied
from 0 to 5 bar. In view of the small changes caused by varying formulation (Table 1)
and process parameters (Table 3) it was clear that these parameters lack the necessary
Table 2: Between day (n=6) variation of the properties of α-lactose monohydrate
tablets manufactured by cold extrusion at 250 rpm and a total input of 5.6
kg.h-1 formulated without PVP and with 2.5% PVP (w/w) at a water content
during extrusion of 11.5 and 9.5 % (w/w), respectively.
Tensile strength Friability Disintegration Power consumption Die pressure
(MPa) (%) (s) (%) (bar)
1.02 0.87 35 23 0
1.23 0.62 37 27 1
0.82 0.79 32 23 2
0.91 0.66 33 23 1
1.01 0.74 38 23 0
1.32 0.78 41 24 0
Avg 1.05 0.74 36 24 1
SD 0.19 0.09 3 2 1
CV% 18 12 9 7 114
1.68 0.5 294 25 2
1.78 0.7 160 27 5
2.16 0.61 423 25 5
2.04 0.61 275 26 2
1.85 0.55 295 20 0
1.58 0.82 218 25 1
Avg 1.85 0.63 279 25 3
SD 0.22 0.11 91 2 2
CV% 12 18 33 10 83
1 Based on dry weight (w/w). 2 Based on wet extruded mass (w/w).
a-Lactose monohydrate (water content during extrusion 11.5%2)
a-Lactose monohydrate with 2.5%1 PVP (water content during extrusion 9.5%2)
Tablet properties Process evaluation parameters
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sensitivity to be used as indicators to optimise the process and that visual evaluation is
required. However, these parameters are worthwhile recording as they allow early
detection of problems (die blocking, too high friction, etc.), enabling to stop the
process before any damage to the extruder occurs.
For tablets, formulated without PVP, the tablet tensile strength was above 0.8 MPa,
the friability below 0.9% and the disintegration time below 1 min, while tablets
formulated with 2.5% (w/w) PVP had a tablet tensile strength above 1.5 MPa, a
friability below 0.85% and a disintegration time below 8 min. From these results it
was clear that for cold extrusion of α-lactose monohydrate formulations without as
well as with PVP resulted in good quality tablets. This was in contrast to the
manufacturing of α-lactose monohydrate tablets by direct compression or
compression of granules, where PVP-addition or high compression forces are required
to obtain acceptable tablet tensile strength and friability (Riepma et al., 1993; Bolhuis
and Zuurman 1995; Juppo et al., 1995; Becker et al., 1997; Horisawa et al., 2000;
Wostheinrich and Schmigt, 2000, Keleb et al., 2002).  These data indicate that cold
extrusion could be useful as a single step granulation and tableting technique for
materials that normally require granulation.
7.5.4 Influence of process parameters
In Table 3 the process evaluation parameters obtained at different screw speeds and
total input rates are presented. If for pure α-lactose monohydrate the screw speed was
progressively increased above 350 rpm at a constant input rate of 5.6 kg.h-1 blocking
of the die occurred. A similar effect was observed when the total input rate was
decreased to 4.5 kg.h-1 or below at 250 rpm. In both cases the extruder load was
decreased leading to an insufficient filling of the screws and a pressure too low to
push the mass through the die. This induced accumulation and drying of α-lactose
monohydrate at the die, leading to partial die obstruction. On the contrary, decreasing
the extruder load during extrusion of α-lactose monohydrate with PVP did not result
in die blockage, but a discontinuous flow of the extrudates was noticed. This indicates
again the lubricating effect of PVP during cold extrusion of α-lactose monohydrate.
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Table 3: Influence of the screw speed and the total input rate on the process evaluation
parameters for extrusion of α-lactose monohydrate formulated without PVP and
with 2.5% (w/w) PVP at a water content during extrusion of 11.5 and 9.5 %
(w/w), respectively.
This was also reflected in the large within-run variation of the power consumption and
die pressure. Increasing the total input rate to 7.5 kg.h-1 at a constant screw speed of 250
rpm, resulted in screw overloading. In order to obtain a higher throughput the total input
rate as well as the screw speed have to be increased. These findings indicated that in this
extrusion process the full screw transport capacity must be used and that the feed rate
should be optimised in order to prevent die blocking and to guarantee a continuous
discharge of the extrudate.
PVP Water Total feed rate Screw speed Power consumption Die pressure Remarks
(%) (%) (kg./h) (rpm) (%) (bar)
0 11.5 5.6 200 27 0
250 24* 1*
300 24 0
350 16 0
400 >90 >15 Die blocking
450 >90 >15 Die blocking
2.5 9.5 5.6 200 28 3
250 25* 3*
300 24 1
350 25-27 1 Discontinuous extrudate flow
400 23-31 1 Discontinuous extrudate flow
450 22-30 1 Discontinuous extrudate flow
0 11.5 3.5 >90 >15 Die blocking
4.5 >90 >15 Die blocking
5.6 24* 1*
6.5 26 3
7.5 Powder accumulation at inlet
2.5 9.5 3.5 21-25 0-5 Discontinuous extrudate flow
4.5 22-25 0-7 Discontinuous extrudate flow
5.6 25* 3*
6.5 26 2
7.5 Powder accumulation at inlet
*Average of 6
Process evaluation parametersProcess parametersFormulation
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Figure 3a: Influence of the screw speed on the tensile strength (V), the porosity (O)
and the disintegration time (Q) of α-lactose monohydrate tablets formulated
without PVP at a water concentration during extrusion of 11.5 % (w/w) and a
total input rate of 5.6 kg.h-1.
The total input rate did not affect tablet properties, even if it was decreased from 6.5 to
3.5 kg.h-1 at a constant screw speed of 250 rpm. It is also important to notice that tablet
properties remained the same even if the extrudate output was discontinuous. Fig. 3
shows the influence of the screw speed on the properties of α-lactose monohydrate
tablets formulated without (a) and with PVP (b). The friability varied from 0.65 to 0.99%
for tablets without PVP and from 0.5 to 1.07% with PVP, but was always below 1% at
conditions that allowed continuous tablet production. The screw speed also had no effect
on the properties of tablets formulated without PVP, while there was a significant
positive correlation between screw speed and porosity (r=0.843) and a significant
negative correlation between screw speed and tensile strength (r=-0.632) and
disintegration time (r=-0.844) for tablets formulated with PVP. ANOVA analysis
revealed that varying the screw speed only resulted in significant differences for
disintegration time and porosity. This difference between the effect of screw speed on the
disintegration time of tablets formulated without and with 2.5% (w/w) PVP could be due
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to the higher viscosity of the liquid phase penetrated into the pores in the presence of
PVP. This increase in viscosity will dramatically affect the penetration rate of the liquid
into the tablet. In this case disintegration is probably mainly determined by the amount of
liquid that can penetrate into the tablet and is thereby strongly affected by changes in
porosity. For tablets without PVP the disintegration is probably mainly determined by the
dissolution rate of α-lactose monohydrate. As α-lactose monohydrate is soluble in water,
the disintegration is not affected by the changes in porosity.
From these experiments it can be concluded that the screw speed as well as the total input
rate should be optimised to allow continuous processing. Varying of these parameters
within the optimum working range did not affect the tablet quality, except for the screw
speed which influenced the disintegration time of tablets formulated with 2.5% (w/w)
PVP.
Figure 3b: Influence of the screw speed on the tensile strength (V), the porosity (O)
and the disintegration time (Q) of α-lactose monohydrate tablets formulated
with PVP at a water concentration during extrusion of 9.5 (w/w) and a total
input rate of 5.6 kg.h-1.
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7.5.5 Cold extrusion and the incorporation of drugs
Incorporation of 10% hydrochlorothiazide in α-lactose monohydrate tablets formulated
without and with 2.5% (w/w) PVP had no effect, neither on the process feasibility nor on
the tablet properties. All tablets containing hydrochlorothiazide formulated without and
with 2.5% (w/w) PVP had a tablet tensile strength above 1.1 and 1.7 MPa, a friability
below 0.85 and 0.8% and a disintegration time below 1 and 5 min, respectively. Content
uniformity measurements revealed that each tablet contained between 95 and 105% of the
theoretical concentration. All tablets containing hydrochlorothiazide complied with the
USP XXIII dissolution specifications (60% dissolved within 30 min): 73 and 71%
hydrochlorothiazide being released after 10 min from tablets without and with PVP,
respectively.
7.5.6 Comparison of α-lactose monohydrate tablets prepared by direct compression and
by cold extrusion
The properties of α-lactose monohydrate tablets prepared by direct compression and by
cold extrusion are shown in Fig 4a. Tablets prepared by extrusion have a significantly
higher porosity and have larger pores than those prepared by compression.
This difference could explain the significantly faster disintegration of tablets prepared by
extrusion. However, the tensile strength of tablets prepared by extrusion is not
significantly different to that of tablets prepared by direct compression. These differences
in tablet properties could be explained by a different bonding mechanism involved in the
different tablet manufacturing techniques used. During cold extrusion only limited
compression of the material occurs, while the dissolved α-lactose monohydrate fraction
will crystallise on drying forming solid bridges. During mechanical compression of α-
lactose monohydrate the applied forces are much higher and will cause α-lactose
monohydrate to fragment and to bind mainly through intermolecular bonds (hydrogen
bonds and Van der Waals interactions).
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Figure 4a: Tensile strength, porosity, friability and disintegration time of α-lactose
monohydrate tablets prepared by direct compression (Q) (9 mm diameter,
250 mg, 10 kN) and cold extrusion (   ) (water concentration during extrusion
11.5 % (w/w), screw speed 250 rpm and total input rate 5.6 kg.h-1).
However, these intermolecular bonds are much weaker (1-10 kcal/mol) than solid bridges
(50-200 kcal/mol) (Nystrom et al., 1993). The similar tensile strength of tablets prepared
by cold extrusion and by direct compression indicated that the intermolecular bonds
formed during compression are more numerous compared to the solid bridges formed
during cold extrusion. This is confirmed by the porosity data (Fig. 4b) and by SEM
pictures (Fig. 5) which clearly show that tablets prepared by extrusion have much larger
pores than conventional tablets prepared by compression. The strength of solid bridges is
mainly determined by the amount of solids deposited in the solid bridges and by the rate
of crystallisation (Khankari and Hontz, 1997). Both factors are more likely to be affected
by formulation variables such as water content during extrusion and PVP addition than
by process parameters. This could explain the fact that tensile strength is only affected by
changes in water concentration during extrusion and PVP addition, but not by varying the
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process parameters. These data clearly show that cold extrusion results in tablets with
similar tensile strength, with a higher porosity and a lower disintegration time compared
to conventional tablets prepared by direct compression. Similar phenomena i.e. a higher
porosity and faster disintegration time for the same tensile strength as tablets prepared by
compression were seen by Bi et al. (1999) after wet compression of α-lactose
monohydrate granules. However, to obtain tablets with acceptable tensile strength a
compression force above 500 kN, which is much higher than the compression force
routinely used in tablet production, was required.
Figure 4b: Pore size distribution of  α-lactose monohydrate tablets prepared by direct
compression (----) (9 mm diameter, 250 mg, 10 kN) and cold extrusion (—)
(water concentration during extrusion 11.5 % (w/w), screw speed 250 rpm
and total input rate 5.6 kg.h-1).
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    a
    b
Figure 5: SEM pictures of α-lactose monohydrate tablets prepared (a) by direct
compression (9 mm diameter, 250 mg, 10 kN) and (b) by cold extrusion (water
concentration during extrusion 11.5 % (w/w), screw speed 250 rpm and total
input rate 5.6 kg.h-1).
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7.6 Conclusion
From this study it is clear that cold extrusion allows single step continuous tableting of
pure α-lactose monohydrate, in contrast to conventional tableting which requires high
compression force or PVP addition. Optimisation of the formulation and the process
parameters is a prerequisite for the feasibility of the process, but these parameters had
only a minor influence on the tablet properties under conditions which allow continuous
tablet production. The high porosity of tablets prepared by cold extrusion indicates that
this technique might also be suited for the tablet production of formulations with poor
disintegration properties.
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8 Single-step granulation/tabletting results in strong and fast-
disintegrating tablets: mechanism
Accepted for publication in Eur. J. Pharm. Biopharm.
8.1 Introduction
Recently, single-step granulation/tabletting was reported as an interesting alternative
for conventional granulation followed by compression (Keleb et al. 2001). This
technique resulted in strong and fast disintegrating tablets with a higher porosity and
larger pores than obtained by compression and allowed to avoid problems associated
with compression and scaling-up. For different types of lactose single-step
granulation/tabletting resulted in tablets with a higher tensile strength and faster
disintegration than obtained by compression of granules prepared by high-shear
granulation (Keleb et al. 2004). Single-step granulation/tabletting also resulted in
strong and fast disintegrating tablets for highly dosed drugs with inherent difficulties
in tablet manufacturing such as poor compressibility (e.g. paracetamol) and poor flow
and disintegration properties (e.g. cimetidine) (Chapter 10). Similar tablet properties,
namely a high tensile strength and fast disintegration, were reported after wet
compression of α-lactose monohydrate (Bi et al. 1999). The fast disintegration was
attributed to the more porous structure. The higher tensile strength, despite the
relatively high porosity, was suggested to be due to a different mechanism of tablet
formation i.e. by solid bridges rather than by intermolecular distance forces, such as
Van der Waals attraction forces and hydrogen bonding the main forces involved in α-
lactose monohydrate tablets made by compression. It was therefore thought
reasonable to assume that solid bridges are the dominating bonding mechanism
involved in tablets prepared by single-step granulation/tabletting. Several methods
have been described to calculate the dominating interparticulate bonding mechanism
in a compact (Adolfsson et al., 1999; Nystrom and Karehill, 2001). Recently, Olsson
and Nyström (2001) proposed an interaction factor to provide qualitative information
on the dominating bond types in tablets. The interaction factor is expected to be
higher for tablets in which bonding occurs mainly through strong bonds (i.e. solid
bridges) than for tablets in which bonding occurs solely by weaker forces (i.e.
distance forces). Although the interaction factor could indicate the involvement of
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strong bond types, its value to identify these strong bond types as solid bridges is
limited. The mechanism of bonding or bond type has been assessed in several ways.
Compacting tablets or evaluating the strength of tablets in media with differing
dielectric constants were used to investigate the contribution of intermolecular
attraction forces (Olsson et al. 1996; Luangtana-Anan and Newton 1990), while
electrical conductivity measurements showed to be a valuable tool to prove the
presence of solid bridges in tablets (Bhatia and Lordi, 1979).
The purpose of this study was to explain the high tensile strength and fast
disintegration of tablets prepared by single-step granulation/tabletting by analysing
the internal tablet structure and determination of the bonding mechanism. To evaluate
whether the internal tablet structure and the bonding mechanism are affected by the
formulation, formulations with different physical properties were analysed.
8.2 Materials
α-Lactose monohydrate 200M (aqueous solubility: 1 in 4.6, particle size: 98% <
150µm) (DMV, Veghel, The Netherlands) was used as an excipient. Paracetamol
(aqueous solubility: 1 in 70, particle size: 98% < 600 µm) (Mallinckrodt Inc., Capitol
Boulevard, NC, USA) and cimetidine (aqueous solubility: 1 in 88, particle size: 100%
< 250µm) (Roig Farma S.A., Barcelona, Spain) were used as drugs with poor
compactibility and poor flow and disintegration properties, respectively.
Polyvinylpyrrolidone (PVP, Kollidon K30, BASF, Ludwigshafen, Germany) was
used as a binder.
8.3 Methods
8.3.1 Single-step granulation/tabletting
Single-step granulation/tabletting was performed on a MP 19 TC 25 laboratory scale
co-rotating twin screw extruder (APV Baker, Newcastle-under-Lyme, UK) having a
length - to - diameter ratio of 25/1 and equipped with a standard screw profile having
two mixing sections and a circular 9 mm die attached to the extruder outlet (Keleb et
al., 2001). Processing parameters were set at 25°C barrel temperature, 250 rpm screw
speed and 5.6 kg/h total input rate (powder feed rate + liquid feed rate). The powder
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(α-lactose monohydrate, paracetamol and cimetidine or a mixture of one of these
drugs with α-lactose monohydrate) was fed on top of the screws using a twin screw
feeding system. Drug/excipient mixtures were previously blended for 15 min at 60
rpm in a planetary mixer (Kenwood Major, Hampshire, UK). The granulation liquid
(pure water or an aqueous PVP solution) was pumped into the first zone of the
extruder barrel by means of a peristaltic pump (Watson Marlow Type 505L,
Cornwall, UK). The water concentration during extrusion was optimized for each
formulation and was 9.5 and 11.5% (w/w) for α-lactose monohydrate with and
without PVP, respectively; 10.5 and 9.5% (w/w) for the formulations containing 97.5
and 80% (w/w) paracetamol, respectively and 14.5% (w/w) for all formulations
containing cimetidine. All water concentrations were calculated based on the wet
extruded mass, whereas all PVP and drug concentrations were calculated based on dry
tablet weight. In order to ensure equilibration of the extruder at the test conditions,
samples were only taken 10 min after the process was started. Immediately after
extrusion tablets (thickness: 4 mm) were manually cut using surgical blades. The
tablets were oven-dried at 25°C for 20 h.
8.3.2 Granulation
The extrusion/granulation was performed on a MP 19 TC 25 laboratory scale co-
rotating twin screw extruder (APV Baker, Newcastle-under-Lyme, UK) having a
length - to - diameter ratio of 25/1 and equipped with two standard screws and die
block (Keleb et al., 2002). The extruder was set at a constant temperature of 25°C.
Processing conditions during extrusion were: a screw speed of 250 rpm and a total
input rate of 5.6 kg/h. The water concentration during extrusion was 7.5% (w/w). The
powder (α-lactose monohydrate, paracetamol and cimetidine or a mixture of one of
these drugs with α-lactose monohydrate) was fed on top of the screws using a twin
screw feeding system. Drug/excipient mixtures were previously blended for 15 min at
60 rpm in a planetary mixer (Kenwood Major, Hampshire, UK). The granulation
liquid (pure water or an aqueous PVP solution) was pumped into the first zone of the
extruder barrel by means of a peristaltic pump (Watson Marlow type 505L, Cornwall,
UK). At the end of the extruder barrel large extrudates were obtained. Those
extrudates (400 g) were immediately wet sized using a 1 mm oscillating sieve
(Frewitt, Fribourg, Switzerland), operated at a minimal distance between rotor and
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sieve. In order to ensure equilibration of the extruder at the test conditions, samples
were collected only 10 min after the process was started.
High shear granulation was performed in a Gral 10 (Machines Collette, Wommelgem,
Belgium). The granulation process was performed at 500 rpm impeller speed, 3000
rpm chopper speed, a total load of 0.16 kg/l and 10% (w/w) water concentration. After
mixing the powder for 2 min, the required amount of granulating liquid was
continuously added over a period of 10 min using a peristaltic pump (Watson Marlow,
Cornwall, UK). Wet massing was continued for 2 min following complete liquid
addition. The granules were oven dried at 25°C for 20 h.
8.3.3 Compression
Granules (F250-710 µm) were blended with 0.5% (w/w) magnesium stearate (<90 µm)
(BUFA, Brussels, Belgium) in a Turbula mixer (W.A. Bachofen, Basel, Switzerland)
for 1 min. Tablets (250 mg) were prepared using an eccentric compression machine
(Korsch EKO, Berlin, Germany) equipped with a flat faced double punch of 9 mm at
a compression force of 10 kN.  Similarly, the powder mixtures were compressed into
tablets after mixing with 0.5% (w/w) magnesium stearate (<90 µm). Tablets intended
for electrical conductivity measurements were prepared without magnesium stearate
as this compound dramatically decreased the conductivity. For the preparation of
these tablets die lubrification with a magnesium stearate solution (1%, w/v) in ethanol
was performed.
8.3.4 Tablet characterisation
The same methods as described in Chapter 3 were used to determine the tensile
strength and disintegration time of the tablets. The same method as used in Chapter 4
was used to determine the porosity of the tablets and the internal structure of the
tablets was evaluated by scanning electron microscopy (SEM) (JSM 5600 LV
scanning electron microscope, JEOL Europe, Zaventem, Belgium).
8.3.4.1 Measurement of total pore surface area (BET)
Specific surface area of the granules was measured in triplicate using nitrogen
adsorption (Gemini, Micromeretics). The samples were vacuum dried for 60 min
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before analysis. The specific surface area was calculated according to the BET
equation.
8.3.4.2 Electrical conductivity measurements
A schematic diagram of the system used to measure the electrical resistivity of the
tablets is shown in figure 1. A Cu-plate of 8 cm diameter and 0.8 cm thickness was
attached to a teflon block. On top of the Cu-plate and on both sides of the tablets, Ag-
paste (Acheson Electrodag 1415M, Rotterdam, The Netherlands) was applied to
obtain good electrical contact between the sample and the electrometer. Two contact
needle electrodes were used to measure conductance through the tablets. One
electrode made contact with the Cu-plate, the second one was contacted to the tablet.
The height of the needle could be varied to obtain good contact with the tablets. In
parallel, a 10 V battery was connected. A shielded cable connected the needle
electrodes to the electrometer (Keithly 610B, Cleveland, Ohio, USA). Stable values
were obtained within 1 min. of recording. The accuracy of the measurements was
checked by connecting standard resistors (1 MOhm-10 GOhm) between the electrodes
and the plate. For each tablet type, a minimum of five tablets was measured to obtain
statistical significance. The reported values are averages of replicated runs. Sample
dimensions were recorded with a micrometer.
Figure 1: Schematic diagram of the system used to measure the electrical resistivity
of the tablets.
Cu-plate +
Ag-paste
Tablet
Electrometer
Grounding
+ -
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The specific resistance was calculated from the measured currents and the dimensions
of the tablets according to:
           
areaPunch   .
cknessTablet thi   .resistance Specific
I
V= (Ω.cm) (3)
Where I is the measured current (A) and V is the voltage of the battery (10V).
8.3.4.3  Determination of dominating bonding mechanism
The dominating bonding mechanism was determined by calculating the interaction
factor (σb*) as follows:
                                                   σt / (1-ε) * S   (4)
in which σt is the tablet tensile strength, ε is the tablet porosity and S is the specific
surface area. The thus obtained value (σb*) should be regarded as a qualitative
description of the bond types in the tablet, and not a quantitative value of average
bond strength. The interaction factor (σb*) is expected to be higher for tablets in
which bonding occurs mainly by strong bonds (i.e. solid bridges) than for tablets in
which bonding occurs solely by weaker forces (i.e. distance forces).
8.4 Statistical analysis
Before any analysis was performed, the data were tested for normal distribution with
the Kolmogorov-Smirnov test and the homogeneity of variances was tested with the
Levene’s test. The influence of the production process on the tablet characteristics
was determined using one-way ANOVA (P < 0.05). To further compare the effects of
different production processes, a multiple comparison among pairs of means was
performed using the Scheffé test with P < 0.05 as a significance level. For all
statistical analyses, the computer program SPSS version 11.0 was used.
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8.5 Results and discussion
Table 1 presents the tensile strength, the disintegration time, the porosity and the
specific surface area obtained for tablets manufactured using the different processes.
As tablets containing 97.5% (w/w) paracetamol could only be manufactured by
single-step granulation/tabletting, tablets containing 80% (w/w) paracetamol were
prepared to compare the different techniques. Single-step granulation/tabletting
resulted in a higher tensile strength than obtained with the other manufacturing
techniques, except in the case of cimetidine tablets. In all cases tablets manufactured
by single-step granulation/tabletting had a similar or lower disintegration time. The
faster disintegration could be explained by differences in internal tablet structure.
Porosity and BET measurements revealed that tablets made by single-step
granulation/tabletting had a similar or higher porosity and a similar or lower surface
area. These data indicated that larger pores were present in tablets manufactured by
single-step granulation/tabletting than in compressed tablets. This was in agreement
with a previous study showing that the pore size of α-lactose monohydrate tablets
prepared by single-step granulation/tabletting was 10-fold larger than in tablets
manufactured by direct compression (Keleb e al., 2001). The differences in pore
structure were also obvious from the SEM pictures of the tablet fracture planes (Fig.
2). Tablets manufactured by single-step granulation/tabletting showed a more porous,
sponge-like structure, while compressed tablets showed a more dense structure. In all
cases differences in internal tablet structure could explain the superior disintegration
properties.
As tablets produced by single-step granulation/tabletting had larger pores, their higher
tensile strength could not be attributed to a larger number of bonds. Therefore, it was
assumed that a stronger bond type was involved. Determination of the interaction
factor confirmed this hypothesis. For each formulation studied a higher interaction
factor was obtained for tablets manufactured by single-step granulation/tabletting than
for compressed tablets, except for tablets containing cimetidine (Fig. 3).
Electrical conductance measurements revealed for all tablets manufactured by single-
step granulation/tabletting a significantly lower specific resistivity than for
compressed tablets (Fig. 4), indicating that solid bridges were involved. This was
confirmed by SEM pictures (Fig. 2), showing that in tablets prepared by single-step
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Table 1: Properties of tablets prepared by different manufacturing techniques.
Formulation Tablet production process Tensile strength Disintegration time Porosity Specific surface area
(MPa)  (s) (%)  (m²/g)
α-Lactose monohydrate Single-step granulation/tabletting 1.00 ± 0.15 a 35 ± 3 a 22.9 ± 1.46 a 0.98 ± 0.01 a
High shear granulation + compression 0.67 ± 0.05 b 83 ± 16 b 14.5 ± 1.08 b 1.73 ± 0.00 b
Extrusion granulation + compression 0.50 ± 0.04 b 12 ± 24 c 13.5 ± 0.61 b 1.74 ± 0.01 b
Direct compression 0.89 ± 0.17 a 161 ± 9 d 14.2 ± 1.70 b 1.84 ± 0.01 c
 α-Lactose monohydrate (97.5%), PVP (2.5%) Single-step granulation/tabletting 1.85 ± 0.22 a 279 ± 91 a 22.9 ± 0.58 a 1.00 ± 0.06 a
High shear granulation + compression 0.91 ± 0.07 b 266 ± 32 a 20.2 ± 0.83 a 0.97 ± 0.00 b
Extrusion granulation + compression 0.79 ± 0.05 b 615 ± 50 b 21.3 ± 0.95 a 1.78 ± 0.00 c
Direct compression 0.70 ± 0.08 b 311 ? 39 a 18.3 ± 0.60 a 1.80 ± 0.01 c
Paracetamol (97.5%), PVP (2.5%) Single-step granulation/tabletting 0.92 ± 0.09 a 593 ± 107 da 22.1 ± 2.04 a 1.37 ± 0.01 a
Paracetamol (80%), α-lactose monohydrate (17.5%), Single-step granulation/tabletting 1.39 ± 0.22 b 184 ± 50 b 22.0 ± 0.40 a 1.35 ± 0.03 a
PVP (2.5% High shear granulation + compression 0.75 ± 0.13 a 2799 ± 145 c 14.7 ± 0.86 b 0.98 ± 0.00 b
Extrusion granulation + compression 0.95 ± 0.14 a 1712 ± 250 d 19.5 ± 0.32 c 1.44 ± 0.01 c
Direct compression - - - -
Cimetidine (97.5%), PVP (2.5%) Single-step granulation/tabletting 0.85 ± 0.17 a 638 ± 267 a 30.7 ± 1.40 a 2.27 ± 0.01 a
High shear granulation + compression 1.83 ± 0.19 b > 3600b 8.9 ± 2.30 b 1.85 ± 0.01 b
Extrusion granulation + compression 1.86 ± 0.21 b > 3600b 15.1 ± 0.09 c 2.55 ± 0.01 c
Direct compression 0.89 ± 0.14 a > 3600b 7.9 ± 2.10 b 2.08 ± 0.01 d
Cimetidine (80%), α-lactose monohydrate (17.5%), Single-step granulation/tabletting 1.30 ± 0.16 c 198 ± 25 c 25.5 ± 1.08 d 2.28 ± 0.03 a
PVP (2.5%)
a,b,c,d values within the same group having the same subscript were not significantly different  (Scheffé test, p < 0.05).
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a: α-lactose monohydrate (97.5%, w/w) and PVP (2.5%, w/w) prepared by high shear
granulation followed by compression
b: α-lactose monohydrate (97.5%, w/w) and PVP (2.5%, w/w) prepared by single-step
granulation/tabletting
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c: tablets containing paracetamol (80%, w/w), α-lactose monohydrate (17.5%, w/w)
and PVP (2.5%, w/w) prepared by single-step granulation/tabletting
d: cimetidine (97.5%, w/w) and PVP (2.5%, w/w) prepared by single-step
granulation/tabletting
Figure 2: SEM pictures of tablets.
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Figure 3: Interaction factor for tablets consisting of pure α-lactose monohydrate, α-
lactose monohydrate and PVP (2.5%, w/w), α-lactose monohydrate,
paracetamol (80%, w/w) and PVP (2.5%, w/w), and cimetidine and PVP
(2.5%, w/w) prepared by single-step granulation/tabletting (   ), extrusion
granulation + compression (    ), high shear granulation + compression (    )
and direct compression (    ).
granulation/tabletting the particles were glued together by solid bridges formed by
solidification of dissolved excipient and/or drug particles.
Comparison of the characteristics of tablets of different formulations manufactured by
single-step granulation/tabletting revealed differences in tablet strength, porosity,
disintegration time, total pore surface area as well as differences in interaction factor.
SEM pictures also showed different internal structure of these tablets (Fig. 2). In an
attempt to explain these differences, the characteristics of paracetamol and cimetidine
tablets with the same drug concentration (both drugs have a similar solubility, but a
different particle size) and those of pure cimetidine and lactose tablets with PVP
(cimetidine and α-lactose monohydrate have a similar particle size, but a different
solubility) were compared. Comparison of formulations with a different solubility
revealed that a lower solubility resulted in a lower tensile strength, a higher
disintegration time, a higher specific surface area and a lower interaction factor (i.e.
an interaction factor of 0.54 and 1.24 for tablets containing 97.5% (w/w) cimetidine
and paracetamol, respectively, and 2.40 for tablets containing 97.5% (w/w) α-lactose
monohydrate). These differences are due to the tablet binding mechanism during
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single-step granulation/tabletting as a soluble (lactose) dissolves to a larger extent
during processing and on subsequent drying more solid bridges are formed. These
results were in agreement with Khankari and Hontz (1997) who reported that the
strength of solid bridges is mainly determined by the amount of solids deposited in the
solid bridges. However, it should be emphasized that even for these formulations with
less solid bridge formation during single-step granulation/tabletting (due to the poor
solubility of the component), tablets with acceptable strength were obtained.
Comparison of the cimetidine and paracetamol formulations revealed that particle size
had an important effect on the interaction factor. This is also due to the tablet
formation mechanism during single-step granulation/tabletting as the particles of these
poorly soluble formulations will only dissolve partially and the original particle size
will determine the pore structure of the tablet (larger pores being obtained for
formulations having a larger particle size).
Figure 4: Resistivity (mean ± s.d., n= 5- 7) of tablets consisting of pure α-lactose
monohydrate, α-lactose monohydrate and PVP (2.5%, w/w), α-lactose
monohydrate, paracetamol (80%, w/w) and PVP (2.5%, w/w), and
cimetidine and PVP (2.5%, w/w) prepared by single-step
granulation/tabletting (    ), extrusion granulation + compression (    ) , high
shear granulation + compression (   )  and direct compression (   ). (*)
Significantly different from other values in the same group (Scheffé test,
P<0.05)
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Hence fewer but larger solid bridges will be formed, explaining the larger interaction
factor for paracetamol. The similar tensile strength of 97.5% (w/w) paracetamol and
cimetidine tablets, despite their different interaction factor, could be explained by a
higher number of solid bridges formed in the cimetidine tablets. This again confirmed
the proposed mechanism of tablet formation.
8.6  Conclusion
During single-step granulation/tabletting solid bridges are the predominant bonding
mechanism involved in tablet formation. The physical properties of the formulation
clearly affected the tensile strength and the internal structure, but this never resulted in
an unacceptable tablet quality. This is in contrast to tabletting techniques involving
compression, whereby the material properties determine the dominating bond type
and can have a detrimental effect on the tablet properties.
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9 Single step granulation/tabletting of different grades of lactose: a
comparison with high shear granulation
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9.1 Introduction
Recently a novel tabletting method, called single-step granulation/tabletting, was
developed and described by Keleb et al.(2001). This technique not only allowed
continuous production, but also yielded stronger and faster disintegrating tablets than
conventional granulation/tabletting. Further investigation of α-lactose monohydrate
tablets produced by this technique revealed that tablet formation by single-step
granulation/tabletting is mainly due to formation of solid bridges between particles
without major particle deformation or fracture (Keleb et al., 2001; Vermiere et al.,
2004). Therefore, the particle properties may have an influence on the tablet
formation and tablet properties.
Lactose is the most widely used excipient in tablet formulation and available in
different grades. Lactose exists in two isomeric forms and can be either crystalline or
amorphous. These two polymorphic types of lactose possess different properties such
as solubility, density, melting point and hardness. In addition the different types of
lactose are available in different particle size. It is well-known that the different
lactose grades have different granulation and compression properties (Lerk, 1993).
The first aim of this study was to investigate the influence of the physical properties
of lactose on the single-step-granulation/tabletting process and on the properties of
tablets obtained using this process and to compare the quality of those tablets with
tablets produced by compression after high shear granulation. In addition the stability
of α-lactose monohydrate 200M tablets prepared by single-step granulation/tabletting
was evaluated.
9.2 Materials
The different grades of lactose used were: crystalline α-lactose monohydrate
(Pharmatose 450M, Pharmatose 200M, Pharmatose 100M, Pharmatose 90M),
anhydrous β-lactose (Pharmatose DCL 21) and spray dried lactose (Pharmatose
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DCL 11), all obtained from DMV (Veghel, The Netherlands). The physical properties
of the different grades of lactose used are listed in Table 1. Polyvinylpyrrolidone
(PVP, Kollidon K30) was received from BASF (Ludwigshafen, Germany).
Table 1: The physical properties of different grades of lactose.
9.3 Methods
9.3.1 Single-step granulation/tabletting
Single-step granulation/tabletting was performed on a MP 19 TC 25 laboratory scale
co-rotating twin screw extruder (APV Baker, Newcastle-under-Lyme, UK) having a
length - to - diameter ratio of 25/1, equipped with a standard screw profile and a
circular 9 mm die attached to the extruder outlet. Processing parameters were set at
25°C barrel temperature, 250 rpm screw speed, 5.6 kg/h total input rate and 11.5 and
9.5% water concentration for formulations without and with 2.5% PVP, respectively.
These parameters are the optimal processing parameters for α-lactose monohydrate
200M (Keleb et al. 2001). Each formulation was processed at these reference
conditions. If the process blocked (for formulations without PVP) or discontinuous
extrudate flow (for formulations containing PVP) was observed, further process
optimisation was performed.
The granulation liquid (pure water or an aqueous PVP solution) was pumped into the
extruder barrel using a peristaltic pump (Watson Marlow, Cornwall, UK). All water
concentrations mentioned are based on the wet extruded mass, while the PVP
concentration is based on dry weight. Immediately after extrusion, tablets (thickness:
4 mm) were manually cut using surgical blades (Keleb et al. 2001). The tablets were
oven-dried at 25°C for 20 h.
Type Crystallinity* Particle size** Morphology Bulk density Solubility
(%) (µm) (g/cm3 )
α-Lactose monohydrate  90M 100 135 non-granular 0.76 1 in 5
α-Lactose monohydrate  100M 100 130 non-granular 0.75 1 in 5
α-Lactose monohydrate  200M 100 40 non-granular 0.55 1 in 5
α-Lactose monohydrate  450M 100 20 non-granular 0.47 1 in 5
Anhydrous β-lactose 100 150 granular 0.67 1 in 2.2
Spray dried lactose 80-85 110 granular 0.61 Unknown
* Crystalline fraction
**Sieve diameter (certificate of analysis, DMV)
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9.3.2 High shear granulation and tabletting
Formulations successfully processed by single-step granulation/tabletting were also
processed by high shear granulation. The high shear granulation process was
performed in a Gral 10 (Machines Collette, Wommelgem, Belgium) (capacity of high
shear mixer: 8 l) at 500 rpm impeller speed, 3000 rpm chopper speed, a total load of
0.16 kg.l-1 and 10% water concentration. These parameters are the optimal granulation
parameters of α-lactose monohydrate 200M (Keleb et al. 2002; Ameye et al., 2002).
After a 2 min mixing period of the powder, the required amount of granulation liquid
(pure water or an aqueous 2.5% PVP solution) was continuously added over a period
of 10 min using a peristaltic pump (Watson Marlow, Cornwall, UK). Wet massing
was continued for 2 min following complete liquid addition. All water concentrations
mentioned are based on the wet extruded mass, while PVP concentration is based on
dry weight.
The granules (F250-710 µm) were blended with 0.5% (w/w) magnesium stearate (<90
µm) (BUFA, Brussels, Belgium) in a Turbula mixer (Bachofen, Basel, Switzerland)
for 1 min. Tablets (250 mg) were prepared using an eccentric compression machine
(Korsch EKO, Berlin, Germany) equipped with a flat faced double punch of 9 mm at
a compression force of 10 kN per tablet. Similarly, tablets were prepared with die
lubrication using magnesium stearate solution (1%, w/v) in ethanol.
9.3.3 Tablet evaluation
The same methods as described in Chapter 3 were used to determine the friability,
tensile strength and disintegration of the tablets. The porosity of the tablets was
determined as described in Chapter 4.
9.3.4 Tablet stability
α-Lactose monohydrate tablets without and with 2.5% PVP prepared by single-step
granulation/tabletting, were stored at 60% RH – 25°C and 75% RH – 40°C for one
year. The tablets were evaluated for tensile strength, friability and disintegration time
after 1, 90, 180 and 360 days.
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9.4 Statistical analysis
The influence of lactose grades, production technique and storage on tablet tensile
strength and disintegration time was determined using one-way ANOVA. To further
compare the influence of those factors on the tablet properties a multiple comparison
among pairs of means of tensile strength and disintegration time was performed using
Scheffé test with P < 0.05 as a significance level. The data were first tested for
normality with a Kolmogorov-Smirnov test and for homogeneity of the variances with
a Levene’s test. Statistical analysis was performed using the computer program SPSS
version 11.0.
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9.5 Results and discussion
The influence of lactose particle size on the feasibility of single-step
granulation/tabletting and on the properties of the tablets was investigated by
comparing α-lactose monohydrate 450M, 200M, 100M and 90M. The influence of
lactose morphology and crystallinity was investigated by comparing anhydrous β-
lactose, spray dried lactose and α-lactose monohydrate 90M, which have a similar
particle size but different particle morphology and crystallinity.
9.5.1 Influence of the particle properties on single-step granulation/tabletting
process.
9.5.1.1 Influence on powder feeding
Although α-lactose monohydrate 200M was easily fed from the feed hopper towards
the extrusion barrel using a double screw feeder, the other lactose grades exhibited
problems during feeding. α-Lactose monohydrate 100M and 90M induced too much
friction resulting in a gradual decrease in feeding rate and difficulties in the screw
rotation or even blocking of the screw movement. α-Lactose monohydrate 450M
tended to stick at the hopper surface during feeding, mainly due to the cohesiveness of
the powder leading to feeding inconsistencies. Powder feeding of anhydrous β-lactose
exhibited similar problems as α-lactose monohydrate 90M. However, spray dried
lactose, which has a similar particle size but different shape (round particles) was
reproducibly fed into the extruder barrel. These results indicated that not only particle
size but also particle morphology affected feeding by the double screw feeder. These
observations clearly indicated the need of the use of a suitable feeding system.
9.5.1.2 Influence on the total input rate
To perform single-step granulation/tabletting adequate pressure at the die block is
required to push the wet plastic mass through the die. For formulations without PVP
sufficient pressure is required to avoid die blocking (probably due to drying of the
extrudates in the die). For formulations with PVP a sufficient pressure is required to
ensure good shape and continuous flow of the extrudates. The required pressure is
only obtained at a certain degree of screw filling, which depends on the material
properties. For instance, a total input rate of 5.6 kg/h used previously for α-lactose
Single-step granulation/tabletting of different lactose grades 129
monohydrate 200M (Keleb et al. 2001) was too low for α-lactose monohydrate 100M
and 90M, which required a total input rate of at least 6.5 kg/h. On the other hand for
α-lactose monohydrate 450M the process was only possible at a total input rate of 4.5
kg/h. Anhydrous β-lactose and spray dried lactose had a lower optimal total input rate
(5.6 kg/h) when compared with α-lactose monohydrate 90M. This indicated that
particle size and particle morphology of lactose affected the total input rate and thus
the capacity of the process.
9.5.1.3 Influence on the optimal water concentration
Water concentration during extrusion has a great influence on the extrudability (Keleb
et al., 2002; Kleinebudde and Lindner 1993). At concentrations above the optimum
level the mass became oversaturated and the resulting extrudates were difficult to
manipulate, while concentrations just below the optimum yielded dry extrudates
which were difficult to cut. A further reduction of the water concentration blocked the
process due to the high viscosity of the wet mass.
For formulations without PVP, the extrudability during single-step granulation/tablet-
ting was highly influenced by the size of lactose particles as shown in Table 2.
Without PVP, it was only possible to process α-lactose monohydrate 200M at the
reference screw speed. Other grades of lactose were difficult to process even at a
higher water concentration due to improper viscosity and elasticity. Possibly the
residence time at the reference screw speed is to short to produce a mixture with
suitable properties to be extruded.
Addition of 2.5% PVP allowed single-step granulation/tabletting of all lactose grades
studied. Comparison of the optimal water concentration during the process revealed
that this was affected by the particle size. Decreasing lactose particle size resulted in a
increasing the water concentration required for single-step granulation/tabletting.
9.5.2 Influence of particle properties on the tablet properties
Without PVP, single-step granulation/tabletting was only feasible for α-lactose
monohydrate 200M. These tablets exhibited a tensile strength of 1.0 MPa, a friability
of 0.74% and a disintegration time of 36 s. Compared to single step
granulation/tabletting α-lactose monohydrate 200M tablets without PVP produced by
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Table 2: Process evaluation parameters obtained during single-step granulation/tablet-
ing of different lactose grades.
compression after high shear granulation exhibited a significantly lower tensile
strength (0.67 and 0.71 MPa for tablets produced with 0.5% magnesium stearate and
with die lubrication, respectively) and a higher friability (1.67 and 1.74%,
respectively). However, a significantly higher disintegration time (83 s) was only
obtained for tablets produced with 0.5% magnesium stearate.
Input Water PVP Temperature Power consumption
(kg/h) (%) (%) (°C) (%)
5.6 11.5 0        Process blocked due to die blocking
6.5 11.5 0
6.5 13.5 0
5.6 9.5 2.5
6.5 9.5 2.5 40 51
5.6 11.5 0
6.5 11.5 0
6.5 13.5 0
5.6 9.5 2.5
6.5 9.5 2.5 40 23
5.6 11.5 0 33 23
5.6 9.5 2.5 36 25
5.6 11.5 0
4.5 11.5 0
4.5 15.5 0
5.6 9.5 2.5
4.5 9.5 2.5
4.5 10.5 2.5 45 27
5.6 11.5 0
5.6 15.5 0
5.6 20.0 0
5.6 9.5 2.5
5.6 10.5 2.5 36 31
5.6 11.5 0
5.6 13.5 0
5.6 9.5 2.5 36 39
α-Lactose monohydrate 100M
Discontinuous extrudates flow
       Process blocked due to die blocking
       Process blocked due to die blocking
       Process blocked due to die blocking
       Process blocked due to die blocking
       Process blocked due to die blocking
Process stopped due to hard screw movemen
Wet extrudates
    Powder accumulated at inlet
α-Lactose monohydrate 200M
Anhydrous β-lactose
Process parameters Process evaluation parameters Remarks
       Process blocked due to die blocking
       Process blocked due to die blocking
α-Lactose monohydrate 90M
       Process blocked due to die blocking
Wet extrudates
Spray dried lactose
Discontinuous extrudates flow
α-Lactose monohydrate 450M
       Dry extrudates
       Process blocked due to die blocking
       Process blocked due to die blocking
Wet extrudates
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Fig. 1a shows the tensile strength of tablets with 2.5% PVP obtained by single-step-
granulation/tabletting and by compression (after blending with magnesium stearate
and after die lubrication) after high shear granulation. For tablets prepared by single
step granulation/tabletting lactose particle size and particle morphology did not
significantly affect tensile strength and it was always higher than 1 MPa. Comparing
the lactose tablets with 2.5% PVP and produced by both techniques revealed that
single-step granulation/tabletting resulted in a significantly higher tensile strength for
all formulations.
Figure 1a: Tensile strength of tablets (mean ± standard deviation) produced with
different grades of lactose with 2.5% PVP produced by single-step
granulation/tabletting (   ) and by compression after high shear granulation
with magnesium stearate (    ) and with die lubrication (    ).
The friability was below 1% for all tablets containing PVP, except for α-lactose
monohydrate 100M tablets prepared by compression after high shear granulation.
Fig. 1b shows the disintegration time of tablets with 2.5% PVP obtained by single
step-granulation/tabletting and by compression after high shear granulation.
All tablets produced by single-step granulation/tabletting had a disintegration time
below 400 s. Changing the particle size of α-lactose monohydrate significantly
influenced the disintegration time whereas, disintegration of α-lactose monohydrate
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90M tablets was significantly slower compared with spray dried lactose and
anhydrous β-lactose probably due to solubility differences.
Comparison of tablet disintegration time obtained by both techniques indicated that
single-step granulation/tabletting yielded tablets with a significantly lower
disintegration time compared with those produced by compression after high shear
granulation, except for tablets prepared from α-lactose monohydrate 90M and 200M,
which had a similar disintegration time.
Figure 1b: Disintegration time of tablets (mean ± standard deviation) produced with
different grades of lactose with 2.5% PVP produced by single-step
granulation/tabletting (   ) and by compression after high shear granulation
with magnesium stearate (    ) and with die lubrication (    ).
9.5.3 Stability of tablets produced by single-step granulation/tabletting
It is well known that the properties of α-lactose monohydrate tablets can be affected
by storage (Stubberud et al., 1996) and that this is mainly due to change in the
bonding. Tablets obtained by single-step granulation/tabletting are bond mainly by a
solid bridges, whereas tablets prepared by compression are bond mainly by
intermolecular bonds.
The properties of these tablets could be affected differently during storage according
to the type of bonds acting between tablet particles. Therefore, the stability of tablets
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Table 3: The influence of long term and accelerated stability conditions on the properties of α-lactose monohydrate tablets without and with
2.5% PVP produced by single-step granulation/tabletting.
PVP Time Tensile strength Friability Disintegration Tensile strength Friability Disintegration
(%) (d) (MPa) (%) (s) (MPa) (%) (s)
0 1 1.09 (0.17) 0.65 27 (7) 1.07 (0.10) 0.99 42 (12)
90 1.07 (0.16) 0.58 32 (20) 0.93 (0.25) 0.64 45 (20)
180 0.97 (0.18) 0.82 53 (13) 0.96 (0.18) 0.84 99 (17)
360 1.03 (0.15) 0.80 43 (10) 1.10 (0.13) 0.70 125 (49)
2.5 1 1.47 (0.14) 0.42 162 (37) 1.29 (0.31) 0.73 182 (44)
90 1.60 (0.20) 0.57 193 (42) 0.99 (0.36) 0.79 313 (28)
180 1.32 (0.22) 0.59 172 (69) 1.34 (0.22) 0.65 223 (92)
360 1.63 (0.24) 0.90 297 (86) 1.27 (0.14) 0.59 358 (40)
75% RH - 40°C60% RH - 25°C
Standard deviations are given between parentheses 
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of α-lactose monohydrate 200M produced by single-step granulation/tabletting was
evaluated during one year storage at 60% RH-25°C and 75% RH-40°C.
Table 3 shows the influence of storage on the properties of tablets without and with
2.5% PVP produced by single-step granulation/tabletting. Storage did not result in
significant changes in the tensile strength, while a significant increase in the
disintegration time was observed for both formulations at both storage conditions. The
disintegration time always remained below 400 s. This is in contrast to Stubberud et
al. (1996) who reported that lactose monohydrate tablets prepared by compression
hardened during storage and indicate that the effect of storage on the mechanical
properties of tablets is dependent on the bonding mechanism.
Comparing the tablet properties obtained at different conditions revealed no
significant influence on the tensile strength, while a significantly higher disintegration
time was observed for the tablets stored at 75% RH and 40°C. The high disintegration
time at 75% RH-40°C could be attributed to a decrease in the tablet porosity from
24.6 to 18.1%. This change in porosity was mainly due to the continuous swelling and
transformation of PVP from the glassy state to a rubbery state at elevated humidity
and temperature (Kiekens et al., 2000; Fitzpatrik, 2002).
9.6 Conclusion
This study showed that the particle size and morphology of lactose can have a major
impact on the performance of single-step granulation/tabletting. However, selection of
the proper lactose grade and optimisation of the total input rate as well as PVP and
water concentration can easily solve these problems. Tablets of different grades of
lactose produced by single-step granulation/tabletting possess better qualities
compared to those obtained by compression after high shear granulation.
The stability study revealed that the physical properties of lactose tablets prepared by
single-step granulation/tabletting were maintained during storage.
It can be concluded that single-step granulation/tabletting can be applied to different
grades of lactose. Moreover, this technique is efficient and allows continuous
processing.
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10 Single step granulation/tabletting of highly dosed drugs: a
comparison with high shear granulation
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10.1 Introduction
The pharmaceutical industry often faces difficulties in the processing of highly dosed
drugs because many active substances have poor compactability or bad flow
properties. Using conventional tabletting techniques, suitable excipients are required
in order to obtain satisfactory tablets containing such drugs. However, for highly
dosed drugs, the percentage of excipient that can be incorporated in the formulation is
limited.
For some highly dosed drugs an improved compactability could be obtained by
changing the morphology of the drug crystals, but this requires strict process control
and can result in the incorporation of impurities in the drug crystals (Garekani et al.,
1999; 2000; Abdelillah et al., 1995; Di-Martino e al., 2001).
Recent experiments revealed that single-step granulation/tabletting of α-lactose
monohydrate yielded stronger and faster disintegrating tablets compared with those
produced by conventional compression.(Keleb et al., 2001). Further investigation of
these tablets indicated that their high tensile strength was attributed to a different
bonding mechanism, while the faster disintegration was explained by a higher
porosity and a larger pore size. This technique might therefore be useful for
processing highly dosed drugs.
Paracetamol is a highly dosed, medium water soluble drug possessing a poor
compactability and yielding tablets exhibiting a high tendency to cap and laminate.
Cimetidine is a highly dosed drug exhibiting good compactability, but poor flow and
poor tablet disintegration properties. The aim of this study was to assess the suitability
of single-step granulation/tabletting for the production of highly dosed paracetamol
and cimetidine tablets and to compare the properties of these tablets with those
obtained by compression after high shear granulation. The influence of storage on the
stability of paracetamol tablets produced by single-step granulation/tabletting was
assessed.
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10.2 Materials
α-Lactose monohydrate, with an average particle size of 36 µm, (Pharmatose 200M)
was obtained from DMV (Veghel, The Netherlands), cimetidine, with an average
particle size of 61 µm, was purchased from Roig Farma (Barcelona, Spain),
paracetamol with an average particle size of 139 µm, was obtained from Mallinckrodt
(Capitol Boulevard, NC, USA). Polyvinylpyrrolidone (PVP, Kollidon K30) and
crospovidone (PVP-CL, Kollidon CL) were received from BASF (Ludwigshafen,
Germany).
10.3 Methods
10.3.1 Single-step granulation/tabletting
Single-step granulation/tabletting was performed on a MP 19 TC 25 laboratory scale
co-rotating twin screw extruder (APV Baker, Newcastle-under-Lyme, UK) having a
length - to - diameter ratio of 25/1, equipped with a standard screw profile and a
circular 9 mm die attached to the extruder outlet (Keleb et al., 2001). Processing
parameters were set at 25°C barrel temperature, 250 rpm screw speed and 5.6 kg/h
total input rate (powder and binding liquid). The water concentration was optimised
for each formulation. When α-lactose monohydrate or crospovidone was incorporated
in the formulation it was preblended with the drug for 15 min at 60 rpm in a planetary
mixer (Kenwood Major, Hampshire, UK). The granulation liquid (pure water or a
2.5% aqueous PVP solution) was pumped into the barrel by means of a peristaltic
pump (Watson Marlow, Cornwall, UK). Immediately after extrusion, tablets
(thickness: 4 mm) were manually cut using surgical blades (Keleb et al., 2001). The
tablets were oven-dried at 25°C for 20 h. All water concentrations were calculated
based on the wet mass, while PVP, cimetidine and paracetamol concentrations were
calculated based on dry weight.
Single-step granulation/tabletting was characterised by monitoring the following
process parameters: die pressure, power consumption and barrel temperature. If the
power consumption exceeded 80% of its maximum or the die pressure was above 5
bar the process was stopped in order to avoid machine damage.
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10.3.2 High shear granulation and tabletting
High shear granulation was performed in a Gral 10 (Machines Collette, Wommelgem,
Belgium). When α-lactose monohydrate or crospovidone was incorporated in the
formulation it was blended with the drug for 15 min at 60 rpm in a planetary mixer
(Kenwood Major, Hampshire, UK). The granulation process was performed at 500
rpm impeller speed, 3000 rpm chopper speed, a total load of 0.16 kg.l-1 and 10%
water concentration. After a 2 min mixing period of the powder, the required amount
of granulation liquid (water or a 2.5% aqueous PVP solution) was continuously added
over a period of 10 min using a peristaltic pump (Watson Marlow, Cornwall, UK).
Wet massing was continued for 2 min following complete liquid addition. Granules
were oven dried at 25°C for 20 h.
The granules (F250-710 µm) were blended with 0.5% (w/w) magnesium stearate (<90
µm) (BUFA, Brussels, Belgium) in a Turbula mixer (W.A. Bachofen, Basel,
Switzerland) for 1 min. Tablets (250 mg) were prepared using an eccentric
compression machine (Korsch EKO, Berlin, Germany) equipped with a flat faced
double punch of 9 mm at a compression force of 10 kN per tablet.
10.3.3 Tablet evaluation
Tablet friability, tensile strength and disintegration were determined as described in
Chapter 3. To determine tablet porosity and in-vitro dissolution the methods described
in Chapter 4 were used.
10.4 Tablet stability
Tablets without PVP containing 20% paracetamol and with 2.5% PVP containing
80% paracetamol, prepared by single-step granulation/tabletting, were stored at 60%
RH and 25°C and at 75% RH and 40°C for one year. Tablets were evaluated for
tensile strength, friability, disintegration and dissolution after 1, 90, 270 and 360 days.
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10.5 Statistical analysis
Statistical analysis was performed using the computer program SPSS version 11.0.
Statistically significant differences between the tensile strength and disintegration
time of tablets produced by single-step granulation/tabletting and by compression
after high shear granulation as well as the influence of storage time and storage
conditions on tablet tensile strength and disintegration time were determined using a
one-way ANOVA. For further comparison of the influence of production technique,
storage time and condition on the tablet properties a multiple comparison among pairs
of means performed using Scheffé test with P < 0.05 as a significance level was used.
The data were tested for normal distribution with a Kolmogorov-Smirnov test. The
homogeneity of variances was tested with the Levene’s test.
10.6 Results and discussion
10.6.1 Process characterization
Table 1 shows the process parameters obtained during preparation of paracetamol and
cimetidine tablets by single-step granulation/tabletting. Paracetamol processing
without PVP was only possible at a drug load of 20%. Processing of formulations
containing 40% paracetamol or more created too much friction inside the extrusion
barrel and process blocking within the first few minutes of the process (even at higher
water concentrations). Cimetidine processing without PVP was not possible even at a
drug load of 20%. The fact that single-step granulation/tabletting of pure cimetidine
and paracetamol without PVP was not possible at the set parameters was probably due
to their physical properties. Both drugs have lower (1 in 70 for paracetamol and 1 in
88 for cimetidine) water solubility than α-lactose monohydrate 200M (1 in 5), which
was easily processed at the same settings. A formulation containing 20% paracetamol
could be processed whereas, single-step granulation/tabletting of a mixture containing
20% cimetidine was not feasible. This can be attributed to their different particle size.
This is in agreement with previous experiments showing that the feasibility of the
single-step granulation/tabletting depends on the particle size (Keleb et al., 2004).
Addition of 2.5% PVP improved processing and allowed single-step
granulation/tabletting of formulations containing up to 97.5% of both drugs
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investigated. Smooth surfaced extrudates were obtained at all concentrations except
for 97.5%, which had minor surface roughness. This roughness disappeared on
addition of 5% crospovidone.
When processing 97.5% cimetidine, a higher water concentration was required than
for the 97.5% paracetamol formulation. This difference could again be attributed to
the differences in particle size.
10.6.2 Tablet properties
Fig. 1a shows the tensile strength of paracetamol tablets produced by single-step
granulation/tabletting and by compression after high shear granulation. Tablets
without PVP containing 20% paracetamol prepared by single-step granulation/tablet-
ting showed an average tensile strength of 0.92 MPa. Although, high shear
granulation of formulations without PVP containing more than 20% paracetamol was
feasible, no acceptable tablets could be prepared from those granules. For the
formulation containing up to 40% paracetamol the tablet tensile strength was below
Table 1: Process parameters during single-step granulation/tabletting of formulations
containing paracetamol and cimetidine.
Drug PVP PVP-CL Water Die Pressure Barrel temperature Power consumption
(%) (%) (%) (%) (bar) (°C) (%)
20 0 0 11.5 1 33 22
40 0 0 11.5
100 0 0 11.5
20 2.5 0 9.5 0 33 19
40 2.5 0 9.5 1 33 22
60 2.5 0 9.5 1 31 19
80 2.5 0 10.5 3 30 25
97.5 2.5 0 10.5 3 35 27
92.5 2.5 5 10.5 0 38 30
20 0 0 17.5
100 0 0 11.5-25.0
80 2.5 0 14.5 0 36 25
97.5 2.5 0 14.5 0 36 34
92.5 2.5 5 14.5 0 33 31
Processing not feasible
Processing not feasible
Process parametersFormulation
Cimetidine
Paracetamol
Processing not feasible
Processing not feasible
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0.60 MPa for tablets prepared with blending with magnesium stearate and with die
lubrication. However, no tablets were obtained from granules containing 60%
paracetamol due to the tendency for capping and lamination. These data are in
agreement with Becker et al. (1997) who reported that paracetamol tablets produced
without binder had a poor strength.
Addition of 2.5% PVP to paracetamol formulations resulted in a significant increase
in tensile strength for both production techniques. This resulted in hard tablets up to a
paracetamol load of 97.5% when prepared by single-step granulation/tabletting. On
the contrary, the formulation containing 97.5% paracetamol still showed poor
compactability after high shear granulation. Becker et al. (1997) and Symecko et al.
(1993) reported similar results and stated that at least 5% binder (e.g. PVP) is required
to obtain paracetamol tablets with an adequate tensile strength. The results of tablet
tensile strength of both granulation techniques indicated that single step
granulation/tabletting resulted in improved tensile strength mainly due to the different
bonding mechanism, which come in agreement with data reported by Keleb et al
(2004) for different grades of lactose.
Comparison of the tensile strength obtained by both techniques revealed a
significantly higher tensile strength for all paracetamol tablets produced by single-step
granulation/tabletting.
Figure 1a: Tensile strength of paracetamol tablets produced with high shear
granulation without PVP (    ) and with 2.5% PVP (    ) and by single-step
granulation/tabletting without (    ) and with 2.5% PVP (    ).
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This higher tensile strength can be explained by the different bonding mechanism
involved in both techniques. By conventional compression, bonding occurs mainly
through intermolecular bonds. Paracetamol exhibits poor compactability due to the
weak intermolecular bonds established during compression. In single-step
granulation/tabletting bonding occurs mainly through solid bridges formed during
drying by resolidification of the material dissolved during the process (Keleb et al,
2001; Vermiere et al., 2004) and these solid bridges are much stronger than
intermolecular forces (Nystrom et al., 1993). Evaluation of the effect of paracetamol
concentration on tensile strength revealed that only an increase of the paracetamol
concentration to 97.5% resulted in a significant decrease of tensile strength. For all
formulations the friability of tablets produced by single-step granulation/tabletting
ranged between 0.68 and 0.91%, whereas tablet friability was above 1% for all tablets
produced by high shear granulation and compression, regardless of the lubrication
method employed. The addition of PVP resulted in a considerable reduction of the
tablet friability, but did not reduce the friability below 1%.
Fig. 1b shows the disintegration time of paracetamol tablets produced by single-step
granulation/tabletting and by compression after high shear granulation. For all
paracetamol tablets produced by single-step granulation/tabletting the disintegration
time remained below 10 min and was significantly lower than that of tablets made by
high shear granulation and compression. This faster disintegration can be attributed to
the higher tablet porosity as shown in Fig. 1c. For both production techniques, tablets
containing 2.5% PVP showed a significantly higher disintegration time than those
without PVP.
For tablets processed by single-step granulation/tabletting increasing the paracetamol
concentration resulted in a significantly higher disintegration time only when the drug
load was increased to 97.5%, while for tablets produced by high shear granulation and
compression the disintegration time increased progressively in function of drug
concentration.
For tablets containing more than 20% paracetamol prepared by high shear granulation
and compression the addition of PVP resulted in a disintegration time above 15 min.
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Figure 1b: Disintegration of paracetamol tablets produced  by high shear granulation
without PVP (  ) and with 2.5% PVP (  ) and by single-step
granulation/tabletting without PVP (    ) and with 2.5% PVP (    ).
Figure 1c: Porosity of paracetamol tablets produced with high shear granulation
without ( ) and with 2.5% PVP ( ) and by single-step
granulation/tabletting without (    ) and with 2.5% PVP (    ).
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At increasing paracetamol concentration the fraction of α-lactose monohydrate,
(having a 20-fold higher aqueous solubility) decreased and thus the overall solubility
of the formulation decreased. This decrease in solubility clearly affected the
disintegration time of tablets with low porosity (Fig. 1c) obtained by high shear
granulation and compression. The fact that this did not affect the disintegration time
of tablets produced by single-step granulation/tabletting indicated that the higher
porosity allowed to compensate for the differences in solubility.
Results of the dissolution testing of paracetamol tablets are shown in Fig. 2a and b.
Evaluation of the dissolution profiles revealed that tablets prepared by single-step
granulation/tabletting exhibited faster dissolution. As for the disintegration, this faster
dissolution can be explained by the higher porosity of tablets produced by single-step
granulation/tabletting. Tablets produced by single-step granulation/tabletting
complied with the USP requirements up to a drug load of 80%, while tablets produced
by compression after high shear granulation did only comply up to a drug load of
40%.
Figure 2a: Dissolution profiles of tablets with 2.5% PVP containing 80% (O), 97.5%
(V) paracetamol and 92.5% paracetamol with 5% crospovidone (  )
prepared by single-step granulation/tabletting process.
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Figure 2b: Dissolution profiles of tablets containing 20% (O), 40% (  ), 60% (Q) and
80% (♦)paracetamol prepared by compression after high shear
granulation.
Evaluation of the different tablet properties shows that by compression, no acceptable
tablets could be obtained without PVP and acceptable tablets were only obtained with
2.5% PVP up to 40% paracetamol. This clearly showed that for formulations with
poor compaction properties single-step granulation/tabletting allowed to manufacture
quality tablets, whereas conventional high shear granulation and tabletting failed. The
potential of the single-step granulation/tabletting process for producing tablets of
formulations with poor disintegration and flow properties was assessed using
cimetidine as a model drug.
Fig. 3a, b and c show the tensile strength, the disintegration time and the porosity of
cimetidine tablets produced by single-step granulation/tabletting and by compression
after high shear granulation. Tablets containing 97.5% cimetidine and 2.5% PVP
produced by single-step granulation/tabletting showed a significantly lower tensile
strength (0.85 MPa), a significantly lower disintegration time (< 15 min), lower
friability (0.93%) and faster dissolution than those produced by high shear granulation
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and compression (with blending with magnesium stearate). Similarly single step
granulation/tabletting showed a significantly lower tensile strength and lower
disintegration time than tablets produced after high shear granulation and compression
with die lubrication (data not shown). These results indicated that the improved
disintegration for tablets produced by single step granulation/tabletting is mainly due
to the higher porosity.
Although single-step granulation/tabletting resulted in an improved disintegration
time of cimetidine tablets mainly due to the higher porosity (Fig. 3c), incorporation of
17.5% α-lactose monohydrate 200M in the cimetidine formulation with PVP yielded
tablets with a significantly lower disintegration time (198 s), a significantly lower
tensile strength (1.30 MPa) and faster dissolution than those produced by high shear
granulation and compression. The dissolution profile of these cimetidine tablets with
17.5% α-lactose monohydrate complied with the pharmacopoeial requirements (Fig.
4). In another attempt to improve the disintegration and dissolution of pure cimetidine
tablets, 5% crospovidone was added. This resulted in a disintegration time below 3
min (Fig. 3b). The tablets produced by both techniques complied with the USP
requirements (not less than 75% of the labelled amount dissolved in 15 min) (Fig. 4).
Figure 3a: Tensile strength of cimetidine tablets containing 2.5% PVP produced by
high shear granulation  (    ) and by single-step granulation/tabletting (    )
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Figure 3b: Disintegration time of cimetidine tablets containing 2.5% PVP produced
by high shear granulation (    ) and by single-step granulation/tabletting
(    ).
Figure 3c: Porosity of cimetidine tablets containing 2.5% PVP produced by high
shear granulation (    ) and by single-step granulation/tabletting (    ).
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Figure 4: Dissolution profiles of cimetidine tablets with 2.5% PVP produced by
single-step granulation/tabletting containing 97.5% (O), 92.5% + 5%
crospovidone (Ο), 80% + 17.5% α-lactose monohydrate 200M (Q) and by
compression after high shear granulation containing 97.5% (  ) and 92.5%
cimetidine + 5% crospovidone (V).
10.6.3 Stability of paracetamol tablets produced by single-step granulation/tabletting
As it is known that tablet properties can be affected by storage conditions, the stability
of tablets produced by single-step granulation/tabletting was evaluated during one
year storage at 60% RH-25°C and 75% RH-40°C. This stability study was performed
on tablets without PVP containing 20% paracetamol and with 2.5% PVP containing
80% paracetamol.
Table 2 shows the influence of storage on the properties of those tablets. It is obvious
that storage had no significant influence on the tensile strength, but resulted in a
significant increase in the disintegration time for both formulations studied. However,
the disintegration time remained below 5 min. The increase in disintegration time
could be explained by a minor decrease in the tablet porosity. Additional porosity
measurements after one year revealed that storage of tablets at 75% RH–40°C resulted
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in a reduction of the porosity from 23 and 22% to 18.7 (± 0.85) and 19.3% (± 0.73)
for formulations containing 20 and 80% paraceatmol, respectively. However, no
influence on the tablet porosity was observed for tablets stored at 60% RH–25°C. For
both formulations no change in dissolution profile was observed over a period of one
year as shown in Fig. 5.
It is clear that paracetamol tablets produced by single step-granulation/tabletting were
not influenced by the storage conditions. After a storage period of one year, these
tablets had a high tensile strength, fast disintegration time and a dissolution profile
that complied with the pharmacopoeial requirements. Whereas, paracetamol tablets
produced by compression after wet granulation exhibited a significant increase in the
tablet tensile strength and disintegration time and a slower dissolution after storage,
even though they contained disintegrant (Khatab et al., 1993; Sarisuta and Parrot,
1988).
Table 2: The influence of storage on the properties of tablets (without PVP)
containing 20% paracetamol and tablets (with 2.5% PVP) containing 80%
paracetamol produced by single-step granulation/tabletting.
Time Paracetamol PVP Tensile strength Friability Disintegration Tensile strength Friability Disintegration
(d) (%) (%) (MPa) (%) (s) (MPa) (%) (s)
1 20 0 0.84 (0.19) 0.44 32 (6) 0.88 (0.12) 0.84 36 (8)
60 0.76 (0.11) 0.68 39 (5) 1.07 (0.14) 0.66 72 (29)
180 0.81 (0.19) 0.83 33 (17) 0.98 (0.25) 0.68 86 (19)a
360 0.88 (0.20) 0.88 70 (15)a 0.95 (0.18) 0.68 119 (20)a
1 80 2.5 1.39 (0.21) 0.99 112 (23) 1.24 (0.11) 1.02 91 (18)
60 1.40 (0.27) 0.95 109 (23) 1.37 (0.32) 0.75 121 (23)
180 1.43 (0.21) 0.72 130 (31) 1.42 (0.22) 0.97 173 (25)
360 1.50 (0.47) 0.97 201 (31)a 1.27 (0.37) 0.83 210 (48)a
75% RH - 40°C60% RH - 25°C
a Significantly different from the other values in the same group.
Standard deviations are given between parentheses
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a
b
Figure 5: Dissolution profiles of (a) tablets containing 20% paracetamol without PVP
and (b) tablets with 2.5% PVP containing 80% paracetamol prepared by
single-step granulation/tabletting after storage for 1 (O), 90 (Q), 270 (V),
and 360 days (    ) at 60% RH–25°C (    )  and at 75% RH– 40°C (  ),
respectively
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10.7 Conclusion
From these experiments it can be concluded that single-step granulation/tabletting
allowed to produce acceptable tablets at a higher drug level than conventional high
shear granulation and compression. Single-step granulation/tabletting allows to
produce paracetamol and cimetidine tablets with acceptable tensile strength, fast
disintegration time and dissolution profile that complied with the pharmacopoeial
requirements up to a drug load of 80%. However, addition of PVP and incorporation
of 5% crospovidone allowed to produce tablets containing 92.5% paracetamol or
cimetidine that complied with the pharmacopoeial requirements.
The paracetamol tablets and the cimetidine tablets produced by single-step
granulation/tabletting exhibited a higher tensile strength and faster disintegration
compared with tablets produced by compression after high shear granulation.
Paracetamol tablets produced by single-step granulation/tabletting were not
influenced by the storage conditions investigated over a period of one year.
It can be concluded that single-step granulation/tabletting is an efficient tool for the
preparation of tablets of highly dosed drugs and can significantly improve their tablet
properties.
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11 Physical stability of tablets: a comparison between single step
granulation/tabletting and compression
Submitted for publication in Int. J. Pharm.
11.1 Introduction
Physical tablet properties may be altered during storage, the effect of storage depending on
the physical properties of the raw materials (crystallinity, solubility, etc.), the manufacturing
process and the storage conditions (time, relative humidity and temperature). The most
commonly occurring physical changes are tablet hardening and softening. These changes are
suggested to be due to changes in the bonding between particles. Tablet hardening is mainly
attributed to the formation of solid bridges between particles or an increase in the bonding
surface area, while tablet softening is mainly due to the disruption of the bonds formed during
compaction (e.g. transition of amorphous molecules from a glassy state to a rubbery state).
As these phenomena are not always reversible tablet properties not only depend on the actual
storage conditions, but can be dramatically affected by prior storage (Riepma et al., 1992;
Alderborn and Ahlneck, 1991; Kiekens et al., 2000; Stubberud et al., 1996a and b).
Continuous single-step granulation/tabletting was reported to be a promising and robust
technique, yielding good quality tablets for formulations with poor compactibility or
disintegration properties (Keleb et al., 2001, 2004). These tablet properties were explained by
a different mechanism of tablet formation, i.e. by solid bridges rather than by short distance
forces as in compressed tablets (Vermeire et al., 2004). As modifications at the bonding sites
induce physical changes, the physical stability of tablets prepared by both techniques (single-
step granulation/tabletting vs. compression) might be different. Because solid bridges are the
dominating bonding mechanism in tablets prepared by single-step granulation/tabletting,
these tablets might not harden on storage. Moreover, single-step granulation/tabletting yields
tablets with a different internal structure, and are possibly differently affected by glass-to-
rubber transitions of amorphous material. The effect of storage conditions on lactose
compacts and lactose/PVP compacts has been studied previously. From these studies it was
clear that α-lactose monohydrate tablets can harden on storage and that transferring the
tablets from a high to a low relative humidity environment caused a dramatic increase in
tensile strength. These changes were attributed to the formation of solid bridges (Riepma et
al., 1992; Stubberud et al., 1996). The presence of PVP was reported to weaken the compacts
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when stored at high relative humidity. Because of the glass-to-rubber transition of amorphous
PVP (Stubberud et al., 1996).
The aim of the present study was to investigate the influence of storage conditions on the
physical stability of α-lactose monohydrate tablets prepared by single-step
granulation/tabletting. To evaluate whether the behaviour during storage could be related to
the bonding mechanism, tablets manufactured by conventional compression were evaluated
in parallel.
11.2 Materials
α-Lactose monohydrate (Pharmatose 200M) was used as the excipient (DMV, Veghel, The
Netherlands) and polyvinylpyrrolidone (PVP, Kollidon K30, BASF, Ludwigshafen,
Germany) as a binder.
11.3 Methods
11.3.1 Preparation of tablets
α-Lactose monohydrate tablets without and with 2.5% (w/w) PVP were prepared by single-
step granulation/tabletting, by extrusion/granulation + compression, by high shear granulation
+ compression and by direct compression.
Extrusion/granulation and single-step granulation/tabletting were performed on a MP 19 TC
25 laboratory scale co-rotating twin screw extruder (APV Baker, Newcastle-under-Lyme,
UK) having a length - to - diameter ratio of 25/1 and equipped with a standard screw profile
with two mixing sections and a die block. The α-lactose monohydrate powder and the
granulation liquid (pure water or an aqueous PVP solution) were fed into the first zone of the
extruder barrel. The powder was fed on top of the screws using a screw operated feeder,
while the liquid was pumped into the extruder barrel by means of a peristaltic pump (Watson
Marlow, Cornwall, UK). The extrudates were collected 10 min after the process was started
in order to allow the system to equilibrate. During processing the extruder was set at a
constant temperature (25°C) and the powder volume in the feed hopper was maintained at a
constant level (85 – 100% of the total feeder capacity).
For the single-step granulation/tabletting process a 9 mm die was attached to the extruder
outlet. Processing parameters were: a screw speed of 250 rpm, a total input rate (powder feed
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rate + liquid feed rate) of 5.6 kg.h-1 and a water concentration during extrusion of 11.5 and
9.5% (w/w) for the formulation without and with PVP, respectively. Immediately after
extrusion, tablets (thickness: 4 mm) were manually cut using surgical blades and oven-dried
for 20 h at 25°C (Keleb et al., 2001).
Extrusion/granulation was performed at a screw speed of 250 rpm, a total input rate of 5.6
kg.h-1 and a water concentration during extrusion of 7.5% (w/w). Immediately after extrusion
the extrudates (400 g) were wet sized using a 1 mm oscillating sieve (Frewitt, Fribourg,
Switzerland), operated at a minimal distance between rotor and sieve, and were oven-dried
for 20 h at 25°C (Keleb et al., 2002). Prior to compression, the granules (F250-710µm) were
blended with 0.5% (w/w) magnesium stearate (<90 µm) (BUFA, Brussels, Belgium) in a
Turbula mixer (W.A. Bachofen, Basel, Switzerland) for 1 min. Granules were compressed into
tablets (250 mg) using an eccentric compression machine (Korsch EKO, Berlin, Germany)
equipped with a flat faced double punch of 9 mm diameter at a compression force of 154 MPa.
High shear granulation was performed in a Gral 10 (Machines Collette, Wommelgem,
Belgium) at an impeller speed of 500 rpm, a chopper speed of 3000 rpm, a total load of 0.16
kg.l-1 and a water concentration of 10% (w/w). After mixing the powder for 2 min, the
required amount of granulation liquid (water or an aqueous PVP solution) was continuously
added over a period of 10 min using a peristaltic pump (Watson Marlow, Cornwall, UK). Wet
massing was continued for 2 min following complete liquid addition. The granules were
oven-dried for 20 h at 25°C. Tablets were prepared from these granules as described above.
Tablets were also prepared by direct compression. Formulations with PVP could not be
evaluated as tablets with a too low tensile strength were obtained. α-Lactose monohydrate
was mixed with magnesium stearate and compressed as described above for the granules.
11.3.2 Storage conditions of tablets
The effect of relative humidity (RH) and temperature during short and long term storage on
the tablet properties was studied.
11.3.2.1 Short term storage
α-Lactose monohydrate tablets (n=30), produced by single-step granulation/tabletting and by
compression of granules made by extrusion/granulation, were stored at 33, 60, 75 and 93%
RH (25°C). After 24 hrs the tensile strength of 6 tablets was determined, while the tablets
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(n=24) remaining at each RH were evenly distributed for storage at the different RH’s. After
another 24 hrs of storage the tensile strength of all tablets was determined.
In another experiment α-lactose monohydrate tablets (produced using the different
techniques under evaluation) were stored for 10 days (25°C), alternating the storage
conditions every 24 hrs between 33 and 75% RH. Tablets prepared by extrusion granulation
+ compression were also stored for 6 days, alternating the RH every 24 hrs between 33 and
93% (25°C).
The effect of storage temperature was evaluated by storing tablets (produced using the
different techniques under evaluation) for 10 days at constant RH (33%), alternating the
temperature every 24 hrs between 25 and 40°C.
11.3.2.2 Long term storage
α-Lactose monohydrate tablets (produced by single-step granulation/tabletting and by
compression of granules made by extrusion granulation) were stored for one month at 33, 75
and 93% RH (25°C).
In addition α-lactose monohydrate tablets (produced by compression of granules made by
extrusion/granulation) were stored for 2 months at 33 and 75% RH, alternating the RH every
month between both conditions. During the first month part of the tablets was stored at 33%
RH and part at 75% RH. This experiment was performed at 25 and 40°C.
α-Lactose monohydrate tablets (produced by single-step granulation/tabletting and by
compression of granules produced by extrusion granulation) were also stored for 15 months
at 25°C/60% RH and at 40°C/75% RH. Next the tablets were transferred to 25°C/33% RH for
24 hrs.
11.3.3 Tablet tensile strength
The same method as described in Chapter 3 was used to determine the tensile strength of the
tablets.
11.3.4 Differential scanning calorimetry
Samples of 5 mg PVP were stored in aluminium pans at 25°C (33 and 75% RH) and 40°C
(33 and 75% RH) for 1 and 7 days. In addition samples were initially stored for 7 days at
33% RH (or 75% RH) and were then transferred to 75% RH (or 33% RH) for 24 hrs. The
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samples were analysed in hermetically sealed aluminium pans by modulated differential
scanning calorimetry (MDSC 2920, TA Instruments, New Castle, DE, US). The sample was
cooled at rate of 10°C/min to –35°C and maintained at –35°C for 5 min. Afterwards the
sample was heated to 80°C at a rate of 2°C/min, a modulation amplitude of 0.5°C and a
period of 60s. The glass transition temperatures were determined using peak analysis.
11.4 Statistical analysis
Statistically significant differences between the formulations, manufacturing techniques,
storage conditions and storage time were determined using ANOVA. The data were tested for
normal distribution with a Kolmogorov-Smirnov test. The homogeneity of variances was
tested with the Levene’s test. To further compare the effects a multiple comparison among
pairs of means was performed using a Scheffé test with P<0.05 as significance level. For
statistical analysis SPSS version 11.0 was used.
11.5 Results and discussion
11.5.1 Physical stability during storage at constant RH and temperature
Table 1 shows the influence of RH during storage on the tensile strength of α-lactose
monohydrate tablets (prepared by single-step granulation/tabletting and compression of
granules made by extrusion granulation). Comparison (one-way ANOVA) of the tablet
tensile strength after storage at different RH revealed that the tensile strength significantly
decreased with increasing RH, this effect was more pronounced for the tablets containing
PVP as a binder. The decrease in tensile strength for these tablets observed ≥75% RH is due
to the glass-to-rubber transition of PVP as confirmed by the glass transition temperature (Tg)
of PVP samples stored at different conditions (Table 2). These data show that already after 1
day at ≥75% RH the Tg of PVP was reduced below the storage temperature, inducing a
transition of PVP from its rigid glassy state to a mobile rubbery state. A similar reduction of
Tg in function of RH was reported by Oksanen and Zografi (1990). The decrease in tensile
strength of compacts containing PVP stored at high RH confirmed earlier findings (Kiekens
et al., 2000; Stubberud et al., 1996a and b). The decrease in tensile strength of tablets
formulated without PVP and prepared by single-step granulation/tabletting at 93% RH could
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be explained by moisture absorption of α-lactose monohydrate above 90% RH (Kibbe, 2000,
Alderborn and Ahlneck, 1991), moisture weakening the structure of tablets as it dissolves the
solids after condensation on internal pore surfaces.
Table 1: Tensile strength (MPa)(mean ± sd, n=6) of α-lactose monohydrate tablets (produced
by single-step granulation/tabletting and by compression of granules made by
extrusion/granulation) after storage at 33, 75 and 93% RH (25°C).
PVP
(%)
Storage time
(days)
Tensile strength (MPa)
33% R.H. 75% R.H. 93% R.H.
Extrusion granulation + compression
0 1 0.56 ± 0.09 0.62 ± 0.06 0.50 ± 0.03
7 0.58 ± 0.05 0.62 ± 0.06 0.45 ± 0.02
14 0.54 ± 0.10 0.60 ± 0.03 0.46 ± 0.02
28 0.40 ± 0.14 0.50 ± 0.04 0.48 ± 0.02
2.5 1 0.96 ± 0.15 0.80 ± 0.10 0.46 ± 0.02
7 1.26 ± 0.20 0.78 ± 0.08 0.42 ± 0.02
14 1.38 ± 0.11 1.19 ±  0.08 0.39 ± 0.02
28 1.44 ±  0.13 1.42 ± 0.05 0.41 ± 0.01
Single-step granulation/tabletting
0 1 0.94 ± 0.15 0.99 ± 0.10 0.75 ± 0.07
7 1.06 ± 0.12 1.08 ± 0.07 0.85 ± 0.18
14 0.97 ±  0.14 1.02 ± 0.10 0.72 ± 0.09
28 1.15 ± 0.27 1.10 ± 0.13 0.79 ± 0.13
2.5 1 1.57 ± 0.18 1.07 ± 0.20 0.37 ± 0.12
7 1.56 ± 0.17 1.14 ± 0.26 0.29 ± 0.06
14 1.56 ± 0.24 1.00 ± 0.09 0.33 ± 0.14
28 1.59 ± 0.12 1.02 ± 0.14 0.18 ± 0.04
Table 2: Glass transition temperature (Tg)(°C) of PVP samples stored at different conditions
of relative humidity (RH) and temperature.
Storage conditions
Storage time
25°C/33% RH 25°C/75% RH 40°C/33% RH 40°C/75% RH
1 day 63.2 27.1 57.1 17.8
7 days 59.4 21.0 58.2 23.1
7 days at 75% RH +1 day 57.7 64.2
1 week at 33% RH +1 day 23.0 22.2
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This phenomenon did not affect the tensile strength of compressed tablets as their denser
structure allows less moisture to be absorbed. Moreover, in a dense compact dissolution of
only a small part of lactose will have less effect on the tablet structure.
The tensile strength remained unchanged during storage for one month at the different
conditions, except for the compressed tablets containing PVP as their tensile strength
significantly increased during storage at 33 and 75% RH. The gradual increase in tensile
strength at 33% RH is probably due to recrystallisation of PVP, thus forming additional solid
bridges in the internal tablet structure. The increase in tensile strength at 75% RH could not
be due to recrystallisation of PVP as at this RH PVP is expected to weaken the tablets (Table
2). As this increase was not observed during storage of pure α-lactose monohydrate tablets,
this increase in tensile strength must be due to a combined effect of α-lactose monohydrate
and PVP. As PVP is hygroscopic and will cause more moisture to be absorbed in the
compacts (Stubberud et al., 1996a), it is assumed that the higher moisture content in tablets
containing PVP allowed partial dissolution and resolidification of α-lactose monohydrate.
Besides, the presence of rubbery PVP facilitated rearrangement of solid material at the
particle surface area resulting either in the formation of solid bridges or in an increased
bonding surface area, two mechanisms contributing to an increase in tensile strength
(Alderborn and Ahlneck, 1991). The higher tensile strength of the compressed tablets
containing PVP after one month storage at 75% RH in comparison with tablets prepared by
single-step granulation/tabletting can be explained by their different internal tablet structure.
As compressed tablets are much denser the continuous swelling and recrystallisation of PVP
in combination with the migration of rubbery PVP in the compressed tablets probably
resulted in numerous solid bridges and hence a higher bonding surface area. Whereas in the
porous tablets prepared by single-step granulation/tabletting the weakening effect of the
rubbery PVP on the solid bridges predominated.
No change in tensile strength was observed during long term storage independently of the
production technique (Fig. 1). This seemed in contradiction with the increase in tensile
strength observed for compressed tablets during one month storage at 25°C/75% RH (Table
1). Comparison of the tablet strength at 40°C/75% RH, with the one obtained at 25°C/75%
RH revealed that after one day at 40°C a similar tensile strength was obtained as after one
month at 25°C. This suggests that the same phenomena occur at both temperatures. At both
temperatures the transition of PVP occurred during the first day, as shown by DSC analysis
of PVP samples (Table 2).
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a.
b
Figure 1: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets, prepared by
compression of granules prepared by extrusion/granulation (EG + C) and single-
step granulation/tabletting (S-S G/T) after storage for 1 day, 1, 3, 6, 12 and 15
months at 60% RH/25°C and at 75% RH/40°C. After 15 months storage, the
tablets were transferred to 33% RH/25°C for 24 hours. (a) tablets without binder,
(b) tablets with 2.5% PVP
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However, at 40°C the formation of additional solid bridges was already completed within the
first day, whereas at 25°C this phenomenon proceeded at a slower rate.
11.5.2 Influence of changing storage conditions
The effect on the physical tablet properties of varying RH during storage was determined
during a 2-day storage experiment (Fig. 2): after 24 hrs storage at the initial RH conditions,
the tablets were transferred to the final RH and stored for another 24 hrs. Two-way ANOVA
of the tensile strength values obtained revealed in all cases a significant (P<0.001) interaction
between the effect of the initial and the final RH as well as a significant (P<0.05) main effect
of the initial and the final RH. The effect of the initial RH clearly depended on the
manufacturing technique. A lower RH during the second day of storage (final RH) compared
with the first day (initial RH) did not affect the tensile strength of tablets prepared by single-
step granulation/tabletting, whereas it induced an increase in tensile strength for compressed
tablets. For pure α-lactose monohydrate tablets prepared by compression a significant
increase in tensile strength was only observed after initial storage at 93% RH. This could be
explained by the dissolution of α-lactose monohydrate as described previously. For
compressed tablets containing PVP, a significant increase in tensile strength was already
observed after initial storage at 75% RH. This increase was larger than for the pure α-lactose
monohydrate tablets and was due to the additional effect of the rubber-to-glass transition of
PVP, which occurred at ≥ 75% RH. The magnitude of this effect increased with increasing
difference between the initial and final RH. Contrary to initial storage at a higher RH, initial
storage at a lower RH did not affect the tensile strength, except for PVP-containing tablets
prepared by single-step granulation/tabletting where a lower tensile strength was obtained at a
RH of 93 % after initial storage at 75% RH. A similar effect, though not significant, was
observed for compressed tablets. These results were in agreement with the weakening effect
of long term storage at 75% RH (Table 1). The results of this experiment clearly indicated
that tablets produced by single-step granulation/tabletting do not harden on storage, even at
conditions inducing hardening of the compressed tablets. However, tablet weakening by
glass-to-rubber transition is more pronounced in these tablets compared to compressed
tablets.
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a.                                                                                             b.
 c.                                                                                               d.
Figure 2: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets, prepared by
compression of granules produced by extrusion/granulation (a and b) and single-
step granulation/tabletting (c and d). After 24 hrs storage at the initial RH
conditions, the tablets were transferred to the final RH and stored for another 24
hrs. (a) and (c) tablets without binder, (b)and (d) tablets with 2.5% PVP.
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a.
b.
Figure 3: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets, prepared by
high shear granulation + compression (HSG + C), extrusion granulation +
compression (EG + C), direct compression (DC) and single-step
granulation/tabletting (S-S G/T). Tablets were stored (25°C) for 10 days at 33 and
75% RH, alternating the RH every 24 hrs between both conditions. (a) tablets
without binder, (b) tablets with 2.5% PVP.
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Figure 4: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets without and
with 2.5% PVP, prepared by compression of granules prepared by
extrusion/granulation. Tablets were stored (25°C) for 6 days at 33 and 93% RH,
alternating the RH every 24 hrs between both conditions.
To determine whether these phenomena were reversible tablets were transferred to different
storage conditions every 24 hrs. The effect on the tablet tensile strength of storage conditions
alternating every 24 hrs between 33 and 75%, between 33 and 93%, and between 25 and
40°C is shown in Fig. 3, 4 and 5, respectively. Independent of the manufacturing technique
daily changing RH between 75 and 33% only significantly affected the tensile strength of α-
lactose monohydrate tablets containing PVP. The tensile strength obtained at 33% RH after
prior storage at 75% RH was higher than without prior storage at 75% RH. The increase in
tensile strength was completely reversible during the entire test period and was independent
of the number of RH changes for tablets prepared by single-step granulation/tabletting.
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Figure 5: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets, prepared by
high shear granulation + compression (HSG + C), extrusion/granulation +
compression (EG + C), direct compression (DC) and single-step
granulation/tabletting (S-S G/T). Tablets were stored (33% RH) for 10 days at 25
and 40°C, alternating the temperature every 24 hrs between both conditions. (a)
tablets without binder, (b) tablets with 2.5% PVP.
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Figure 6: Tensile strength (mean ± sd, n=6) of α-lactose monohydrate tablets with 2.5%
PVP, prepared by compression of granules prepared by extrusion/granulation.
Tablets were stored (25 and 40°C) for 2 months at 33 and 75% RH, alternating the
RH every month between both conditions.
However, tensile strength increased with increasing number of changes in case of the
compressed tablets as during each storage period at high RH, additional contact points were
formed by swelling and migration of the rubbery PVP between the lactose particles. In case
of the tablets prepared by single-step granulation/tabletting, having a more porous structure,
the increase in tensile strength was unlikely to be caused by the formation of additional
contact points, but solely to the rubber-to-glass transition of PVP, which is a reversible
phenomenon (Mc Phillips et al. 1999).
A significant increase in tensile strength was seen at 33% RH for tablets (with and without
PVP) prepared by compression of granules made by extrusion when RH during storage
alternated daily between 93 and 33% RH (Fig. 4). It was interesting to observe that for pure
α-lactose monohydrate tablets the tensile strength at 93% RH gradually increased with the
number of changes to a value similar as the one obtained at 33% RH. This clearly confirmed
that hardening of α-lactose monohydrate tablets only occurred after initial storage above the
critical RH at which sufficient moisture is absorbed to allow partial dissolution. In tablets
containing PVP, significantly higher tensile strengths were recorded than those observed
under any condition for tablets prepared by single-step granulation/tabletting. This could
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again be explained by a combination of additional solid bridges formed by α-lactose
monohydrate and the rubber-to-glass transition of PVP.
Changing the storage temperature revealed a significant increase in tensile strength at 40°C
after prior storage at 25°C (Fig. 5). As for RH, these changes depended on the formulation as
well as on the manufacturing technique. Tablets prepared by single-step
granulation/tabletting were not affected by changing the temperature, whereas tablets
prepared by compression of granules tended to get stronger on repeatedly transferring the
tablets between both temperatures (especially when containing PVP). This effect is explained
by the condensation of moisture, which occurs more easily in smaller pores resulting in the
formation of solid bridges (Ahlneck and Alderborn, 1989a and b).
In addition to the effect of the number of changes, the effect of the initial storage period after
which conditions were altered was also evaluated. Comparison of these tensile strength
values with those obtained after daily changing, revealed that changing RH after one month
from 75% to 33% RH resulted in higher tensile strength (2.69 MPa) than changing after one
day (1.80 MPa), but the effect remained reversible. Studying the effect of changing RH after
one year revealed that this did not cause an additional increase in tensile strength (2.50 MPa).
These results indicated that although time and temperature enhance the formation of solid
bridges, at a certain level not much more additional contact points can be formed that
significantly contribute to tablet hardening.
11.6 Conclusion
From these results it was concluded that tablets produced by single-step
granulation/tabletting, where bonding mainly occurred by solid bridges, were not affected by
storage conditions that showed to induce hardening of compressed tablets (time, temperature
and changing from high to low RH). However, due to their porous structure these tablets are
more susceptible to tablet weakening by glass-to-rubber transition of the binder (PVP).
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General conclusion and recommendations
The increasing demand for granulation and the discovery of new drugs that are potent
or expensive urge the development of new wet granulation techniques, which
complies with the GMP requirements, operated in a continuous way and possibly
conducted in a closed circuit with the possibility of automation. Although extrusion
has been studied as a granulation technique research on this topic are sparse.
Therefore this study was aim to develop continuous wet granulation processes based
on cold extrusion technology.
Extrusion granulation using twin screw extruder was the first process studied.
Evaluations conducted on extrusion granulation revealed a semi-continuous process
resulting in better granule and tablet properties compared to the conventional high
shear granulation. In order to have a continuous granulation process based on
extrusion granulation, some modifications were carried out on the twin screw
extruder. Modification of screw profile and removal of the extruder die block resulted
in elimination of the wet sizing step as during extrusion granulation where a
continuous production of granules was obtained. This process showed a high
efficiency for continuous granulation of pharmaceutical formulations, even for
formulations that were difficult to process using high shear granulation. This novel
technique was called continuous twin screw granulation (CTSG).
Single-step granulation/tabletting was also developed in order to improve tablet
properties and eliminate a compression step. This process resulted in tablets with
higher quality than those produced by compression. The bonding mechanism involved
during single-step granulation/tabletting is behind the improvement of the tablet
properties. Study of the mechanism showed that tablets produced by single-step
granulation/tabletting are bound by solid bridges with a high porosity, whereas
compressed tablets were bound by intermolecular forces with a much lower porosity.
In addition those tablets did not harden during storage at different conditions, but
were more susceptible to the influence of storage conditions when containing PVP.
In general this study presented a promising techniques for continuous wet granulation,
however further work is recommended. As further research work the following
suggestions are formulated:
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• To assess the possibility of using larger continuous twin screw granulators based
on geometrical similarities with continuous twin screw granulator.
• The uniformity of active components within granules especially for low dosed and
micronized drugs after twin screw granulation and single step
granulation/tabletting processes.
• Optimization of the properties of tablets produced by single step
granulation/tabletting in order to reduce weight variation and improve tablet
appearance.
• Assess the possibility of continuous drying by optimization of the formulation
variables and incorporation of a drying device that allow continuous drying in a
short period of time.
• The study of the granulation mechanism during twin screw granulation.
• Assess the feasibility of controlling granule properties like porosity and particle
size distribution by machine modification and optimization of processing
parameters.
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Summary
In the pharmaceutical industry wet granulation is considered the most important
process in manufacturing of solid dosage forms. The majority of the granulation
processes are batch processes, which often showed problems during product
development and scaling up. The increase demand for granules and the development
of new expensive and potent drugs urged further research for the development of a
contained and integrated wet granulation process with the possibility of continuity and
automation. In recent years few continuous wet granulation processes were
established. Those processes are reviewed in Chapter 1. Extrusion granulation was
among those techniques, and was not subjected to extensive research. Chapter 1
illustrates different types of extruders with a detailed description of the twin screw
extruder.
This thesis aimed at evaluating the feasibility of using twin screw extrusion for wet
granulation and to develop a continuous wet granulation process that fulfils the needs
of the pharmaceutical industry. The objectives of this study are listed in Chapter 2.
Chapter 3 describes extrusion granulation as a semi-continuous wet granulation
process. During this process the extrudates were produced and wet sized. The
influence of processing parameters and formulation variables on the properties of α-
lactose monohydrate 200M granules was evaluated. Tablets were produced from the
250-710 µm granule fraction and were evaluated. The properties of granules and
tablets obtained by extrusion granulation were compared with those obtained after
high shear granulation. Results showed that granules prepared by extrusion had a higher
quality than those obtained by high shear granulation.
The extrusion granulation process was used for the granulation of different types of
lactose and also for formulations containing paracetamol and cimetidine. Granules
and tablets were evaluated and compared with those produced by high shear
granulation. The different lactose grades had an important effect on the extrusion
granulation process, but had only a minor influence on the granule and tablet
properties obtained by extrusion granulation however, the lactose grades had a major
influence on the granule properties obtained by high shear granulation.
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Granules and tablets of paracetamol and cimetidine prepared by extrusion granulation
exhibited higher qualities than those produced by high shear granulation. Chapter 4.
In Chapter 5 the modification of a twin screw extruder for continuous wet granulation
was investigated. Modification of the extruder set-up as well as the screw design
allowed the continuous wet granulation of α-lactose monohydrate 200M without the
need of a wet sieving step. This new machine set-up was termed continuous twin
screw granulation. The influence of processing parameters and formulation variables
on the process performance and on the properties of granules and tablets was evaluated.
Granules and tablets obtained showed good properties. Meanwhile no problems were
observed during continuous twin screw granulation over a period of 8 h and the
granule and tablet properties were reproducible throughout the process.
In Chapter 6 the efficiency and robustness of continuous twin screw granulation was
assessed. The process was applied to different types of lactose, paracetamol and
cimetidine. Granules produced were evaluated. Tablets were made from those
granules and were also evaluated. The lactose grades had an important effect on the
continuous twin screw granulation process but had only a minor influence on the
granule and tablet properties obtained. Granulation of cimetidine and paracetamol
exhibited a high yield and a low friability. Tablets made using those granules showed
good properties. The results obtained indicated that continuous twin screw granulation
is efficient wet granulation technique.
In Chapter 7 the feasibility of cold extrusion as a continuous granulation/tableting
technique was investigated. α-Lactose monohydrate 200M extrudates were produced
using twin-screw extrusion, cut manually into tablets and dried. The influence of
formulation and process parameters on the process and on the tablet properties was
evaluated. Formulation as well as process parameters affected the process feasibility,
but had only a minor effect on the tablet properties. This technique allows single-step
granulation/tableting of pure α-lactose monohydrate indicating that cold extrusion
could be used as alternative tablet production technique for ingredients with poor
compaction properties. All α-lactose monohydrate tablets without and with PVP
produced at optimum conditions showed a high tensile strength and fast disintegration
time. This high tensile strength and fast disintegration was attributed to the bonding
mechanism. This bonding mechanism was evaluated in Chapter 8 where tablets
containing α-lactose monohydrate, paracetamol, cimetidine and PVP were prepared
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using single-step granulation/tabletting, high shear granulation/compression, extrusion
granulation/compression and direct compression. The internal tablet structure was
analysed by SEM and porosity measurements. The bonding mechanism was assessed
by calculation of the interaction factor and determination of the electrical
conductivity. Analysis of the internal tablet structure revealed that tablets prepared by
single-step granulation/tabletting had a porous, sponge like structure, while the
compressed tablets showed a dense structure. Tablets manufactured by single-step
granulation/tabletting had a higher interaction factor and a significantly lower
resistivity than compressed tablets, indicating that solid bridges were involved.
In Chapter 9 the influence of the lactose particle size, morphology and crystallinity on
the single-step granulation/tabletting and on the quality of tablets obtained were
investigated. Results showed that particle size and type of lactose affected the powder
feeding, the process performance as well as the process capacity. Different grades of
lactose yielded tablets with similar tensile strength, but significantly different
disintegration time. Single-step granulation/tabletting always yielded tablets with a
significantly higher tensile strength and similar or significantly lower disintegration
time compared to high shear granulation and compression. The properties of α-lactose
monohydrate tablets without and with PVP, did not change during one year of storage
at 60% RH-25°C and at 75% RH-40°C.
In Chapter 10 Paracetamol tablets and cimetidine tablets were prepared by single-step
granulation/tabletting and by compression after high shear granulation and were
compared. Paracetamol tablets and cimetidine tablets obtained by single-step
granulation/tabletting exhibited a significantly higher quality compared to those
prepared by compression after high shear granulation. Single-step
granulation/tabletting allowed to produce tablets containing up to 80% paracetamol or
cimetidine with a dissolution profile complying with the USP requirements. Long
term and accelerated stability studies of paracetamol tablets produced by single-step
granulation/tabletting over a period of one year showed no significant influence on the
tablet tensile strength, friability and dissolution. These results indicated that single-
step granulation/tabletting could be an efficient technique for the production of highly
dosed drugs such as paracetamol and cimetidine.
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In Chapter 11 The influence of storage conditions (relative humidity, temperature and
time) on the stability of α-lactose monohydrate 200M tablets prepared by single-step
granulation/tabletting was studied and compared with tablets produced by
compression. The study involved storage of tablets at different humidity and
temperature for short and long term. In addition repeatedly changing the humidity and
temperature storage conditions was also evaluated. Results obtained after storing
tablets for short term showed that increasing relative humidity to 93% decreased
tablet tensile strength. For tablets formulated with PVP the effect was more
pronounced and observed at 75% RH. Changing of relative humidity conditions did
not influence tablets without PVP produced by single-step granulation/tabletting,
whereas it influenced tablets produced by compression after extrusion granulation.
For tablets formulated with PVP changing of relative humidity conditions
significantly influenced tablets produced by both techniques. This effect is dependent
on the initial and final storage humidity conditions. In addition the number of
humidity grade changes did not result in a progressive increase in the tensile strength
for tablets produced by single-step granulation/tabletting, whereas tensile strength was
increased with increasing the number of changes for tablets produced by compression.
The temperature changes did not influence tablets produced by single-step
granulation/tabletting, whereas repeatedly changing storage temperature resulted in
stronger tablets for those prepared by compression after extrusion granulation. These
results indicated that tablets produced by single-step granulation/tabletting do not
harden during the storage conditions evaluated. However, these tablets were more
susceptible to the weakening effect when containing PVP.
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Samenvatting
Binnen de farmaceutische industrie wordt vochtige granulatie beschouwd als één van
de belangrijkste technieken voor het produceren van vaste doseringsvormen. Terwijl
de meeste granulatieprocessen batchgewijs verlopen is er – omwille van de
schaalvergroting binnen de farmaceutische wereld, de toenemende vraag naar
kwalitatieve granules en de synthese van nieuwe dure en sterk actieve geneesmiddelen
– nood aan volledig geïntegreerde granulatieprocessen welke de mogelijkheid bieden
op een continue manier te granuleren. Gedurende de laatste jaren werden reeds enkele
continue vochtige granulatietechnieken ontwikkeld welke beschreven worden in
Hoofdstuk 1. Eén van deze continue granulatiemethodes is extrusie/granulatie, een
techniek waaraan tot op heden weinig aandacht is besteed binnen de farmaceutische
industrie. Hoofdstuk 1 beschrijft eveneens de verschillende types extruders die
beschikbaar zijn met specifieke aandacht voor de ‘twin screw’ extruders.
Het doel van deze thesis (Hoofdstuk 2) is het potentieel na te gaan van ‘twin screw’
extrusie als vochtige granulatietechniek en een continu vochtig granulatieproces te
ontwikkelen dat volledig tegemoet komt aan de huidige noden van de farmaceutische
industrie.
Hoofdstuk 3 beschrijft extrusie/granulatie als een semi-continue vochtige
granulatietechniek, waarbij het noodzakelijk was het extrudaat vochtig te zeven
alvorens granules werden bekomen. De invloed van proces- en formulatieparameters
op de eigenschappen van α-lactose monohydraat 200M granules werd bepaald.
Tabletten werden gecomprimeerd met behulp van de 250-710 µm granulaatfractie. De
eigenschappen van granules en tabletten geproduceerd via extrusie/granulatie werden
vergeleken met deze van materiaal geagglomereerd via ‘high shear’ granulatie. De
resultaten toonden aan dat de granules geproduceerd via extrusie van een betere
kwaliteit waren in vergelijking met deze bereid via ‘high shear’ granulatie.
Het extrusie/granulatie-proces werd eveneens aangewend voor het granuleren van
verschillende types lactose en voor het agglomereren van formulaties op basis van
paracetamol en cimetidine (Hoofdstuk 4). Opnieuw werd de kwaliteit van de granules
en tabletten vergeleken met deze geproduceerd via ‘high shear’ granulatie. Het
gebruik van verschillende lactoses had een belangrijke invloed tijdens het
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extrusie/granulatie-proces, maar slechts een beperkte invloed op de granulaat- en
tableteigenschappen. Daarentegen was de kwaliteit van granules geproduceerd via
‘high shear’ granulatie wel afhankelijk van het type lactose. Granulaten en tabletten
geformuleerd met paracetamol of cimetidine en geproduceerd via extrusie/granulatie
waren van betere kwaliteit in vergelijking met deze geproduceerd via ‘high shear’
granulatie.
Hoofdstuk 5 beschrijft hoe de ‘twin extruder’ werd gemodificeerd (extruder set-up en
schroefdesign) zodat een volledig continu granulatieproces werd bekomen. Door
middel van deze continue ‘twin screw’ granulatie-methode was het mogelijk α-lactose
monohydraat 200M te agglomereren waarbij vochtig zeven niet noodzakelijk is. De
invloed van proces- en formulatieparameters op het granulatieproces en op de
granulaat- en tableteigenschappen werd bepaald. Zowel de granules als de tabletten
hadden goede eigenschappen. Uit een granulatieexperiment uitgevoerd over een
periode van 8 uren bleek dat de granulaat- en tableteigenschappen reproduceerbaar
waren gedurende het volledige proces.
In Hoofdstuk 6 wordt de efficiëntie en de robuustheid van de continue ‘twin screw’
granulatie-methode nagegaan, dit door formulaties op basis van verschillende types
lactose, paracetamol of cimetidine via deze techniek te agglomereren. Zowel de
granulaatkwaliteit als de kwaliteit van tabletten geproduceerd met deze granules werd
bepaald. Het type lactose had een belangrijke effect op het continue ‘twin screw’
granulatie-proces, maar het effect op de granulaat- en tablet-eigenschappen was
beperkt. Granulatie van cimetidine en paracetamol werd gekenmerkt door een hoge
opbrengst en een lage friabiliteit van de granules. Tabletten geproduceerd met deze
granulaten waren van goede kwaliteit. Deze resultaten toonden aan dat de continue
‘twin screw’ granulatie-methode een efficiënte vochtige granulatie-techniek is.
In Hoofdstuk 7 werden de mogelijkheden geëvalueerd van extrusie als continue
granulatie/tabletteer-techniek. Hierbij werden α-lactose monohydraat 200M
extrudaten geproduceerd via ‘twin-screw’ extrusie, welke manueel tot tabletten
werden gesneden en vervolgens gedroogd. De invloed van proces- en
formulatieparameters op het extrusieproces en de tableteigenschappen werd bepaald.
Hieruit bleek dat zowel de formulatie- als de procesparameters een invloed hadden op
het extrusieproces, terwijl de tableteigenschappen slechts in beperkte mate werden
beïnvloed. Aangezien deze ‘single-step’ techniek toelaat op een continue wijze
tabletten te produceren kan deze techniek aangewend worden als alternatieve methode
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voor het produceren van tabletten van materialen met beperkte compressie-
eigenschappen. Zowel de α-lactose monohydraat tabletten geformuleerd zonder als
met PVP hadden een hoge treksterkte en snelle desintegratietijd. Beide eigenschappen
zijn het gevolg van het specifieke bindingsmechanisme tussen de individuele partikels
in de tabletten geproduceerd via de extrusie/tabletteer-techniek. Het
bindingsmechanisme wordt bestudeerd in Hoofdstuk 8 waarbij tabletten op basis van
α-lactose monohydraat, paracetamol, cimetidine en PVP werden bereid zowel via
‘single-step’ granulatie/tabletteren, ‘high shear’ granulatie + compressie,
extrusie/granulatie + compressie als directe compressie. De interne tabletstructuur
werd geanalyseerd via scanning electronen microscopie en porositeitsmetingen. Het
bindingsmechanisme werd bepaald door het berekenen van de interactiefactor en door
het bepalen van de electrische geleidbaarheid. Analyse van de interne tabletstructuur
toonde aan dat tabletten geproduceerd via de ‘single-step’ granulatie/tabletteer-
techniek een poreuze, sponsachtige structuur hadden, terwijl tabletten geproduceerd
via klassieke compressie een dense structuur hadden. Tabletten geproduceerd via de
‘single-step’ granulatie/tabletteer-techniek hadden een hoge interactiefactor en een
significant lagere weerstand in vergelijking met gecomprimeerde tabletten, een
indicatie dat vaste bruggen worden gevormd tussen de individuele deeltjes.
In Hoofdstuk 9 wordt de invloed van de deeltjesgrootte, morfologie en kristalliniteit
van lactose op de ‘single-step’ granulatie/tabletteer-techniek en op de tabletkwaliteit
bepaald. De resultaten toonden aan dat zowel het voedingssysteem van het poeder als
het extrusieproces beïnvloed werden door de deeltjesgrootte en het type van lactose.
De verschillende lactoses resulteerden in tabletten met een gelijkaardige treksterkte,
maar een significant verschillende desintegratietijd. Via de ‘single-step’
granulatie/tabletteertechniek werden steeds tabletten geproduceerd met een significant
hogere treksterkte en een gelijkaardige of significant lagere desintegratietijd in
vergelijking met tabletten geproduceerd via ‘high shear’ granulatie en compressie. De
eigenschappen van α-lactose monohydraat tabletten geformuleerd zonder of met PVP,
wijzigden niet gedurende 1 jaar bewaring bij 60% RH/25°C en 75% RH/40°C.
In Hoofdstuk 10 werden paracetamol- en cimetidine-tabletten geproduceerd via de
‘single-step’ granulatie/tabletteer-techniek en via compressie na ‘high shear’
granulatie. De ‘single-step’ granulatie/tabletteer-techniek resulteerde in tabletten met
een significant betere kwaliteit en liet toe tabletten te produceren met 80%
geneesmiddelbelading (zowel voor paracetamol als cimetidine) waarbij de dissolutie-
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eigenschappen voldeden aan de eisen gesteld in de United States pharmacopoeia.
Zowel een lange-termijn stabiliteitsstudie over een periode van 1 jaar als een
versnelde stabiliteitsstudie toonden aan dat de eigenschappen van tabletten
(treksterkte, friabiliteit, dissolutie) geproduceerd via de ‘single-step’
granulatie/tabletteer-techniek geen significante wijzigingen ondergingen in functie
van de tijd.  Deze resultaten toonden aan dat de ‘single-step’ granulatie/tabletteer-
techniek een efficiënte methode is voor het produceren van tabletten beladen met
hooggedoseerde geneesmiddelen (vb. paracetamol, cimetidine).
In Hoofdstuk 11 wordt de invloed bepaald van bewaring (relatieve vochtigheid,
temperatuur en tijd) op de stabiliteit van α-lactose monohydrate 200M tabletten
geproduceerd via de ‘single-step’ granulatie/tabletteer-techniek in vergelijking met
tabletten geproduceerd via compressie. Hierbij worden de tabletten zowel gedurende
kortere periodes als gedurende langere periodes bewaard bij verschillende relatieve
vochtigheden en temperaturen.  De korte-termijn stabiliteitstudie toonde aan dat een
relatieve vochtigheid van 93% de treksterkte van de tabletten deed dalen. Voor
tabletten geformuleerd met PVP was deze daling meer uitgesproken en manifesteerde
deze zich reeds vanaf 75% RV. Het variëren van de relatieve vochtigheid gedurende
bewaren had geen invloed op tabletten (zonder PVP) geproduceerd via de ‘single-
step’ granulatie/tabletteer-techniek, terwijl dit wel het geval was voor tabletten
geproduceerd via compressie na extrusie/granulatie. In het geval van tabletten met
PVP beïnvloedde een verandering van relatieve vochtigheid de kwaliteit van tabletten
geproduceerd via beide technieken. In welke mate de tabletten beïnvloed werden was
afhankelijk van zowel de condities aan het begin als op het einde van de
bewaarperiode. Daarenboven resulteerde het aantal veranderingen van relatieve
vochtigheid niet in een progressieve toename van de treksterkte van tabletten
geproduceerd via de ‘single-step’ granulatie/tabletteer-techniek, terwijl dit wel het
geval was voor tabletten geproduceerd via extrusie/granulatie en compressie. De
temperatuur had geen invloed op tabletten geproduceerd via de ‘single-step’
granulatie/tabletteer-techniek, terwijl de treksterkte van tabletten geproduceerd via
compressie na extrusie/granulatie toenam. Deze studie toonde aan dat tabletten
geproduceerd via de ‘single-step’ granulatie/tabletteer-techniek niet uitharden onder
invloed van de geteste bewaarcondities. Hierbij dient wel opgemerkt te worden dat de
treksterkte van deze tabletten sneller daalde indien ze PVP bevatten.
